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The material properties of the mitral valve chordae tendineae are important for the 
understanding of leaflet coaptation configuration and chordal pathology.  However, there 
is limited information about the mechanical properties of the chordae during physiologic 
loading.  This research combines basic histology with standard mechanical tests to 
determine the functioning role of the chordae tendineae during the cardiac cycle. 
Dual camera stereo photogrammetry was used to measure strains of the chordae 
tendineae in vitro under normal physiologic loading conditions.  Two high speed (500 
fps); high resolution (1280 X 1023) cameras were set up to capture the movement of 
graphite markers attached to the central section of the chordae using autotracking 
software developed in house.  A uniaxial test simulating the same loading conditions as 
the left heart simulator was conducted on the same chordae using the same markers.  The 
final strain/time and load/time curves were correlated to the pressure distribution 
obtained from the flow loop measurements in order to determine the behavior of the 
chordae tendineae during the cardiac cycle.  Mitral valve chordae tendineae from fresh 
porcine hearts were stained for collagen and elastin using either a Verhoeff/van Gieson 
stain, or Verhoeff/light green stain.  Cellular distribution was determined using a 
Hematoxylin and Eosin stain.  Immunohistochemistry was used to verify the findings of 
vasculature.  Biochemical assays were performed to quantify DNA, collagen, and elastin 
content of each of the six different types of chordae tendinae.  
Six porcine mitral valves were used for the in vitro flow loop study.  It was found that the 
maximum strain experienced during the cardiac cycle was 4.29% ± 3.43% and was 
experienced at 249 msec after the start of valve closure.  The loading rate (valve closure) 
xvii 
 
was slightly higher at 75.3% ± 48.6% strain per second than the unloading rate (valve 
opening) at -54.8% ± -56.6% strain per second.  The strut chordae which inserted into the 
anterior lateral papillary muscle had a slightly higher maximum strain (5.7% ± 3.8%) and 
loading rate (80.5% ± 51.9% strain per second) than the strut chordae which inserted into 
the posterior medial papillary muscle (5.5% ± 2.3% strain and 68.1% ± 48.3% strain per 
second).  The strut chordae which inserted into the posterior medial papillary muscle had 
a higher unloading rate (-68.5% ± -59.1% strain per second) than the strut chordae which 
inserted into the anterior lateral papillary muscle (-44.9% ± -57.2% strain per second).   
Histological examination revealed blood vessels in both the longitudinal and 
circumferential directions of the chordae.  Each chordae contained vessels; however, it 
was found that the anterior strut chordae contain significantly more vessels than the other 
chordae.  The anterior strut chordae contained 4.73±3.13 vessels, the anterior marginal 
chordae contained 1.50±2.07 vessels, the commissural chordae contained 1.50±1.35 
vessels, the basal posterior chordae contained 1.27±1.74 vessels, the posterior 
intermediate chordae contained 1.43±1.13 vessels, and the posterior marginal chordae 
contained 1.00±1.53 vessels.  Different structural levels were observed for all chordae 
tendineae.  The inner layer was characterized by a higher concentration of collagen; 
whereas, the middle layer was mostly collagen with interwoven elastin fibers.  The 
collagen microstructure was characterized by directional crimping.  The Hematoxylin and 
Eosin stain showed fibroblasts evenly distributed throughout both the inner and outer 
layer of the chordae tendineae.       
The anterior and posterior marginal chordae contained statistically significantly more 
DNA per mg of tissue than the other chordae (p<0.01).  The anterior strut chord was 
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found to contain significantly less DNA per mg of tissue (0.63 ± 0.19 µg of DNA per mg 
of tissue dry weight) than all the other chordae (p<0.01).  There was no significant 
difference between the amount of DNA per mg of tissue for the commissural, posterior 
intermediate, and basal posterior chordae.  There was also no significant difference 
between the anterior (1.90 ± 1.14 µg of DNA per mg of tissue dry weight) and posterior 
(2.70 ± 1.24 µg of DNA per mg of tissue dry weight) marginal chordae. 
The collagen assay results showed that the posterior marginal chord contained 
significantly more collagen per mg of tissue than the other chordae (p<0.01).  The 
posterior marginal chordae contained 14.89 ± 6.83 µg of collagen per mg of tissue dry 
weight.  There was no significant difference between the other chordae.   
The Fastin Elastin assay results showed no significant difference in the amount of elastin 
per mg of tissue between the chordae.   
This study demonstrates the first in vitro examination of the strain experienced by the 
chordae tendineae of the mitral valve.  This technique allows the investigation of the 
behavior of biological tissues under physiologic loading conditions.  It was found that the 
chordae experience different strain rates in the loading and unloading phases when the 
valve opens and closes.  Three features can be observed from the uniaxial tests: a non-
linear stress-strain relationship; a hysteresis loop in cyclic loading and unloading; and 
preconditioning in repeated cycles which all are typical responses of biological soft 
tissues.  This suggests that the chordae exhibit similar material properties to those of 
tendons which are supported by their histological examination.   
Histological examination indicated that previous studies had not adequately described the 




were found in the chordae running from the papillary muscle to the insertion sites of the 
chordae on the mitral leaflets.  Chordae tendineae of the mitral valve have different 
microstructures according to chordal type.  Biochemical examination showed that the 
chordae contain different amounts of collagen, elastin, and DNA depending on chordal 
type.  It was concluded that the amounts of these different components is related to the 
function and location of the chordae.   
The findings in this study confirm that the mitral apparatus is composed of many 
components which work together in a complex, dynamic environment to ensure proper 
function.  Further understanding of the mitral apparatus, including the chordae tendineae, 
will help better define surgical techniques aimed at repairing the mitral valve to its 









In 2001, one-third of all deaths, 16.6 million people, were related to cardiovascular 
diseases, according to the World Health Organization[1].  By 2020, the World Health 
Organization estimates that approximately 25 million people will die each year from 
cardiovascular diseases.  The total cost spent on cardiovascular disease for the 
64,400,000 people that have cardiovascular disease was estimated at $368.4 billion[2].  
Since 1900, cardiovascular disease has been the number one killer in the United States.  
Nearly 2,600 Americans die of cardiovascular disease each day, an average of 1 death 
every 34 seconds.  Cardiovascular disease claims more lives each year than the next five 
leading causes of death combined, which are cancer, chronic lower respiratory diseases, 
accidents, diabetes mellitus, and influenza and pneumonia.   
There are approximately 12,737 mortalities related to valvular heart disease and 90,000 
hospital discharges[2].  Of these mortalities, 12,380 are aortic valve disorders, 2,865 are 
mitral valve disorders, 12 are pulmonary valve disorders, and 3 are tricuspid valve 
disorders.  The National Heart, Lung, and Blood Institute’s Framingham Heart Study 
reports that among people ages 26-84, the prevalence of a mitral valve disorder is 1-2% 
and equal between men and women[2].       
Mitral valve prolapse (MVP) is the most common heart valve abnormality in the United 
States.  Recent studies estimate that approximately 2 to 6% of the adult population in the 
United States has MVP[2].  The most common cause of chronic mitral regurgitation (MR) 
is MVP.  Recent studies have found that 10% of healthy men and women between the 
 1
ages of 23 and 35 have some degree of MR, and 93% of these people have mild MR.  
Ten percent of those over age 65 have MR, and approximately 26% have moderate to 
severe regurgitation[2]. 
Surgery is often required for MR and is generally performed for MVP only when MR is 
present.  Valve repair or replacement are the two types of surgery available to treat these 
conditions.  Surgery for MVP is based upon the degree of valve or heart damage and 
whether the person with MVP also has severe MR, poor function of the lower left 
ventricle, and possibly symptoms of heart failure.  Surgery for MR is recommended when 
the symptoms of heart failure are present, or when the ejection fraction drops below 60% 
and the left ventricle is larger than 45 mm at rest[2].  Repair is more successful if there is 
limited damage to the mitral valve leaflets or chordae tendineae.  Replacement, however, 
is usually preferred for people who have a hard, calcified mitral annulus or widespread 
damage to the valve and surrounding tissue. 
The question of repair versus replacement is a topic of discussion among many surgeons.  
Although most surgeons prefer repair, they are performing more replacements than repair 
due to the unknown mechanisms which cause complications such as ischemic mitral 
regurgitation.  According to a study by Gillinov et al.[3] from 1985 through 1997, a total 
of 397 patients underwent valve repair and 85 patients underwent valve replacements for 
ischemic mitral regurgitation.  Completion of the study revealed that most patients with 
ischemic mitral regurgitation benefited from mitral valve repair over replacement.  
However, patients with a high-risk setting attain the same survival rating regardless of 
repair or replacement.   
 2
 3
A better understanding of mitral valve mechanics will help surgeons decide whether 
repair or replacement of the mitral valve is more beneficial to the specific patient.  The 
complete understanding of the papillary muscles, the chordae tendineae, and the mitral 
apparatus is crucial to this understanding.   
The studies presented in this thesis are designed to improve the understanding of the 
mitral apparatus.  The Georgia Tech left heart simulator was used to isolate the effects of 
the different parts of the mitral apparatus.  A new left heart model was created such that 
the effects of the chordae tendineae could be determined using dual camera stereo 
photogrammetry.  This experimental method allowed the measurement of strain attained 
by the chordae tendineae during normal physiologic function.  Uniaxial tests were 
conducted to determine the mechanical behavior of the chordae tendineae during 
physiologic loading conditions.  Basic histology was performed on the chordae tendineae 
to determine the underlying microstructure and how this microstructure relates to the in 
vitro behavior.  Verhoeff and van Gieson stains were performed on both radial and 
longitudinal sections of six different chordae tendineae to determine the collagen and 
elastin distribution of the chordae tendineae.  The Verhoeff and van Gieson stains also 
allowed the observance of vascular structures.  Immunohistochemistry of the von 
Wildebrand Factor was performed to verify the vascular structures.  Hematoxylin and 
Eosin (H & E) stains were also performed on the same sections to determine the cellular 
distribution in the chordae tendineae.  This research combines basic histology with 
standard mechanical tests to determine the functioning role of the chordae tendineae 





2.1 Anatomy of the Heart 
The heart is one of the most important muscles in the body.  The main purpose of the 
heart is to pump blood; which carries oxygen and nutrients to the other organ systems of 
the body.  The heart is composed of four chambers, two atria and two ventricles.  The 
right side of the heart, the right atrium and ventricle, receives deoxygenated blood from 
the systemic circulation and pumps it to the pulmonary circulation where the lungs 
replenish the oxygen in the blood.  The left side of the heart, the left atrium and ventricle, 
receives oxygenated blood from the pulmonary circulation and pumps it to the systemic 




Figure 2.1: Diagram showing the anatomy of the heart. Illustrations copyright 2000 by Nucleus 
Communications, Inc. All rights reserved. http://www.nucleusinc.com 
   
There are four valves located in the heart which separate each chamber.  The right atrium 
and ventricle are separated by the right atrioventricular or tricuspid valve.  This valve is 
composed of three fibrous flaps that are attached at the free edge to tendinous chords; 
which are attached to the heart wall by papillary muscles.  During relaxation (ventricular 
diastole), the valve opens allowing the blood to drain directly from the inferior and 
superior vena cava, through the right atrium and into the right ventricle.  However, during 
ventricular contraction (ventricular systole), the valve closes and prevents the backflow 
of blood into the atrium.  The pulmonary semilunar valve consists of three semilunar 
cusps composed of thick connective tissue.  During ventricular relaxation, this valve is 
closed such that blood cannot enter the right ventricle from the pulmonary trunk.  When 
the ventricle contracts, the valve opens allowing the blood to flow into the pulmonary 
trunk, and beginning the pulmonary circuit.  
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The mitral or left atrioventricular valve consists of two cusps that prevent the backflow of 
blood into the left atrium during ventricular contraction.  Tendinous connective tissue 
fibers called the chordae tendineae attach the free edges of the mitral valve to the 
papillary muscles.  The papillary muscles are conical muscular projections that arise from 
the inner surface of the left ventricle.  During ventricular contraction, the papillary 
muscles contract and tense the chordae tendineae preventing the mitral valve from 
prolapsing during ventricular contraction.  The aortic semilunar valve is composed of 
three cusps that open during ventricular contraction allowing the left ventricle to pump 
the blood from the heart through the ascending aorta and to the systemic circulation.  
During relaxation, the three cusps are closed allowing the blood to pool in the left 
ventricle. 
The function of the atrial chambers are to collect blood that is returning to the heart and 
deliver it to the attached ventricles.  Due to the similarities in function of the two atrial 
chambers, they are similar in structure; however, the demands on the ventricles are much 
different and therefore they must have different structures.  The right ventricle pumps 
blood to the pulmonary blood vessels which are thin and wide and hence provide little 
resistance to blood flow.  Therefore, the right ventricle needs to create relatively low 
pressures to push the blood through the pulmonary circuit.  The wall of the right ventricle 
is relatively thin, compared to the left ventricle, and acts like a bellows pump, squeezing 
the blood against the thick, muscular wall of the left ventricle.  The left ventricle has to 
provide enough pressure to push the blood through the entire systemic circulation.  When 
compared to the right ventricle, the left ventricle must exert six to seven times as much 
force to push the blood around the systemic circulation.  The left ventricle has extremely 
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thick muscular walls and is round in cross sectional area.  In order to generate enough 
force, the chamber squeezes and twists during contraction.  This is a helical motion due 
to fiber arrangement.  When squeezing, the distance between the base and apex 
decreases; when twisting, the diameter of the chamber decreases.  By combining these 
two motions, the left ventricle is able to generate enough force to push the blood through 
the systemic circulation and also help the right ventricle push blood through the 
pulmonary circulation. 
The heart wall is comprised of three distinct layers: the epicardium, the myocardium, and 
the endocardium.  The epicardium is a serous membrane that covers the outer layer of the 
heart.  This membrane is composed of an exposed mesothelium and an underlying layer 
of loose connective tissue that is attached to the myocardium.  The myocardium is the 
muscular portion of the heart wall consisting of concentric layers of cardiac muscle 
tissue.  The muscle bundles of the atrial myocardium wrap around the atria and form 
figure eights that pass through the interatrial septum.  The muscle bundles of the 
ventricular myocardium wrap around both ventricles and spiral around the ventricles 
toward the apex.  The endocardium covers the inner surface of the heart wall including 
the valves.  The endocardium is composed of simple squamous epithelium that is 
continuous with the endolethium of the blood vessels.       
 
2.2 Cardiac Cycle 
The cardiac cycle includes alternating periods of contraction and relaxation that are 
divided into two phases: systole and diastole.  During systole, the chamber contracts and 
pushes blood into another chamber or into an arterial trunk.  During diastole, immediately 
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following systole, the chamber relaxes and fills with blood.  The cardiac cycle consists of 
one cycle of atrial systole and atrial diastole.  For a heart rate of 70 beats per minute, this 
cardiac cycle, or sequence of either atria or ventricle systole and diastole, lasts 860 ms.  
The movement of blood is influenced by the pressure induced in the chambers by systole 




Figure 2.2: Pressure and volume relationships in the cardiac cycle. 
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The cardiac cycle starts with atrial systole, approximately 100 ms, in which rising 
pressure pushes blood from the atria to the ventricles through the open AV valves.  Since 
the ventricles fill passively during the previous cardiac cycle, the ventricles are already 
filled with 70% of their capacity with blood.  During atrial systole, the ventricle receives 
the remaining amount of blood to fill the ventricle; which is the maximum amount of 
blood that it will hold during the cardiac cycle called the end-diastolic volume.  
Ventricular systole occurs at the end of atrial systole and lasts for approximately 270 ms 
in a resting adult.  As the pressure inside the ventricles surpasses that of the atria, the AV 
valve closes.  A period called isovolumetric contraction occurs in which all the valves of 
the heart are closed and the pressure in the ventricles continues to rise as the ventricles 
contract isometrically.  Ventricular ejection occurs when the pressure in the ventricles 
exceeds that of the pulmonary or aortic trunks.  The aortic and pulmonary valves open 
and the ventricles contract isotonically pushing blood into either the pulmonary or 
systemic circulation.  During this period of contraction, the ventricles expel 
approximately 70 ml of blood, or 5 L/min.  This volume of blood is called the stroke 
volume and is 60% of the end-diastolic volume.  At the end of ventricular systole, the 
pressure in the ventricles falls causing blood to flow back into the ventricles; however, 
the closure of the pulmonary and aortic valves prevents this backflow.  The amount of 
blood remaining in the ventricle with the valves closed is the end-systolic volume.  The 
ventricles then reach ventricle diastole when the muscle cells begin to relax.  Since the 
pressure is still higher in the ventricle than the atria, the heart goes through a period 
called isovolumetric relaxation.  As the ventricles relax to their resting state, the pressure 
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decreases rapidly.  This causes the AV valves to open and blood to passively fill the 
ventricles and begin the cardiac cycle again.        
  
2.3  Anatomy of the Mitral Valve 
The mitral valve complex is composed of an annulus, the mitral valve leaflets, the 
chordae tendineae, two papillary muscles, and the underlying left ventricular 
myocardium.  The mitral valve controls the flow of blood from the left atrium to the left 
ventricle.  During ventricular systole, the mitral valve closes to prevent the backflow of 
blood into the left atrium and hence ensure the blood flows to the systemic circulation.  
The mitral leaflets are composed of three layers, the atrialis or spongiosa, the fibrosa, and 
the ventricularis.  The mitral valve has also been shown to be a viscoelastic material.   
The mitral valve can be decomposed into four sections: two commissural areas, 
anterolateral and posteromedial; and two leaflet areas, anterior and posterior.  The 
commissural areas are defined by the insertion of the commissural chordae.  The anterior 
leaflet is the largest leaflet with either a semicircular or triangular shape.  The line of 
leaflet closure is defined by a distinct ridge that follows the rim of the leaflet, but is 0.8 to 
1.0 cm from its free margin[4].  The rough zone of the leaflet tissue is distal to this ridge.  
During valve closure, the rough zones on both the anterior and posterior leaflet come into 
contact to form the closure line, line of coaptation.  The majority of chordae tendineae 
insert into this rough zone on the leaflet.  Between the rough zone and the annulus, the 
leaflet is membranous and normally free of chordae insertions.  The posterior leaflet is 
the tissue posterior to the commissural areas.  The posterior leaflet has a scalloped 
appearance with each scallop is semi-oval with either a smooth or a finely serrated free 
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margin.  Three zones can be identified on the posterior leaflet: the rough zone, the 
membranous or clear zone, and the basal zone[4].  The rough zone is defined by the line of 
leaflet closure and its free margin.  Figure 2.3 is a diagram representation defining the 
rough zone of the mitral valve.   
 
Figure 2.3: Diagram representation of the mitral valve (Ranganathan et al.[4]). 
 
Under normal physiologic function, the mitral valve undergoes high fluid shear stresses, 
substantial hydrostatic pressures, and large in plane tensions.  A study by Sacks et al.[5] 
was the first to complete a study of surface strains on the anterior leaflet of a functioning 
mitral valve.  The central region of the anterior leaflet was found to experience large, 
anisotropic stretches during valve closure.  However, after closure, further leaflet 
deformation ceased.  This leaflet deformation was found to be reversed during valve 
opening.  Even though the leaflet experienced large stretches, there was very little shear 
exerted during the cardiac cycle.  It was also found that the peak stretch rates during the 
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closing and opening phases reached values as high as 500%-1000% per sec[5].  The leaflet 
appeared to stiffen when the areal strain plateaus.  This is explained by the locking of the 
collagen fibers.  This implies that the collagen fiber network of the valve allows for 
sufficient initial compliance to allow for adequate leaflet coaptation, followed by leaflet 
stiffening to prevent further deformation[5].  It was also concluded that the mitral valve 
has a finely tuned closing mechanism that works together with the chordae tendineae and 
the papillary muscles to ensure proper valve closure; hence, preventing regurgitation and 
mitral valve prolapse.   
 
2.4  Anatomy of the Chordae Tendineae 
The chordae tendineae of the mitral valve function to transmit the contractions of the 
papillary muscles to the leaflets of the mitral valve complex.  They also serve to secure 
the leaflets to maintain valve closure and prevent mitral valve prolapse.  In order to 
perform these functions, the chords must contain a high degree of elasticity, as well as 
considerable strength and endurance.  These tendinous chords are composed of collagen 
and elastin fibers arranged in parallel.  A study done by Millington-Sanders et al.[6] 
showed that the chordae tendineae are composed of multiple layers of elastic fibers, 
collagen, and an outer layer of endothelial cells.  The outer layer of elastic fibers was 
found to be approximately 4µm thick, arranged at inclined angles to the axis of the 
chordae.  The second layer of elastic fibers appeared to be arranged longitudinally.  In the 
lower endocardium, there is a dense distribution of elastic fibers mixed with wavy 
collagen.  Cross sectional views of the chordae revealed that the elastic fibers diminish 
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towards the interior of the chord while the amount of collagen increased.  Figure 2.4 is a 
computer generated model of the chordae tendineae. 
 
Figure 2.4: Computer generated model of the microsection of the chordae tendineae (Millington-
Sanders et al.[6]).  There are three layers: an inner collagen core, a middle elastin layer, and an outer 
endothelium layer. 
 
The chordae must withstand the large repetitive forces that are encountered in the left 
ventricle.  The arrangement of their elastic fibers and wavy collagen increases the 
mechanical properties of the chordae and allows them to withstand these forces.  The 
wavy arrangement of collagen that is surrounded by elastic fibers is well adapted to the 
cyclic stresses to which the chordae are continuously subjected.  This arrangement also 
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provides a mechanism for smooth transfer of forces to the valve leaflets thus protecting 
the structural components of the valve which have to withstand rapidly applied forces at 
systole.  During stretching, when papillary muscle contraction straightens the chords, the 
collagenous wavy pattern disappears and transfers the peak stress during contraction to 
the leaflets.  The sleeve-shaped elastic network which surrounds the internal collagen 
suggests that on relaxation of tension, the elastic fibers would tend to restore the collagen 
to their wavy configuration.  This layer of elastic fibers also serves as a protective barrier 
between the collagen and the delicate layer of the endocardium.  
The mitral valve consists of 8-12 chordae tendineae, 15-20mm long, and approximately 
0.45mm in diameter before branching[6].  The chordae branch either soon after their 
origin in the papillary muscle, or shortly before they insert into the leaflet.  The chordae 
insert into either the anterior leaflet, the posterior leaflet, or the commissural section.  The 
chordae tendineae inserting into the anterior leaflet insert obliquely on either side of the 
anterior leaflet; however, those inserting into the posterior leaflet are aligned parallel to 
each other[7].  The arrangement and morphology of the chordae tendineae can be 
classified according to their insertion sites.  The average number of chordae tendineae 
and their insertion locations presented by Lam et al.[7] are displayed in Table 2.1.1.  The 
commissural chords branch radially immediately after extending from the papillary 
muscles and insert into the free margin of the commissural section.  There are two 
commissural chords that insert into the anterior lateral commissural area or the posterior 
medial area.  The commissural area is defined by the lateral spread of attachment of the 
branches of the commissural chordae.  The average length and thickness of the 
commissural chordae recorded by Lam et al.[7] are displayed in Table 2.1.   
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The anterior leaflet has two types of chordae, the rough zone chordae and the strut 
chordae.  The rough zone chordae insert into the rough zone of the anterior leaflet, and 
typically split into three chords soon after their origin in the papillary muscle.  One chord 
inserts into the free margin of the valve leaflet, one into the intermediate area, and one 
beyond the free margin at the line of closure.  These chords occasionally branch into 
secondary chords which insert into the same area as the parent chord.  The two thickest 
and largest chordae originate from the tips of the anterior lateral and posterior medial 
papillary muscles and insert into the ventricular surface of the anterior leaflet near the 
line of closure between the 4 and 5 o’clock positions on the posterior medial side and 
between the 7 and 8 o’clock positions on the anterior lateral side[7].  These chords are 
termed the strut chords and are present in the majority (90%) of mitral valves.  The 
average length and thickness of the chordae inserting into the anterior leaflet recorded by 
Lam et al.[7] are displayed in Table 2.1. 
The posterior leaflet has three types of chordae, the basal chordae, the rough zone 
chordae, and the cleft zone chordae.  The basal chordae; which are unique to the posterior 
leaflet, insert into the basal portion of the leaflet.  These chordae are typically a single 
strand that extends from the papillary muscle and flares prior to its insertion in the leaflet.  
The rough zone chordae of the posterior leaflet has a morphology similar to that of the 
rough zone chordae of the anterior leaflet, but they are shorter and thinner than those 
inserting into the anterior leaflet.  The cleft chordae insert into the free margin of the cleft 
in the posterior leaflet.  These chordae have tiny radial branches like the struts of a fan.  
Two cleft chordae divide the posterior leaflet into three scallops.  The average length and 
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thickness of the chordae inserting into the posterior leaflet recorded by Lam et al.[7] are 
displayed in Table 2.1. 
Table 2.1: Average length, thickness, and insertion locations of chordae tendineae (Lam et al.[7]). 
Site of insertion Types of chordae Length (cm) Thickness (mm) 
Anterior leaflet Rough zone chordae 1.75 ± 0.25 0.84 ± 0.28 
 Strut chordae 1.86 ± 0.43 1.24 ± 0.51 
Posterior leaflet Rough zone chordae 1.40 ± 0.08 0.65 ± 0.24 
 Basal chordae 0.84 ± 0.21 0.40 ± 0.29 
 Cleft chordae 1.30 ± 0.18 0.78 ± 0.15 
Commissural areas Anterior lateral commissural chordae 1.2 ± 0.31 0.70 ± 0.20 
 Posterior medial commissural chordae 1.4 ± 0.40 1.0 ± 0.30 
 
The chordae tendineae of the mitral valve can also be classified into first order (primary) 
chordae, second order (secondary) chordae, or third order chordae[7].  The primary 
chordae consists of the commissural chordae, the rough zone chordae of the anterior and 
posterior leaflets that insert into the free margin of the leaflets (marginal chordae), and 
the branches of cleft chordae of the posterior leaflet.  The secondary chordae consists of 
the rough zone chordae of the anterior and the posterior leaflets that insert beyond the 
free margin, the strut chordae of the anterior leaflet, and the main stems of cleft chordae 
of the posterior leaflet.  The third order chordae consist of the basal chordae of the 




Figure 2.5: Diagram representation of the insertion locations of the chordae tendineae in the mitral 
valve.  There are six primary chordae tendineae: anterior strut, anterior marginal, commissural, 






















2.5 Mechanical Properties of the Chordae Tendineae 
The mechanical properties of the chordae tendineae have been shown to vary with 
chordal size and type.  A study done by Liao et al.[8] postulated that when grouped 
according to cross-sectional area and according to chordal type, there is a clear 
relationship between chordal size, type, and mechanical properties.  It was found that the 
thicker strut chordae were more extensible and less stiff than the thinner marginal 
chordae.  These findings are described by Liao et al.[8] in Tables 2.2 and 2.3.  The average 
collagen fibril crimp period showed a decrease in crimp period as the chordal diameter 
increased.  Also, the marginal chordae consistently had smaller fibril diameters and a 
greater average fibril density than the basal and strut chordae.  The extensibility of the 
mitral valve chordae tendineae increases with their diameter, while their tensile modulus 
decreases.  The extensibility of the thicker chordae is due to the more highly crimped 
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collagen fibril and hence the smaller crimp period.  All of these findings support the 
conclusion that the thicker strut chordae are more extensible than the thinner marginal 
and basal chordae.  The findings by Liao et al.[8] are consistent with those of Lim et al.[9] 
and Kunzelman et al.[10]. 
Table 2.2: Comparison of mechanical properties of chordae according to their cross-sectional area    
(Liao et al.[8]). 
Range of chordal area (mm2) 0.1-0.5 0.5-1.0 1.0-2.0 2.0-3.0 Significance 
Extensibility (% strain) 4.2±1.5 8.1±2.5 15.7±3.9 18.4±2.8 p < 0.001 
Tensile modulus (MPa) 90.1±22.3 83.7±18.5 66.3±13.5 61.7±13.3 p = 0.001 
Note: Values given as Mean ± S.D. Comparisons were made using one-way ANOVA. p-Values denote significant differences between groups.  
 
Table 2.3: Comparison of mechanical properties of chordae according to chordal type (Liao et al.[8]). 
Chordal type Marginal Basal Strut Significance 
Extensibility (% strain) 4.3±1.6 8.5±2.0 17.5±3.3 p < 0.001 
Tensile modulus (MPa) 84.4±21.2 86.1±20.9 64.2±13.5 p = 0.002 
Average chordal size (mm2) 0.38±0.18 0.71±0.25 2.05±0.40 p < 0.001 
Note: Values given as Mean ± S.D. Comparisons were made using one-way ANOVA. p-Values denote significant differences between groups.  
 
Lim et al.[11] report that the mitral valve chordae tendineae exhibit a nonlinear quasi-static 
elastic response.  After removal of the outer elastin sheath, they demonstrated that the 
more readily extensible elastin layer cannot contribute to the nonlinear elastic behavior of 
the chordae tendineae.  This further leads to the conclusion that the mechanical properties 
of this tissue are governed primarily by the behavior of the inner collagen core.  As the 
chordae were stretched further, a force greater than the initial force was needed to strain 
the tissue.  This further stretching involves the straining of the bonds and bond angels 
within the fibrils.  This straining is evident in the observed nonlinear stress-strain curve.  
Lim et al.[11] also reported that the initial segment of the nonlinear stress-strain curve 
could not be attributed to the presence of the more extensible elastin.  This is in contrast 
to the properties of arteries, which contain the same structural components as the 
chordae, but have an elastic response which cannot be explained by the same theory. 
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Failure mechanisms of the chordae tendineae have been examined by Sedransk et al.[12].  
It was observed that the marginal chordae and posterior leaflet chordae were thinner and 
required less strain and load to fail than basal chordae and anterior leaflet chordae, 
respectively.  These findings are in agreement with those found earlier, Lim et al.[11], 
which concludes that the marginal chordae have a decreased extensibility in comparison 
to the thicker strut and basal chordae.  It was also concluded that the failure strength and 
the failure strain of the chordae depend primarily on the insertion position (marginal or 
basal/strut) and less on the particular leaflet (anterior or posterior).   
An in vitro study conducted by Jimenez et al.[13] indicates the importance of annulus 
configuration on chordal force distribution.  It was concluded that when comparing the 
dynamic changes in tension on the chordae, the secondary chords bore the larger loads on 
each of the leaflets when compared with the primary chords.  The anterior strut chord had 
a tension 0.74 ± 0.46 N higher than the anterior marginal chord.  The load on the 
posterior intermediate chordae was 0.18 ± 0.16 N higher than the load on the posterior 
marginal chordae.  The average forces on the chordae found by Jimenez et al.[13] are 
displayed in Table 2.4.  This force distribution is consistent with the results found by 
Sedransk et al.[12] and Lim et al.[11]; which conclude that the secondary chordae are 
thicker and have a larger failure strength and failure strain than the primary chordae.  
Table 2.4:  Force distribution of the chordae tendineae (Jimenez et al.[13]). 













Anterior Strut 6 1.22±0.52 0.95±0.35 18.5±16.1 0.018 
Posterior Intermediate 5 0.25±0.14 0.30±0.18 -22.3±17.1 0.022 
Posterior Marginal 4 0.03±0.04 0.06±0.05 -137.8±188.6 0.12 
Basal Posterior 6 0.19±0.10 0.31±0.25 48.5±89.9 0.122 
Anterior Marginal 6 0.31±0.17 0.35±0.16 -58.5±111.4 0.145 




2.6 Mitral Valve Pathologies 
The World Health Organization reports that 16.6 million people die each year to 
cardiovascular diseases[1].  In 2001, one-third of all deaths were related to cardiovascular 
diseases, and by 2020, the World Health Organization estimates that approximately 25 
million people will die each year from cardiovascular diseases. 
Mitral valve prolapse (MVP) is the most common heart valve abnormality in the United 
States.  Recent studies estimate that approximately 2 to 6% of the adult population in the 
United States have MVP[2].  Mitral valve prolapse is a condition in which the mitral valve 
leaflets prolapse upward into the left atrium rather than forming a line of coaptation as 
the heart contracts.  Figure 2.6 is a diagram representation of a normal valve and a valve 
with mitral valve prolapse.  The most common cause of chronic mitral valve regurgitation 
(MR) is MVP.   
 
Figure 2.6: Diagram representation of a normal and prolapsed mitral valve. Image copyright 2000 by 




Mitral valve regurgitation occurs when the flow proceeds in the reverse direction through 
the mitral valve during ventricular contraction.  Chronic MR is a common disorder, 
although the exact number of people affected by the condition is difficult to estimate due 
to the presence of murmurs in many adults and the small amount of regurgitation detected 
in 80% of adults[2].  Mitral valve regurgitation can develop suddenly known as acute MR.  
Symptoms of acute MR include sudden heart failure, fluid in the lungs, and chest pain.  
Acute MR requires urgent surgery to repair or replace the mitral valve.  Recent studies 
have found that 10% of healthy men and women between the ages of 23 and 35 have 
some degree of MR, and 93% of these people have mild MR[2].  Ten percent of those 
over age 65 have MR, and approximately 26% have moderate to severe regurgitation[2].  
There are three risk factors associated with MR.  The age of the patient increases 
mechanical stress, wear and tear of the mitral valve over time, and increases the 
likelihood of blood leaking back into the atrium.  During high blood pressure, the left 
ventricle encounters greater resistance as it pumps blood to the body.  The increase in 
resistance ultimately places greater strain on the mitral valve and could cause leakage.      
Chronic MR can result from many pathologies of the heart.  The most common cause of 
chronic MR is MVP.  Calcification of the annulus prevents the mitral valve leaflets from 
closing completely and therefore, blood leaks backward into the left atrium.  Congenital 
heart disease, an abnormality of the heart valve that developed before birth, can lead to 
MR.  Endocarditis can cause scarring of the heart valves that can lead to chronic MR.  
Another common cause of MR is damage to the heart muscles of the chordae tendineae.  
Myocardial infarctions or coronary artery disease can lead to an enlarged left ventricle, 
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damage to the heart muscles or the chordae tendineae which control movement of the 
mitral valve. 
Acute MR can result from three causes.  Rupture of the chordae tendineae is most 
commonly seen in middle-aged and older men and can be caused by endocarditis or 
trauma.  Rupture of the papillary muscles can be caused by a myocardial infarction or by 
trauma.  Also, problems associated with a prosthetic valve can lead to acute MR. 
Once MR develops, little can be done to prevent its progression.  Due to the quick onset 
of acute MR, treatment must be immediate.  Vasodilators such as nitroprusside help 
reduce the amount of blood flowing back into the left atrium and left ventricle.  An intro-
aortic balloon counterpulsation device is used if the condition is not stabilized with 
medications.  Surgery to repair or replace the valve is generally necessary.  Additional 
surgery to correct the underlying cause of MR may also be necessary.   
Surgery is often required for MR and is generally performed for MVP only when MR is 
present.  Valve repair or replacement are the two types of surgery available to treat these 
conditions.  Surgery for MVP is based upon the degree of valve or heart damage and 
whether the person with MVP also has severe MR, poor function of the lower left 
ventricle, and possibly symptoms of heart failure.  Surgery for MR is recommended when 
the symptoms of heart failure are present, or when the ejection fraction drops below 60% 
and the left ventricle is larger than 45 mm at rest[2].  Repair is more successful if there is 
limited damage to the mitral valve leaflets or chordae tendineae.  Replacement, however, 
is usually preferred for people who have a hard, calcified mitral annulus or widespread 
damage to the valve and surrounding tissue. 
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There are three different heart valve repair procedures which include reshaping of the 
valve by removing excess valve tissue, adding support to the valve ring by adding tissue 
or an annulus ring, or attaching the valve to nearby heart chordlike tissues, chordal 
transposition.   
Heart valve replacement surgery involves the removal of the badly damaged valve.  The 
valve is replaced with a plastic or metal mechanical valve, or a bioprosthetic valve 
usually made from pig tissue.  People who receive a mechanical heart valve are more 
likely than those who receive a bioprosthetic heart valve to develop blood clots in the 
heart that may break loose, travel to the brain, and cause a stroke.  Therefore, lifelong 
anticoagulant therapy is necessary for the rest of the patient’s life.  There are many risks 
associated with heart valve replacement.  Effects from the operation, such as bleeding, 
infection, and risks associated with anesthesia are often low risks, but often include a 
psychological component.  Blood clotting caused by the new valve, infection in the new 
valve, and failure of the new valve are all risks associated with heart valve replacement, 
but are significantly lower with heart valve repair. 
Mitral valve stenosis is an uncommon heart condition that develops when the mitral valve 
fails to open as wide as it should.  Although this has no immediate effect on health, it can 
eventually disrupt normal heart function and lead to heart failure, abnormal heartbeat, and 
other heart conditions.  Most cases of mitral valve stenosis were reported to be caused by 
rheumatic fever; however, 60% of the people with mitral valve stenosis do not report a 
history of rheumatic fever[2].  It is unknown how many people have mitral valve stenosis.  
Most people do not have symptoms until after age 40, with symptoms appearing in 
people who are in their 50s and 60s.  People in this age group often have more than one 
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heart problem, which can make it more difficult to diagnose and treat mitral valve 
stenosis.  Figure 2.7 is a diagram representation of a normal and stenosed mitral valve. 
Figure 2.7: Diagram representation of a normal and stenosed mitral valve. Image copyright 2000 
by Nucleus Communications, Inc. All rights reserved. http://www.nucleusinc.com. 
 
Treatment of mitral valve stenosis focuses on managing symptoms and preventing 
complications.  Medication can help manage symptoms and related complications such as 
heart failure.  Balloon valvotomy or valve surgery may be done to repair or replace the 
damaged mitral valve.   Balloon valvotomy is the method of choice for treating mitral 
valve stenosis due to the quicker recovery time than open heart surgery. Complications of 
mitral valve stenosis, including heart failure, arrhythmias, and endocarditis, can greatly 
affect the quality of life.   
There are two situations where surgery is recommended, when symptoms are severe, or 
there are no symptoms, but high blood pressure in a pulmonary artery, pulmonary edema, 
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atrial fibrillation, thromboembolism, or severe mitral valve stenosis.  For mitral valve 
stenosis, the American College of Cardiology and the American Heart Association 
(ACC/AHA) guidelines recommend having the mitral valve replaced once the valve area 
drops below 1.5 cm2 and is accompanied with serious, life limiting symptoms[2].   
Although there are solutions to these mitral valve pathologies, the solutions have inherent 
problems such as lifelong anticoagulant therapy.  Most surgeons today perform mitral 
valve repair instead of mitral valve replacement.  However, many surgeons have 
suggested many repair procedures that require further research before worldwide clinical 
implantation.     
   
 
CHAPTER 3 
HYPOTHESES AND SPECIFIC AIMS 
 
3.1 Hypotheses 
3.1.1 Hypothesis 1 
The chordae tendineae exhibit specific, finely tuned mechanical responses that enhance 
mitral valve function, and are thus not simple struts. 
3.1.2 Hypothesis 2 
The underlying basis for their unique specific behaviors lies in their unique structure.  
Therefore, structural characterization and architecture of mitral valve chordae tendineae 
will provide additional understanding of their mechanical function.   
 
3.2 Specific Aims 
3.2.1 Specific Aim 1 – Hypothesis 1 
Specific aim 1 was to investigate the dynamic strain response exhibited by the chordae 
during normal physiologic function.  Dual camera stereo photogrammetry was used to 
measure the displacement of small graphite markers that were adhered to the central 
region of the chordae.  The mitral valve was placed in a left heart simulator with 
physiologic flow and pressure waveforms.  A left heart model was designed such that 
visualization of all six types of chordae was possible with both cameras during the entire 
cycle time.  Images were taken with a sampling rate of 500 frames per second.  The 
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images were then digitized and the displacement of the markers determined.  From the 
resulting marker displacement, the uniaxial strains along the chordae were computed over 
the cardiac cycle. 
3.2.2 Specific Aim 2 – Hypothesis 1 
In specific aim 2, we investigated the load/strain behavior of the chordae during uniaxial 
testing.  To obtain load/strain information, elongations from the testing device actuator 
(cross-head displacement) and non-contact optical methods were employed and 
compared.  A single high speed camera was set up perpendicular to the chordae in order 
to measure the displacement of the markers on the chordae during uniaxial testing.  This 
is in contrast to earlier studies which have only used the cross-head displacement to 
measure elongations of the chordae.  After appropriate preconditioning, the chordae were 
loaded and unloaded at physiologic loading rates, 40% strain per second, to 2 N of force 
for five cycles.  Images were recorded at 45 frames per second, which was a limitation set 
by the uniaxial machine.  A trigger signal was designed to couple the cameras and the 
uniaxial machine such that the data were recorded simultaneously.  The load from the 
uniaxial machine and the strain measured with the cameras were synchronized and a final 
load/strain curve was generated. 
3.2.3 Specific Aim 3 – Hypothesis 1 
Specific aim 3 was to combine the information from the uniaxial studies with the in vitro 
flow loop data.  The strain determined using the in vitro flow loop was compared to the 
strain found during the uniaxial tests.  The strain from the in vitro flow loop could then be 
correlated with a known load.  If this procedure is completed for all data points collected 
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from the in vitro flow loop, the outcome would be a load/time curve which correlates to 
the dynamic environment the mitral valve chordae experiences during the cardiac cycle.  
3.2.4 Specific Aim 4 – Hypothesis 2 
Specific aim 4 was to characterize the structure and composition of the chordae.  The 
chordae were examined using standard histological staining techniques.  Collagen and 
elastin components were examined to determine if there was a structure function 
relationship between the compositional makeup of the chordae and their function in the 
cardiac cycle.  A hematoxylin and eosin stain was observed under brightfield and 
fluorescent microscopy to visualize cell placement in the chordae.  A Verhoeff and van 
Gieson stain was used to determine the collagen, elastin, and cellular distribution in the 
chordae.  A Verhoeff and light green stain allowed for observing elastin distribution.    
Immunohistochemistry was performed on all six types of chordae tendineae in the radial 
direction to verify the finding of vasculature.  Assays were performed on all six chordae 
tendineae to quantify the amount of DNA, collagen, and elastin contained in each of the 
different chordae.   
CHAPTER 4 
MATERIALS AND METHODS 
 
4.1 Mitral Valve Preparation 
For this study, fresh porcine mitral valves were used.  Fresh porcine hearts were attained 
from a local abattoir; the mitral valves were extracted and stored in 0.9% saline solution.  
The protocol for extraction of the mitral valves can be found in Appendix A.  The sizes of 
the mitral valves were determined using an annuloplasty ring sizer (Edwards Life 
Sciences, CA, USA).  Mitral valves with similar chordae insertion patterns and similar 
orifice size, commissural-commissural sizes of 34 mm, were used.  Figure 4.1 shows the 
intact mitral valve after extraction.   
 
Figure 4.1: Intact mitral valve after extraction. 
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3.2 Chordae Tendineae Marker Technique 
3.2.1 In Vitro Flow Loop 
All experiments were completed in the modified Georgia Tech left heart simulator.  The 
simulator is controlled by a pressure driven, compressible bladder pump, which uses a 
pulse generating computer system to control and synchronize the pump.  Compressed air 
is fed to the system at 40 Psi by a portable compressor (Thomas Ultra Air Pac Model T-
2820, Thomas Compressor and Vacuum Pumps, WI, USA).  Solenoid valves, which are 
synchronized using a generic driver and pulse timer (TeleVideo Model 910, Televideo 
Inc., CA, USA), control the air supply to cyclically compress the silicon bladder in order 
to provide the driving force for the loop simulating ventricular pressure.  By 
synchronizing the solenoid valves, a total cycle time of 860 ms, with a systolic duration 
of approximately 300 ms and a diastolic duration of 560 ms, was maintained.  
Trans-mitral and ventricular pressures were measured using a differential pressure 
transducer (Model DP15-24 T1, Valydine Inc., Northridge, CA, USA) coupled to an 
amplifier/signal conditioner (Model CD23, Validyne Inc., Northridge, CA, USA).  The 
trans-mitral flow rate was measured upstream from the valve using an electromagnetic 
flow probe (Model EP 680, Carolina Medical Instruments Inc., King, NC, USA) 
connected to an analog flow meter (Model FM501, Carolina Medical Instruments Inc., 
King, NC, USA).   
The left heart simulator is composed of a gravity feed reservoir, an atrial chamber, and a 
ventricular chamber and bladder.  Resistance and connective tubing were used to better 
generate physiologic flow conditions.  Figure 4.2 is a schematic diagram of the left heart 
simulator.  The system is filled with 0.9% saline solution as a blood analogue.  The atrial 
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chamber is filled from the reservoir by gravity.  The fluid then flows through the atrial 
chamber into the ventricular chamber through the native mitral valve.  The compressible 
bladder pump creates increased pressure in the ventricular chamber causing the mitral 
valve to close, and the fluid to flow out through the aortic valve.  Immediately following 
the aortic valve are sections of compliant tubing to simulate the aorta.  Resistance is 
controlled using a manual clamp simulating circulatory systemic resistance.  After this 
section of resistance and compliance tubing, the fluid returns to the reservoir to initiate 
the next cycle.  This system is capable of physiologic and pathophysiologic flow and 
pressure waveforms.  The Georgia Tech modified left heart simulator has been described 
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4.2.2 Left Ventricle Model 
The left ventricle chamber is an octagon shaped acrylic chamber, Figure 4.3.  The sides 
of the model are arranged at 60° angles to each other such that the cameras could be 
arranged perpendicular to the surface of the model in order to reduce the effects of 
refraction.  The front section of the chamber, which holds the aortic valve, forms a 135° 
angle with the frontal face of the chamber to ensure geometrical positioning of the mitral 
and aortic valves.  A 25 mm tilting disk mechanical valve (Omnicarbon 3523, 
MedicalCV Incorporated, USA) is used in the aortic position. Two syringes, connected 
through luers on the top of the ventricle chamber, are used as compliance in order to 
reduce fluctuations in the pressure waveforms.  Detailed drawings of the ventricle 
chamber are located in Appendix B.   
 33
 
( a ) 
 
( b ) 
Figure 4.3: Model (a) and schematic (b) of the left ventricle. 
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A papillary muscle holding system was designed which allows three dimensional 
displacements of each papillary muscle individually, Figure 4.4.  This allows the 
papillary muscles to be positioned in both physiologic and pathophysiologic conditions.  
The papillary muscles can be moved in the anterior/posterior, septal/lateral, and 
apical/basal positions independently.  The papillary muscles are attached to holding 
disks, which are then attached to force rods as described in previous documents[14,16].  
The forces rods are attached to the screw driven rod at 90°.  This rod is attached through 
gears to the rod that goes through a tight fitting hole in the back of the ventricle chamber.  
The apical/basal position is determined using a caliper to measure the movement of the 
rod with respect to the back plate.  The rotation of the outer rod allows measurement of 
the septal/lateral positions.  The rotation of the inner rod moves the force rod along the 
elevator to measure the anterior/posterior position.  Using this new system, exact 
displacements can be determined from a reference position without movement of the 
mitral valve, or opening of the ventricle chamber.  Schematic drawings of the papillary 
muscle holding system are given in Appendix B.   
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Figure 4.4: Picture of the papillary muscle holding system.  The papillary muscles are sutured to the 
white holding disks.  The position of the papillary muscle can be modified by: 1) movement of the 
green force rod along the length of the screw allows measurement of the anterior/posterior position; 
2) movement of the rod with respect to the back plate for measurement of the apical/basal position; 
and 3) rotation of the outer rod allows measurement of the septal/lateral position. 
 
4.2.3 Annulus Chamber and Board 
The atrial chamber for the Georgia Tech left heart simulator has a rectangular volume of 
229 cm2 and a 2.5 cm diameter inlet, Figure 4.5.  A cylinder attached to the top of the 
atrial chamber is used as air compliance to create physiologic pressure waveforms.  A 
stopcock on the top of the chamber allows the extraction of air during setup.  The exit 
orifice diameter is 4.5 cm, which attaches to the annular board.  A stopcock on the right 
lateral wall is used to connect the pressure transducer.  The annular board contains a flat 
annulus ring back plate which the mitral annulus was sutured.  Details on the annulus 
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Figure 4.5: Left atrium model and rigid annulus ring.  The valve is sewn using sutures to the rigid 
annulus ring.  The annulus ring and atrial chamber are then connected to the ventricle model. 
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4.2.4 Instrument Calibrations 
The trans-mitral and ventricular pressure transducers were calibrated using a differential 
water column.  The positive and negative terminals of the transducer were calibrated 
independently.  The voltage output of the pressure transducer amplifier was measured 
with a voltmeter and was recorded and plotted against the water column differential 
pressure to obtain the sensitivity of the system.  An example of the calibration curve for 

























Figure 4.6: Calibration curve for the pressure transducer. 
 
The flow probe was calibrated using a precision flow rotometer.  The flow rotometer and 
the flow transducer were connected in series to a steady flow pump.  The average flow in 
the loop was varied, and the output of the voltage of the flow amplifier and the rotometer 
flow were measured with a voltmeter and were recorded.  An example of the calibration 
curve for the flow probe is shown in Figure 4.7.  Detailed calibration procedures for both 
the flow probe and the pressure transducer are discussed in a previous document[14]. 
 38


























Figure 4.7: Flow probe calibration curve. 
 
4.2.5 Graphite Markers 
Graphite markers, approximately 0.368 mm in diameter were affixed to the desired 
chordae tendineae using super glue (Krazy Glue, Elmer’s Products Inc., USA).  Four 
graphite markers were affixed to the central region of the chordae where no branching 
was observed.  Preparation of the graphite markers began by depositing a single drop of 
adhesive onto a plastic sheet.  A suture needle held with forceps was dipped into the 
adhesive.  A graphite particle was then picked up with the suture needle and placed in the 
adhesive until coated.  The particle was then put on a clean sheet of paper to remove 
excess adhesive, leaving only a coating around the graphite marker.  The particle was 
picked up with the suture needle and attached to the chordae.  Care was taken to ensure 
that excess adhesive did not come in contact with the chordae.  Four graphite markers 
were affixed to the central region of the anterior strut chordae where no branching was 
observed approximately 2 mm apart, 10 mm from the papillary muscle, and 12 mm from 
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the insertion into the anterior leaflet.  Figure 4.8 depicts the correct placement of the 
graphite markers.   
  
Figure 4.8: Pictures from cameras A and B showing the correct placement of the graphite markers. 
4.2.6 Dual Camera Stereo Photogrammetry 
Dual camera stereo photogrammetry was used to obtain pictures of the chordae tendineae 
during the cardiac cycle.  Two high speed, high resolution cameras (Basler a504k, Basler 
Vision Technologies, PA) were positioned on tripods approximately 0.5 m from the 
ventricle chamber and 30° relative to each other.  Figure 4.9 is a schematic showing the 
position of the cameras relative to the left ventricle model.  Both cameras were positioned 
such that they were centered on the desired chordae, and light and lens (105mm f/2.8D 
AF Micro-Nikkor, Nikon, USA) were adjusted to achieve maximum contrast between the 
markers and background as seen in Figure 4.8 above.   
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Figure 4.9: Schematic depicting the correct placement of the cameras. 
 
 
Each camera was connected to an individual EPIX high speed frame grabber card (PIXCI 
CL3SD Frame Grabber, EPIX Inc., USA) which were synchronized using the EPIX 
software.  Images were recorded simultaneously at 500 frames per second with an 8 bit 
gray-scale and a resolution of 1280 × 1023 pixels.  A trigger signal was sent to a TTL 
module to ensure that the cameras and pressure data were recorded in synchronization. 
 41
4.2.7 Extension Tubes 
Extension tubes (Vivitar Extension Tube Set f/Nikon AIS, Vivitar, USA) were attached 
to the end of both cameras to increase the resolution of the camera system.  One 
extension tube was attached to each camera to increase the focal length an additional 36 













With the 36 mm extension tube, the markers had an average diameter of 11 pixels, which 
gave an average of 0.37 mm in diameter.  The total magnification achieved with the 
extension tube was 4X.  Figure 4.10 depicts the camera with the 36 mm extension tube 
and lens attached.  
Figure 4.10: Diagram o










f the Basler camera with the Vivitar 36mm extension
42Vivitar 36 mm 
Extension Tube tube and micro-Nikkor 
4.2.8 Experimental Protocol 
After valve extraction, detailed in Appendix A, the papillary muscles were wrapped in 
Dacron cloth and attached to the papillary muscle holding disks described earlier.  The 
mitral valve was then sutured to the annular board described earlier using 3-0 sutures 
(braided silk, Ethicon, NJ, USA).  After suturing, the annular board was inserted into the 
left heart simulator.  The papillary muscles were attached to the force rods.  After filling 
the loop with 0.9% saline solution, the flow probe and pressure transducer were zeroed.  
The valves were then placed in the defined normal position[17]: 
 Apical-Basal location: The papillary muscle rods were moved towards the 
annulus to a point where slack was observed in all the chordae tendineae. The 
papillary force rods were zeroed at this location.  Each force rod was pulled 
backwards until a change in voltage of 0.02 volts (0.09 Newtons) was achieved 
for that particular rod. This was the minimal significant change that may be 
observed by the system. This defined a position with no slack or apparent tension 
on the chordae tendineae.   
 Lateral location: The papillary muscles arranged parallel to each other and 
directly aligned with the valve’s annulus on each commissure. The commissural 
chords inserting in the annulus were vertically perpendicular to the annular plane. 
  Septal-lateral location: The rods were moved septal laterally until an even 
extension of the commissural chords inserting into the annulus was observed. 
Normally, this point was a couple of millimeters below the annular height 
midpoint.    
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The two high speed, high resolution cameras were setup to capture images of the desired 
chordae as detailed in section 4.2.6.  The cameras were set up 30° relative to each other 
and perpendicular to the surface of the ventricle chamber as described above.  Light and 
lens were adjusted such that the markers could be clearly seen with both cameras as 
shown in Figure 4.8 above.   
The simulator was run under physiologic flow and pressure conditions with the valve in 
the normal position (cardiac output: 5 L/min, peak trans-mitral pressure: 120 mmHg, 
heart rate: 70 BPM, systolic duration: 300 ms).  Flow and pressure curves were saved on 
a laptop computer for offline processing.   
Digital images were taken at 500 frames per second with a resolution of 1280 × 1023.  
The images were acquired as a sequence of TIFF images.  The cameras were setup with a 
trigger system such that the cameras recorded images simultaneously and in sequence 
with the flow and pressure waveforms.  A 5 volt signal sent from the waveform generator 
was split between the PCMCIA data acquisition card (Daq-card 1200, National 
Instruments, TX, USA) and the TTL module connected to the EPIX high speed frame 
grabber cards (PIXCI CL3SD Frame Grabber, EPIX Inc., USA).  The DAQ-ANAL and 
EPIX software allowed collection of data at the beginning of the 5 volt trigger signal.  
This allowed the pressure, flow, and camera images to be recorded in synchrony.  The 
images were processed offline.  After collecting the data, a calibration cube 10 mm on 
edge was positioned in the area of the markers such that seven corners of the cube could 
be clearly seen with both cameras.  The images of the cube were taken with both 
cameras, digitized, and used later for direct linear transformation (DLT).    
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4.2.9 Data Collection 
The signal from the flow probe and pressure transducers is sent through a PCMCIA data 
acquisition card (Daq-card 1200, National Instruments, TX, USA).  This card has eight 
different channels, which may be synchronized by a trigger.  The flow and pressure data 
were recorded onto a laptop computer using DAQ-ANAL 2.1, an in house data collection 
program based on LabVIEW 5.0.  Ten cardiac cycles are automatically stored for both 
flow and pressure data.  The curves for the ten stored cardiac cycles were averaged and 
analyzed offline using Microsoft Excel.  After deletion of deficient data, Excel was used 
to plot and store the averaged curves.  The data acquisition system and the DAQ-ANAL 
2.1 software have been described in detail in a previous document[14]. 
Dual camera stereo photogrammetry was used to obtain pictures of the chordae tendineae 
during the cardiac cycle.  Each camera was connected to an individual EPIX high speed 
framegrabber cards (PIXCI CL3SD Frame Grabber, EPIX Inc., USA) which were 
synchronized using the EPIX software.  Images were recorded simultaneously at 500 
frames per second with an 8 bit gray-scale and a resolution of 1280 × 1023 pixels.  A 
trigger signal was sent to a TTL module to ensure that the cameras and pressure data 
were recorded in synchronization. 
4.2.10 Autotracking Code 
The autotracking code was developed in house, and contains two different m-files written 
in Matlab, autotracking.m and marker_check.m.  The first m-file, autotracking.m, 
requires four different inputs from the user; location of the image files, the first frame 
number to be tracked, the last frame number to be tracked, and the total number of 
markers to be tracked.  The first image is displayed and the user must choose regions of 
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interests around each of the markers desired to be tracked.  The program then crops the 
image to the region of interest, and blurs the image to reduce the impact of noisy pixels.  
A set threshold chooses the darkest 10% of the pixels and calculates their centroid.  For 
the first three frames, the centroid of the marker defined in the first frame is used as the 
center of the search box.  After the first three frames, the program estimates marker 
position using position, velocity, and acceleration calculations from the three previous 
frames.  The center of the search box is then located at this new position.   
After the autotracking has finished, the user then utilizes the marker_check.m file to 
check the position of the centroid of the markers and to generate a text file to be imported 
into the 3D reconstruction software.  The autotracking.m and marker_check.m files are 
located in Appendix C. 
The largest difference between five autotracked marker centroids was two pixels.  For 
manual tracking, this difference increased to a five pixels difference.  The position 
variation is due to the size of the search box and the number of pixels included for the 
adaptive threshold.     
4.2.11 Direct Linear Transformation Code 
Direct linear transformation method was used to transform the 2D pixel coordinates to 
3D spatial coordinates.  The program SW3D6.m, written in Matlab, was used to compute 
the 3D coordinates and is detailed in previous publications.  This program utilizes the 
function dltfu.m and reconfu.m originally written by Christoph Reinschmidt from the 
University of Calgary.  This program has four different phases: loading of the 2D data 
sets, calibrating camera coordinates, computing the 3D coordinates, and writing the 
output text file.  When loading 2D data sets, the program will ask for two filenames, 
 46
these are where the 2D coordinates are stored for each camera.  For calibrating the 
camera coordinates, the program will ask for three filenames.  These are where the 2D 
coordinates of the cube corners and the known 3D coordinates of the cube, reference, are 
stored.  When computing the 3D coordinates, the x, y, and z coordinates are calculated 
using the least squares method.  After computation of the 3D coordinates, the output file 
is written.  The program will ask for two pressure files (ventricular and trans-mitral) to 
synchronize the pressure data with the image data.  The output is in the following format:       
Row 1: number of frames, number of markers 
Row n: frame number, time, ventricle pressure, trans-mitral pressure 
Row n+1: X,Y,Z coordinates 
The SW3D6.m code and the supporting m-files are located in Appendix C. 
4.2.12 Strain Code 
The strain was calculated using the infinitesimal strain definition.  This has been proven 
to approximate the strain for soft tissue mechanics if the strains are small.   
The strain.m algorithm written in Matlab takes the text file output from SW3D6.m and 
calculates the distance between each marker and the total distance between markers one 
and three.  After calculating the total distance, the program will ask for one input, the 
reference distance.  The strain is then calculated using the infinitesimal strain definition. 
The reference frame for the strain calculations was determined during the cube 
calibration.  With no pressure on the valve, the valve was defined to be in a relaxed state 
during calibration.  This relaxed state was used as the zero strain reference.  A wire of 
known spatial length was used as a ruler, and positioned parallel to the maker placements 
on the chordae during the calibration to obtain pictures of the chordae in the relaxed state.  
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Pictures were obtained for both cameras and subsequently imported into Sigma Scan Pro 
(Jandel Scientific, San Rafael, CA, USA), and the distance between each centroid of the 
markers was recorded.   
The output from strain.m has the following form: frame number, time (assuming 500 
fps), ventricular pressure, trans-mitral pressure, distance between markers 1 and 2, 
distance between markers 2 and 3, total distance between markers 1 and 3, and the strain.  
This text output is formatted to be inputted into Microsoft Excel for further analysis.  The 
algorithm for strain.m is located in Appendix C.   
4.3 Uniaxial Test 
4.3.1 Specimen Preparation 
The uniaxial tests were performed no more than 24 hours after the in vitro flow loop 
experiments using a Test Resources servohydraulic testing machine (model 650R, 
Shakopee, MN).  The same chordae and the same markers were utilized for both 
experiments.  The chordae were extracted from the mitral valve and separated into 
chordal type by insertion location.  During specimen preparation, a section of leaflet 
tissue 5 mm above the insertion location into the leaflet was left intact.  A section of 
papillary muscle tissue, approximately 8 mm in diameter, was left intact where the 
chordae and the papillary muscle connect.  The leaflet tissue was inserted between two 
clamps and positioned into the upper grip of the machine.  The clamps were constructed 
out of aluminum with teeth spaced 0.5 mm apart, Figure 4.11.  The teeth allowed secure 
clamping of the tissue without slippage which occurred during testing with other 
clamping mechanisms.  The cross head was then jogged until the papillary muscle could 
be placed in the lower grips of the machine.  This preparation technique allowed the 
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clamping mechanisms to not come in contact with the chordae.  This was used to reduce 
grip and end effects that occur during tension testing.  The sample was placed in the 
clamps as shown in Figure 4.11.  The clamping mechanism held the papillary muscle 
below the point of chordae insertion and the leaflet tissue above the point of insertion 
such that the chordae were not gripped by the clamps during testing.   
 
 
Figure 4.11: Chordae placed in the uniaxial clamps.  The clamps were constructed out of aluminum 
with teeth spaced 0.5 mm apart.  A section of leaflet tissue 5 mm above the insertion location into the 
leaflet was left intact.  A section of papillary muscle tissue, approximately 8 mm in diameter, was left 
intact where the chordae and the papillary muscle connect.  The leaflet tissue was inserted between 
two clamps and positioned into the upper grip of the machine.      
Area for upper 
clamping mechanism 
Area for lower 
clamping mechanism 
 
Preliminary experiments were conducted to determine the best method of specimen 
insertion in the testing machine.  If the chordae were extracted from the leaflet and 
papillary muscle and placed in a clamping mechanism such that the chordae was 
clamped, as previous investigators have done, major grip and end effects would occur 
and cause higher stress concentrations on the ends of the tissue.  The ends of the chordae 
in the clamps would also plastically deform during testing.  Therefore, the leaflet tissue 
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above the insertion site and the papillary muscle around the insertion site should be left 
intact and used during clamping.  This is similar to clamping mechanisms used to 
perform tendon testing in which the muscle and bone surrounding the ends of the tendon 
are left intact and placed in the clamping mechanism.  Various clamping mechanisms 
were also investigated during these preliminary experiments.  Standard soft tissue testing 
typically utilizes high grade sandpaper to be placed between two metal clamps to provide 
friction during testing.  However, during these experiments, slippage occurred when 
using sandpaper or sandpaper and superglue to clamp the specimen.  It was found that the 
metal teeth provide the best stability during uniaxial testing.  If the clamps are placed 
correctly in the machine, it was found that no slippage, tearing, or deformation of the 
tissue occurred.       
Since this test was uni-directional, only one high speed, high resolution camera was setup 
perpendicular to the test.  Figure 4.12 shows the setup of the camera for the uniaxial test.  




Figure 4.12: Picture depicting the uniaxial test setup.  One high speed, high resolution camera was set 
up perpendicular to the movement of the test specimen.  A light was placed beside the camera to 
enhance the contrast of the specimen against the background. 
 
4.3.2 Experimental Protocol 
The chordae were inserted into the uniaxial machine and were unloaded until the chordae 
was slack.  A calibration picture of the chordae and a millimetric ruler was taken to 
determine the millimeter to pixel conversion.  Using Sigma Scan Pro, the distance 
between the markers was determined in millimeters.  This calibration allowed the loading 
rate to be set at 40% per second of the distance between the markers for the chordae.  The 
chordae were preloaded at a 40% strain per second rate up to 2 N force for 25 cycles.  
This force was chosen since previous studies have shown that the strut chordae withstand 
a force of approximately 1.5 N during the cardiac cycle[17].  After appropriate preloading, 
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when the loading and unloading curves were repeatable, typically 20 cycles, the chordae 
were immediately loaded with the same parameters (40% strain per second up to 2 N 
force) for five cycles.  The camera and testing machine were set to a frame rate of 45 
frames per second.  This was the highest frame rate that the testing machine could record.       
In order to ensure synchronization between the testing machine and the camera, the signal 
from the computer sent to an external interface box was split between the two systems.  
The signal is then sent from the I/O channel to the machine.  Pin 16 from the digital 
input-output port on the external interface box controls the machine as to when to start 
the test.  This is achieved by sending a 5 volt signal through this pin.  In order for the 
machine and the camera computer to begin recording at the same time, this 5 volt signal 
was split from pin 16.  All the other pins remained the same and were sent to the 
machine.  Pin 16 and pin 1, digital ground, were split and sent to the machine and to the 
TTL module on the camera computer.  This 5 volt signal was sent from the Mtest WR 
software to the external interface box which was then split to the camera computer and 
the machine such that the data could be synchronized. 
4.3.3 Data Analysis 
The pictures of the uniaxial test were processed with the same protocol as the in vitro 
flow loop picture files.  The uniaxial data was processed using the autotracking code to 
track the same markers as those recorded during the in vitro experiments.  Using the 
calibration picture taken before the test as described above, the pixel coordinates were 
transferred to spatial coordinates.  In order to have the same definition for infinitesimal 
strain, the initial length used for the in vitro experiments was used as the initial length for 
the uniaxial data.  The load data obtained from the force transducer was then correlated 
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with the strain data captured with the camera.  Because the camera and the testing 
machine were synchronized with a trigger signal, there was a one-to-one correspondence 
between the load data and the strain data.  The load-strain data were then fitted with a 
mixed linear-exponential curve. 
4.4  Chordae Force Marker Technique 
After data collection from the in vitro flow loop and the uniaxial test, load versus strain 
and stress versus strain curves can be generated.  The data from the uniaxial test must be 
curved fitted in order to generate a relationship between the load and strain.  Due to the 
shape of the uniaxial data, a linear and exponential curve fit is necessary.   
The curve fits were then used with the strain data from the in vitro flow loop data.  The 
strain from the flow loop data was put into the correct equation and the corresponding 
load was calculated.  Then, a load versus time curve was generated for the in vitro flow 
loop.  This curve could also be plotted with trans-mitral pressure to indicate at which 
point in the cardiac cycle the maximum load was attained. 
4.5 Histology and Biochemical Composition 
4.5.1 Tissue Processing 
Chordae tendineae were dissected from fresh porcine mitral valves according to insertion 
location.  Figure 4.13 is a schematic diagram of the chordae tendineae classified by their 
insertion into the leaflets.  After extraction, the chordae tendineae were fixed in 10% 
neutral buffered formalin for 24 hours.  The chordae tendineae were transferred to 70% 
ethanol until tissue processing.  The tissue was processed in paraffin using the Shandon 
Pathcentre.  After tissue processing, the chordae tendineae were embedded in paraffin 
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wax in both the longitudinal and radial directions.  This allowed the tissue to be cut into 5 
micron sections with a Microtome Microm HM355S and placed on specially treated 
slides (Superfrost, Plus, Shandon).  The tissue sections where dried overnight in a 37°C 
incubator, and then utilized for different staining protocols.  Standard deparaffinization 
was performed on each slide before staining.  Deparaffinization was completed with 
xylene, descending grades of alcohol, and finally to deionized water.   
 
Figure 4.13: Diagram showing the chordae insertion pattern of the mitral valve.  The valve was cut 
along the posterior leaflet.  Six different types of chordae are shown.  The histology studies focused 
on all six chordae.  The in vitro tests focused on the anterior strut chord. 
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After staining, all slides were observed with either conventional brightfield microscopy 
or a 100 Watt mercury lamp fluorescence light source using the Nikon Eclipse E600 
microscope/imaging system.   Images were recorded with a high-resolution CCD camera 
(Quantix, Photometrics) using Quantum Image (Release 4.0) software.  All images had a 
final image resolution of 1280 X 1024 and a 48 bit intensity resolution. 
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4.5.2 Hematoxylin and Eosin Stain 
A standard hematoxylin and eosin (H & E) stain was performed to determine cellular 
distribution.  After deparaffinization, the tissues were stained with hematoxylin to stain 
the cell bodies black and eosin to stain the surrounding tissue pink.  The deparaffinization 
and H & E stain were performed with a Leica Autostainer XL following a standard H & 
E protocol which can be found in Appendix D.  Coverslips were mounted over the 
sections with Permount and air dried overnight.  The H & E sections were viewed with 
both brightfield microscopy and fluorescence with the Nikon Eclipse E600 microscope.   
4.5.3 Verhoeff and van Gieson Stain 
A standard Verhoeff stain followed by a van Gieson stain was performed to determine 
collagen, elastin, and cellular distribution.  After deparaffinization, the sections were 
stained for 20 minutes in Verhoeff’s elastic stain.  The sections should appear jet black 
after this stain.  Microscopic differentiation was carried out in 1% ferric chloride until the 
background tissue was colorless and the elastic fibers were black.  If sections were over 
differentiated, they were replaced in the Verhoeff’s elastic stain and microscopic 
differentiation was carried out again.  After rinsing in distilled water, the sections were 
place in sodium thiosulfate for 1 minute to remove the iodine.  After rinsing in running 
tap water, the sections were stained in a van Gieson solution for 1 minute.  The sections 
were dehydrated through ascending grades of alcohol, cleared in xylene, and cover slips 
where mounted with Permount.  Arterial cross sections were used as a control during the 
staining process.   
During the Verhoeff stain, the elastin and cell bodies are stained black.  The iodine in the 
Verhoeff solution may act as a trapping agent for the cationic dye, facilitation staining of 
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elastic fibers and retarding the extraction of stain from elastic fibers during 
differentiation.  The dilute ferric chloride solution used for differentiation is used to break 
the tissue dye complex.  Also note that the picric acid in the van Gieson stain will also act 
as a differentiation agent.  The van Gieson stain is used to differentiate the collagen from 
the other tissue.  The collagen appears red, while the other tissue remains yellow.  The 
Verhoeff and van Gieson stain was observed using brightfield microscopy with the Nikon 
Eclipse E600 microscope. 
4.5.4 Verhoeff and Light Green Stain 
 
A standard Verhoeff stain followed by a light green stain allowed for observing elastin 
distribution.  Due to the picric acid contained in the van Gieson solution, the continued 
differentiation of the elastin fibers caused them to release the dye making it difficult to 
delineate the elastin fibers in the tissue.  Therefore, by using a light green stain as a 
counterstain to the Verhoeff, the elastin maintained the cationic dye.  The procedure 
followed was similar to the Verhoeff and van Gieson stain; however, in place of the van 
Gieson stain, a light green stain was used.  The same clearing and mounting procedure 
was used as before.  The protocol is located in Appendix D.  The elastin and cell nuclei 
stain black and the remaining tissue stains light green.  The Verhoeff and light green stain 
was observed using brightfield microscopy with the Nikon Eclipse E600 microscope.    
4.5.5 Immunohistochemistry 
 
Immunohistochemistry was performed on all six chordae tendineae in the radial direction 
to verify the finding of vasculature.  After standard deparaffinization and rehydration to 
water, the sections were washed in 1X PBS for five minutes.  This wash in PBS stabilizes 
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the antigen-antibody interactions.  The sections were pretreated with 100 µg/ml of 
protease for 10 minutes in order to better expose the antigen of interest.  During 
pretreatment, the sections were incubated in a humid container.  Sections were washed in 
1X PBS to remove the excess enzyme.  Endogenous peroxidase, false positives, was 
blocked using 0.3% H2O2 in methanol for 15 minutes.  After rehydration in 1X PBS, the 
tissue was blocked with 1% gelatin/PBS mixture to neutralize the tissue to prohibit non-
specific binding.  The first antibody, rabbit α-vWF, was applied and the sections placed 
in a humid chamber for 1 hour.  After washing in 1X PBS, a biotinylated secondary 
antibody, goat anti-rabbit IgG, was applied and the sections were incubated for 30 
minutes in a humid chamber.  Once the slides were washed in 1X PBS, the ABC mixture, 
avidine-biotin-peroxidose, was applied to the slides and incubated in a humid chamber 
for 1 hour.  The avidine binds with the biotin which was contained in the second 
antibody.  After washing in 1X PBS and deionized water, diaminobenzidine, DAB, was 
applied to each section for 4 minutes.  The sections were then counterstained with 
hematoxylin, dehydrated through graded alcohols, xylene, and coverslipped with 
Permount.  The sections were observed using brightfield microscopy with the Nikon 
Eclipse E600 microscope.  The exact protocol is located in Appendix D.     
4.5.6 DNA, Collagen, and Elastin Assays 
Assays were performed on all six chordae tendineae to quantify the amount of DNA, 
collagen, and elastin contained in each of the different chordae.  After dehydration for 48 
hours, the tissue was then digested according to the specific assay.  For the DNA and 
elastin assays, the tissue was digested for approximately 6 days with proteinase K, 
incubated in a water bath at 55°C.  Since the chordae contain soluble and insoluble 
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collagen components, two digestion processes were utilized.  For the collagen assay, the 
tissue was digested for approximately 24 hours with pepsin to digest the soluble collagen 
and then placed in a water bath at 80°C to dissolve the insoluble collagen.  The protocols 
for the DNA, collagen, and elastin assays are given in Appendix D. 
4.6  Statistical Analysis 
All mechanical (flow loop and uniaxial) and biological (histology and biochemical) data 
are reported as mean ± one standard deviation unless otherwise stated.  Means were 
compared using t tests for paired comparisons.  A p-value less than 0.05 was considered 









The results for this study are divided into four main sections.  Section 5.2 contains the 
results for the anatomical measurement of the anterior lateral and posterior medial strut 
chordae study.  Section 5.3 contains the results for the in vitro flow loop studies.  All data 
for this study are included in the results chapter.  Section 5.4 contains the results for the 
uniaxial test completed on all eleven strut chordae.  All raw and processed data for this 
study are included in the results chapter.  Section 5.5 contains the results for the 
histological and biochemical composition of the chordae tendineae.  All processed data 
are included in the results chapter.  All raw data for the biochemical assays can be found 
in Appendix E.  Additional histological pictures not shown in the results chapter can be 
found catalogued on CD1. 
5.2 Anatomical Measurements 
Measurements of the diameter and length from the origin in the papillary muscle to 
insertion point on the anterior leaflet were taken of both the anterior lateral and the 
posterior medial strut chordae.  The strut chordae which inserted in the posterior medial 
papillary muscle had a diameter of 1.68 ± 0.22 mm and a length of 36.29 ± 3.23 mm.  
The strut chordae which inserted in the anterior lateral papillary muscle had a diameter of 
1.47 ± 0.12 mm and a length of 29.82 ± 5.18 mm.  It was found that there was a 
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significant difference (p<0.02) between the diameter and lengths of the two strut chordae, 








































( b ) 
Figure 5.1: Geometrical differences between the posterior medial and anterior lateral strut chordae 
in (a) diameter and (b) length  ( * indicates p< 0.05).  It was found that there was a significant 
difference (p<0.02) between the diameter and lengths of the two strut chordae.  The strut chord 
which inserted into the posterior medial papillary muscle was significantly longer and thicker than 




Table 5.1 below contains the values of the diameter and length for all posterior medial 
and anterior lateral strut chordae measured.   
 
Table 5.1: Diameter and length measurements for both strut chordae.  It was found that there 
was a significant difference (p<0.02) between the diameter and lengths of the two strut chordae.  
A p-value less than 0.05 was considered significant. 
  Diameter (mm) Length (mm) 
Specimen Posterior Medial Anterior Lateral Posterior Medial Anterior Lateral 
1 1.826 1.505 37.304 28.109 
2 2.060 1.471 39.544 39.544 
3 1.481 1.526 38.455 25.822 
4 1.610 1.638 29.359 26.953 
5 1.351 1.293 35.423 24.525 
6 1.576 1.302 39.136 34.555 
7 1.611 1.391 33.786 31.715 
8 1.759 1.445 35.486 24.357 
9 1.887 1.631 38.150 32.797 
Average 1.685 1.467 36.294 29.820 
Std. Dev 0.219 0.125 3.232 5.178 
p-value 0.020 0.006 
 
 
5.3 Flow Loop Experiments 
A total of six valves and eleven strut chordae were examined during this study.  Figures 
5.2 a-k depicts the strain experienced during the cardiac cycle under physiologic flow 
conditions for all eleven strut chordae examined.  The valves were tested at a peak trans-
mitral pressure of 106.1 ± 7.7 mmHg and mean cardiac flow of 5.41 ± 0.35 L/min.  When 
tested under the defined normal position[13,17], the valves coapted well with no regurgitant 



























































































































































































( k )  
Figure 5.2: Strain data from eleven strut chordae from the flow loop experiments. Anterior lateral 
strut chordae (a, c, e, g, i) and posterior medial strut chordae (b, d, f, h, j, k). 
 
 
Figure 5.3 describes the cardiac cycle with 0 msec representing when the mitral valve 
begins to close.  All subsequent time references correspond to the time in the cardiac 




















































Figure 5.3: Pressure and flow curves from the Georgia Tech left heart simulator.  The valves were 
tested at a peak trans-mitral pressure of 106.1 ± 7.7 mmHg and mean cardiac flow of 5.41 ± 0.35 
L/min. 
 
The average strain experienced on the chordae is given in Figure 5.4.  The maximum 
strain experienced during the cardiac cycle was 4.43% ± 3.43% and was experienced at 
249 msec after the start of valve closure.  The valve closed between 14 and 150 msec 
with a strain rate of approximately 75.3% ± 48.6% strain per second on both strut 
chordae.  It was also found that the strain increases in both strut chordae after the start of 
valve closure and plateaus before the trans-mitral pressure increases at valve closure; 
hence the trans-mitral pressure and chordae strain increases are not synchronized.  There 
is a strain plateau after the start of valve closure between 192 and 298 msec.  The valve 
opened between 320 and 420 msec with a strain rate of approximately -54.8% ± -56.6% 
strain per second on both strut chordae.  Between 420 and 486 msec, the anterior leaflet 
opened to its maximum.  After 486 msec, the valve remained open until 860 msec, when 
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the next cycle begins.  Immediately after opening, there is a small negative strain on the 
strut chordae which occurs when the strut chordae and the anterior leaflet are parallel to 
each other, causing a no strain situation on the chordae.  Immediately after this negative 
strain, when the anterior leaflet continues to open, there is a large peak in strain at 486 
msec which corresponds to the maximum leaflet opening.  The chordae then pulls the 
anterior leaflet back to a situation of little or no strain.  Small oscillations in the chordae 
occur when the valve is open and the fluid flows from the atrial chamber through the 




































Figure 5.4: An example of strain versus time relationship for the in vitro measurements of strain 
using dual camera stereo photogrammetry.  The maximum strain experienced during the cardiac 
cycle was 4.43% ± 3.43% and was experienced at 249 msec after the start of valve closure.  The valve 
closed between 14 and 150 msec with a strain rate of approximately 75.3% ± 48.6% strain per second 
on both strut chordae.  The valve opened between 320 and 420 msec with a strain rate of 
approximately -54.8% ± -56.6% strain per second on both strut chordae. 
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The maximum strain, loading rates, and unloading rates are given in Figure 5.5.  As can 
be seen, there is no significant difference between the loading and unloading rates.  The 
loading rate (valve closure) was slightly higher at 75.3% ± 48.6% strain per second than 
the unloading rate (valve opening) at -54.8% ± -56.6% strain per second.  Table 5.2 
below contains the values of the maximum strain, loading rates, and unloading rates for 





































Figure 5.5: Maximum strain, loading and unloading rates for the strut chordae from the flow loop 
experiments.  The maximum strain uses the vertical axis on the left (%strain).  The loading and 
unloading rates use the vertical axis on the right (%strain per second).  There was no significant 
difference between the loading and unloading rates.  The loading rate (valve closure) was slightly higher 







The maximum strain, loading, and unloading rates for the two strut chordae were also 
compared, as seen in Figure 5.6.  There was no significant difference in the strain, 
loading rates, or unloading rates between the two strut chordae.  The strut chordae which 
inserted into the anterior lateral papillary muscle had a slightly higher maximum strain 
(5.7% ± 3.8%) and loading rate (80.5% ± 51.9% strain per second) than the strut chordae 
which inserted into the posterior medial papillary muscle (5.5% ± 2.3% and 68.1% ± 
48.3% strain per second).  The strut chordae which inserted into the posterior medial 
papillary muscle had a higher unloading rate (-68.5% ± -59.1% strain per second) than 
the strut chordae which inserted into the anterior lateral papillary muscle (-44.9% ± -










































( c ) 
Figure 5.6: Comparison of (a) max strain, (b) loading and unloading rates for the two strut chordae 
for the flow loop experiments.  There was no significant difference in the strain, loading rates, or 







Table 5.2 below contains the values of the maximum strain, loading rates, and unloading 
rates for all posterior medial and anterior lateral strut chordae measured.  
 
Table 5.2: Maximum strain, loading, and unloading rates determined for both strut chordae during 
the flow loop experiments.  There was no significant difference in the strain, loading rates, or 





Loading Rate  
(%Strain per second) 
Unloading Rate  














1 4.907 5.838 39.423 137.920 -102.730 -24.293 
2 3.582 6.960 139.480 149.500 -5.464 -28.276 
3 9.523 3.190 95.904 47.876 -72.869 -24.947 
4 5.271 12.842 40.856 106.230 -146.050 -172.850 
5 4.388 6.725 24.616 24.474 -15.612 -14.861 
6   2.004   73.713   -9.430 
7   2.339   23.609   -40.315 
Average 5.534 5.699 68.056 80.475 -68.545 -44.996 
Std. Dev 2.318 3.762 48.279 51.971 59.109 57.230 
0.933 0.684 0.504 p-value 
 0.352 
  
5.4 Uniaxial Tests 
Preliminary experiments were conducted to determine the necessity of using a camera 
system to measure strains in a localized region.  Figure 5.7 shows the difference in load-
strain behavior between the uniaxial testing machine and the marker displacement 
recorded by the camera system.  When calculating the strain using the uniaxial testing 
machine, the lengths are determined by the distance between the clamps (cross-head 
displacement).  When calculating the strain using the camera, the lengths are determined 
by using a non-contacting optical method, i.e. tracking the displacement of the markers 
on the chordae.  The distances between markers located on the central region of the 
chordae are recorded using a high speed camera system.  The difference at mid-load (1 
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N) between the high speed camera system and the cross-head displacement was 46.2%.  
The strain calculated at mid-load (1 N) using the cross-head displacement would be 
approximately 46% higher than the strain calculated at mid-load using the high speed 




















Figure 5.7: Uniaxial test results comparing the camera system and the cross head displacement 
strain.  The difference at mid-load (1 N) between the high speed camera system and the cross-head 
displacement was 46.2%.  The strain calculated at mid-load (1 N) using the cross-head displacement 
would be approximately 46% higher than the strain calculated at mid-load using the high speed 
camera system. 
 
The same eleven strut chordae were examined during the uniaxial tests no more than 24 
hours after the flow loop experiments.  Figure 5.8 below shows the raw, unfit data for the 
eleven strut chordae used during this study.  Three features can be taken from the uniaxial 
tests: a non-linear load-strain relationship, a hysteresis loop in cyclic loading and 


































































































































































( k ) 
Figure 5.8: Raw, unfit uniaxial data for the eleven strut chordae.  Anterior lateral strut chordae (a, c, 








The loading and unloading curves obtained from the uniaxial tests were each fit with 
separate mixed linear-exponential curve, shown in Figure 5.9.  The first portion of the 
curve can be described with a simple linear fit; however, this portion of the curve was 
generally in the noise region of the force transducer.  The second portion of the curve can 
be described with an exponential fit.  The loading and unloading curve fits for Figure 5.9 
were:   
Loading curve:  y = 7 10-5e1.2306x  R2 = 0.9738 
Unloading curve:  y = 5 10-5e1.2385 R2 = 0.9688. 
The “toe” region between A and B, see Figure 5.9, is the physiological range in which the 
mitral valve chordal tissue normally functions.  The section B to C is considered the 
reserve strength of the chordae.  The shift that occurs between the loading and unloading 
curves during the uniaxial tests describes the amount of hysteresis inherent in the 
chordae.  The hysteresis is dependent on the loading condition and maximum load which 
was the same for all chordae examined.  The amount of hysteresis calculated at mid-load 
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Figure 5.9: Curve fits of the uniaxial data for (a) unload
region between A and B is the physiological range in wh
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Figure 5.10 below shows the exponential curve fits for the loading and unloading curves 
for each strut chordae examined.  The loading curves had a larger slope than the 
unloading curves which was expected.  The loading curves also began the transition into 
the “toe” region before the unloading curves which is characteristic of viscoelastic 
tissues.  The r-squared values for the curve fits were above 0.8 for all curves.  The 
transition strain and the slope in the linear region for both the loading and unloading 
curve were measured.  There was no significant difference between the posterior medial 
and anterior lateral chordae for these three measurements.  The transition strain, between 
A and B, for the posterior medial chordae was 4.95% ± 0.412% strain and for the anterior 
lateral chordae was 5.41% ± 0.27% strain.  The slope of the loading curve for the 
posterior medial chordae was 3.42 ± 3.08 N / %strain and for the anterior lateral chordae 
was 3.55 ± 1.27 N / %strain.  The slope of the unloading curve for the posterior medial 
chordae was 2.61 ± 2.25 N / %strain and for the anterior lateral chordae was 2.21 ± 1.00 




















Loading y =1·10-7 e2.8835x R2 = 0.8193 
Unloading y = 4·10-7 e2.58x R2 = 0.8318 
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Loading y = 7·10-5 e1.6108x R2 = 0.7443 




















Loading y = 7·10-6 e2.1086x R2 = 0.8201 
Unloading y = 8·10-7 e2.5514x R2 = 0.8747 





















( d ) 
Loading y = 7·10-5 e1.2306x R2 = 0.9738 



















Loading y = 2·10-7 e0.932x R2 = 0.9277 
Unloading y = 4·10-7 e0.8775x R2 = 0.9307 
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Loading y = 4·10-7 e1.4376x R2 = 0.8718 



















Loading y = 1·10-7 e1.705x R2 = 0.9107 
Unloading y = 7·10-8 e1.7229x R2 = 0.8894 





















( h ) 
Loading y = 0.0988 e0.4681x R2 = 0.8131 


















Loading y = 1·10-5 e0.9531x R2 = 0.9652 
Unloading y = 2·10-4 e0.7262x R2 = 0.9225 























( j ) 
Loading y = 0.1747 e1.083x R2 = 0.9677 


















Loading y = 0.0491 e1.2105x R2 = 0.918 
Unloading y = 0.0303 e1.1695x R2 = 0.9364 
( k ) 
Figure 5.10: Exponential curve fits for the uniaxial tests for all eleven strut chordae.  Anterior lateral 
strut chordae (a, c, e, g, i) and posterior medial strut chordae (b, d, f, h, j, k).  The loading curves had 
a larger slope than the unloading curves which was expected.  The loading curves also began the 
transition into the “toe” region before the unloading curves which is characteristic of viscoelastic 




5.5 Histology and Biochemical Composition 
5.5.1 DNA Content 
A Hoechst fluorescent assay was used to determine the DNA content of the chordae 
tendineae.  The anterior and posterior marginal chordae contained statistically 
significantly more DNA per mg of tissue than the other chordae (p<0.01).  The anterior 
strut chord was found to contain significantly less DNA per mg of tissue (0.63 ± 0.19 µg 
of DNA per mg of tissue dry weight) than all the other chordae (p<0.01).  There was no 
significant difference between the amount of DNA per mg of tissue for the commissural 
(1.26 ± 0.61 µg of DNA per mg of tissue dry weight), posterior intermediate (1.01 ± 0.40 
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µg of DNA per mg of tissue dry weight), and basal posterior (1.09 ± 0.38 µg of DNA per 
mg of tissue dry weight) chordae.  There was also no significant difference between the 
anterior (1.90 ± 1.14 µg of DNA per mg of tissue dry weight) and posterior (2.70 ± 1.24 
µg of DNA per mg of tissue dry weight) marginal chordae.  The amount of DNA per mg 
of tissue for each chord is presented in Figure 5.11.  The raw data containing values for 



































Figure 5.11: Amount of DNA per mg of tissue ( * indicates p< 0.05).  A Hoechst fluorescent assay was 
used to determine the DNA content of the chordae tendineae.  The anterior and posterior marginal 
chordae contained statistically significantly more DNA per mg of tissue than the other chordae 
(p<0.01).  The anterior strut chord was found to contain significantly less DNA per mg of tissue than 
all the other chordae (p<0.01). 
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5.5.2 Collagen Content 
The amount of acid-pepsin soluble collagen was quantified using a sircol red colorimetric 
assay kit.  The amount of collagen per mg of tissue for each chord is presented in Figure 
5.12.  The results showed that the posterior marginal chord contained significantly more 
collagen per mg of tissue than the other chordae (p<0.01).  The posterior marginal 
chordae contained 14.89 ± 6.83 µg of collagen per mg of tissue dry weight.  There was no 
significant difference between the other chordae.  The anterior strut chordae contained 
5.49 ± 4.05 µg of collagen per mg of tissue dry weight, the anterior marginal chordae 
contained 8.94 ± 3.38 µg of collagen per mg of tissue dry weight, the commissural 
chordae contained 6.24 ± 3.01 µg of collagen per mg of tissue dry weight, the basal 
chordae contained 6.71 ± 4.21 µg of collagen per mg of tissue dry weight, and the 
posterior intermediate chordae contained 6.23 ± 3.91 µg of collagen per mg of tissue dry 































Figure 5.12: Amount of collagen per mg of tissue ( * indicates p< 0.05).  The amount of acid-pepsin 
soluble collagen was quantified using a sircol red colorimetric assay kit.   The posterior marginal 
chord contained significantly more collagen per mg of tissue than the other chordae (p<0.01).    
 
5.5.3 Elastin Content 
The elastin content for each of the chordae was measured using the Fastin Elastin 
assay™.  The amount of elastin per mg of tissue for each chord is presented in Figure 
5.13.  The results showed no significant difference in the amount of elastin per mg of 
tissue between the chordae.  The anterior strut chordae contained 16.44 ± 11.03 µg of 
elastin per mg of tissue dry weight, the anterior marginal chordae contained 34.58 ± 
31.02 µg of elastin per mg of tissue dry weight, the commissural chordae contained 48.11 
± 53.58 µg of elastin per mg of tissue dry weight, the basal chordae contained 23.09 ± 
14.61 µg of elastin per mg of tissue dry weight, the posterior intermediate chordae 
contained 19.03 ± 34.77 µg of elastin per mg of tissue dry weight, and the posterior 
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marginal chordae contained 27.84 ± 62.45 µg of elastin per mg of tissue dry weight.  The 






























Figure 5.13: Amount of elastin per mg of tissue.  The elastin content for each of the chordae was 
measured using the Fastin Elastin assay™.   The results showed no significant difference in the 
amount of elastin per mg of tissue between the chordae.  
 
 
5.5.4 Hematoxylin and Eosin Stain 
Hematoxylin and Eosin (H & E) stains were performed on each type of chordae to 
determine cellular distribution.  Cell nuclei were stained dark blue, collagen fibers stained 
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( f ) 
Figure 5.14: H&E stains of all six chordae. (a) strut, radial, 4X; (b) anterior marginal, radial, 10X ; 
(c) commissural, radial, 4X ; (d) basal, radial, 10X ; (e) posterior intermediate, radial, 10X ; (f) 
posterior marginal, radial, 20X. 
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The H & E stained images were viewed using fluorescent microscopy to allow the 
directional loading crimping to be observed, as shown in Figure 5.15.  The collagen 
fibers aligned in the direction of loading which is characteristic to tissues whose function 
is mainly to transmit tension[18].  The outer layer of loose collagen fibers did not exhibit 
the same directional loading as the central core.  The fluorescent microscopy also 
exhibited the natural fluorescence of the elastin fibers.  Figure 5.16 shows the elastin 
fibers in the radial direction and circumferential direction.  However, due to the intense 
staining of the collagen, it was difficult to delineate the elastin fibers from the collagen; 
therefore, a Verhoeff counterstained with a light green stain was used to distinguish the 




Figure 5.15: H&E stain of a strut chord observed under fluorescent microscopy to observe 
directional crimping.   The collagen fibers aligned in the direction of loading which is characteristic to tissues 
whose function is mainly to transmit tension[18].  The outer layer of loose collagen fibers did not exhibit the same 
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Figure 5.16: H&E stain of strut chordae observed under fluorescent microscopy to distinguish elastin 
fibers in the (a) longitudinal and (b) radial directions.  The elastin fibers ran in the longitudinal 
direction in both the inner collagen core, and the middle layer of loose collagen. 
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5.5.5 Verhoeff & Light Green Stain 
A Verhoeff stain, counterstained with a light green, stained the elastin fibers and cell 
nuclei black and the remaining tissue light green.  Elastin fibers were observed in both 
the inner collagen core and the outer loose layer of collagen.  The elastin was found to 
exist as single fibers and not arranged in fibrils as normally found in soft tissues.  Figure 
5.17 shows elastin fibers interwoven with the collagen fibers in the central collage core.   
 
 
( a ) 
 
( b ) 
 
( c ) 
 
( d ) 
Figure 5.17: Anterior strut chordae stained with Verhoeff counterstained with light green.  The cell 
nuclei and elastin fibers stain black and the surrounding tissue stains green.  Sections are 5 microns 
thick in both the radial and longitudinal directions. (a) strut, longitudinal, 20X; (b) strut, 
longitudinal, 40X; (c) strut, radial, 20X; (d) strut, radial, 40X.  The elastin was found to exist as 
single fibers and not arranged in fibrils as normally found in soft tissues. 
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5.5.6 Verhoeff & van Gieson Stain 
A Verhoeff stain, counterstained with a van Gieson stain, was performed to distinguish 
between the collagen, elastin, cellular nuclei, and the surrounding tissue.  The collagen 
was stained red, the elastin black, the cellular nuclei black and surrounding tissue yellow.  
As shown in Figure 5.18, the outer layer of the chordae stained red for collagen.  This is 
in contrast to previous findings stating that the outer layer is composed entirely of 
elastin[6].  There were a few single elastin fibers that were seen in the Verhoeff/light 
green stain.  Areas in the outer layer of the chordae stained yellow, indicating tissue that 
was not composed of collagen or elastin.  These structures were vessels; this was verified 
with immunohistochemistry.  The vessels were found to run in the longitudinal direction.  
This indicates that the vessels did not run directly up the chordae, but circle the chordae 
as they proceed from the papillary muscles to the leaflet.  Staining was performed on six 
samples of each chordae.  Figure 5.18 below shows a representative sample of each 
chordae stained with the Verhoeff/van Gieson stain in the radial direction.  Figure 5.19 
shows the vascular distribution between the six chordae.  Each chordae contained vessels; 
however, it was found that the anterior strut chordae contain significantly more vessels 
than the other chordae.  The anterior strut chordae contained 4.73±3.13 vessels, the 
anterior marginal chordae contained 1.50±2.07 vessels, the commissural chordae 
contained 1.50±1.35 vessels, the basal posterior chordae contained 1.27±1.74 vessels, the 
posterior intermediate chordae contained 1.43±1.13 vessels, and the posterior marginal 
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Figure 5.18: Verhoeff and van Gieson stain of all six chordae.  The collagen stains red, the elastin and 
cell bodies stain black, and the remaining tissue stains yellow. (a) strut, radial, 4X; (b) anterior 
marginal, radial, 10X; (c) commissural, radial, 4X; (d) basal, radial, 10X; (e) posterior intermediate, 
radial, 10X; (f) posterior marginal, radial, 20X.  This stain allows the vessel structure to be 
differentiated from the surrounding tissue.  The vessels were found to run in the longitudinal 
direction 
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Figure 5.19: Number of vessels in all six chordae.  The strut chordae contain significantly more 
vessels than the other chordae ( * indicates p< 0.05). 
 
Table 5.3 below contains the number of vessels contained in each of the six types of 
chordae.  The p-values between each chord are listed in Table 5.4.  The number of 
vessels for each type of chord was compared with the other 5 types of chordae using a t 
test for paired comparison.  A p-value less than 0.05 was considered significant.  









Table 5.3: Number of vessels per chordae.  The strut chordae contain significantly more vessels than 
the other chordae. 
Specimen Strut 
Anterior 





1 4 0 1 3 3 0 
2 4 2 4 5 2 2 
3 4 2 2 0 2 0 
4 9 6 2 0 2 1 
5 5 0 2 0 0 0 
6 4 0 1 0 0 0 
7 1 0 0 1 1 4 
8 12 2 3 0     
9 4   0 0     
10 3   0 2     
11 2     3     
Average 4.73 1.50 1.50 1.27 1.43 1.00 
St. Dev 3.13 2.07 1.35 1.74 1.13 1.53 
 
Table 5.4: The number of vessels for each type of chord was compared with the other 5 types of 
chordae using a t test for paired comparison.  p-values are listed below.  A p-value less than 0.05 was 
considered significant.  The strut chord was significantly different than the other five chordae. 
  Strut 
Anterior 





Strut - 0.022 0.007 0.005 0.017 0.01 
Anterior 
Marginal 0.022 - 1 0.798 0.937 0.608 
Commissural 0.007 1 - 0.744 0.911 0.488 
Basal 0.005 0.798 0.744 - 0.837 0.739 
Posterior 
Intermediate 0.017 0.937 0.911 0.837 - 0.562 
Posterior 
Marginal 0.01 0.608 0.488 0.739 0.562 - 
 
5.5.7 Immunohistochemistry 
Immunohistochemistry was performed with von Willebrand factor to stain for porcine 
endothelial cells.  The endothelial cells were stained dark brown, the surrounding tissue a 
light gray and non-endothelial cell nuclei blue.  This stain was performed to verify the 
finding of vasculature in the chordae.  In addition to the vascular endothelium, a single 
layer of endothelial cells surrounding the chordae was detected.  Figure 5.20 shows an 
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Figure 5.20: IHC of the chordae in the radial direction.  The endothelial cells are stained brown, 
other cell nuclei are stained blue, and the surrounding light gray.  Sections are 5 microns in the 
radial direction. (a) anterior marginal, radial, 40X; (b) anterior marginal, radial, 40X; (c) strut, 







In this study, dual camera stereo photogrammetry was used to measure in vitro strains 
experienced by the chordae tendineae of the mitral valve under physiologic conditions.  
This technique has been used in previous studies to measure strains on the surface of the 
anterior leaflet of the mitral valve[5], but has never been utilized to measure strains on the 
chordae tendineae.   
This is the first study to measure dynamic strains on the mitral valve chordae in vitro 
under normal physiologic conditions.  This study further helps to understand the material 
properties, specifically the load and strain characteristics, of the chordae tendineae of the 
porcine mitral valve. 
The in vitro flow loop experiments show that there is no significant difference in the 
strain rate during the loading and unloading phases.  The small but insignificant 
difference in strain rates between the loading and unloading rates are consistent with the 
loading and unloading seen during the uniaxial tests.  It shows the inherent hysteresis in 
the chordae which is found in most soft tissues (Figure 4.3.4).  These differences in the 
loading and unloading phases are in contrast to the differences in strains rates on the 
surface of the anterior leaflet found by Sacks et al.[5].  The anterior leaflet had slightly 
higher strain rates during the unloading phase (opening) than the loading phase (closing).  
The difference in strain rate response during the loading and unloading phases between 
the chordae and the anterior leaflet is due to their function during the cycle.  During the 
closing phase, the chordae must ensure the leaflets form a line of coaptation preventing 
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regurgitation.  The closing phase happens in response to an increase in pressure causing 
the valve to close.  The chordae are put under high strain rates as they straighten to ensure 
coaptation.  During the opening phase, the leaflets are subjected to a higher negative 
transmitral pressure differential causing the leaflets to open.  This pressure forces the 
leaflets to open and allows blood to fill the ventricle hence creating a higher strain rate on 
the leaflets during opening as blood surges through the valve.  Therefore, the chordae 
withstand a higher loading rate during the closing phase while they prevent leaflet 
prolapse, and the anterior leaflet withstands a higher loading rate during the opening 
phase in response to the decrease in pressure in the ventricle.  The mitral valve apparatus 
is a complex system containing many components that work together in synchronization 
to ensure functioning of the mitral valve. 
The loading and unloading strain rates for the strut chordae which originate from either 
the posterior medial or the anterior lateral papillary muscles were also compared (see 
Figures 4.1.1 and 4.2.4).  The strut chord which originates from the posterior medial 
papillary muscle is significantly longer from the insertion point in the anterior leaflet to 
the origin point in the papillary muscle and thicker in diameter than the strut chord which 
originates from the anterior lateral papillary muscle.  The anterior lateral papillary muscle 
is located closer to the annulus than the posterior medial papillary muscle, and hence has 
a shorter strut chord.  It was found that although there is a statistically significant 
difference in the diameter and length of these two strut chordae, there is not a statistically 
significant difference between the loading and unloading rates.  The strut chord which 
inserted into the posterior medial papillary muscle did not have a significant difference 
between loading and unloading rates than the strut chord which originated from the 
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anterior lateral papillary muscle.  When placed in the normal papillary muscle position, 
there was no significant difference in the maximum strain attained during valve closure 
between the two strut chordae.  Even though the two strut chordae differ significantly in 
anatomical measurements, there is no significant difference in their mechanical properties 
which is supported by the uniaxial test results.  There was no significant difference 
between the loading and unloading curves of the uniaxial tests between the two strut 
chordae.    Also, if the forces on the anterior leaflet generated by the strut chordae differ 
on either side of the leaflet, then the shape of the annulus may not be conserved leading 
to a redistribution of forces among the other chordae tendineae.  This redistribution of 
forces could lead to premature chordal dysfunction, if the force is greater than the chord 
can withstand, or malcoaptation between the anterior and posterior leaflets.  The tension 
during valve closure and the angle of insertion into the anterior leaflet is similar between 
the two strut chordae[19]. Therefore, in order to maintain valve integrity, the strut chordae 
must have differences in their points of origin in the papillary muscles, insertion angle or 
location, so that the two strut chordae exert the same mechanical force on the anterior 
leaflet.       
As found on the surface of the anterior leaflet[5], there is a plateau of nearly constant 
strain in the chordae during valve closure.  This constant plateau indicates that there is 
minimal creep during valve closure.  Although this plateau does not extend over the 
entire closure period as that seen in the anterior leaflet, it still suggests that there is 
minimal creep.  The highly crosslinked collagen within the chordae contain the 
mechanisms to prevent creep due to the low amount of proteoglycans.  The tissue in the 
chordae must act more as an elastic tissue, which would have minimal creep 
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characteristics such that there is no regurgitation.  If the chordae experienced creep seen 
in many visco-elastic tissues, the chordae would become elongated during valve closure 
and malcoaptation would occur leading to regurgitation.  It is known that collagen types I 
and III has a significant amount of stress relaxation.  Stress relaxation studies conducted 
on collagen substrates show that when collagen is held at a constant strain (2%), there is a 
30% decrease in stress at 50 seconds due to stress relaxation[20].  The collagen/GAG 
structure found in the chordae help to prevent the stress relaxation that could occur during 
the cycle[37].  The amount of fibrillar interactions affects the amount of relaxation in the 
chordae.  The chordae which contain more fibrillar interactions, such as the anterior and 
posterior marginal chordae, would have less slippage of the collagen bonds and have less 
relaxation[37].  This is important in maintaining the function of the marginal chordae 
during the closure period.  Without the integrity of the marginal chordae, the tips of the 
valve could cause miscoaptation leading to regurgitation. 
The strain plateau experienced during valve closure had strain values between 3.75-
4.29%, which is in the “toe” region of the uniaxial test, indicating that the strain incurred 
on the chordae during valve closure occurs in the range of normal physiologic function 
for the chordae.  This is similar to the findings of Sacks et al.[5] when measuring surface 
strains on the anterior leaflet.  It was found that the strain plateau on the anterior leaflet 
during valve closure was within the “toe” region of the stress-strain curve.  In the “toe” 
region, the collagen fibers have been stretched until they are straight.  After the “toe” 
region, the collagen fibers lock and there is a nonlinear stress-strain response.  The 
stretching in the region immediately following the locking of the collagen fibers involves 
the straining of the bonds and bond angles within the fibrils[11].  The tissue becomes stiff 
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to the point where further deformations of the tissue are prevented even when the 
transmitral pressure increases.  If the chordae functioned outside of the “toe” region, 
further deformation of the tissue, such as plastic deformation of the collagen, could occur 
during this strain plateau.   Histological studies are being conducted to evaluate if the 
collagen fibers lock subsequent to the “toe” region of the stress-strain curve.  
During the time period of the strain plateau, the collagen fibers lock and a force greater 
than the initial force, the force needed to cause the valve to close, is needed to strain the 
tissue.  A study conducted by Lim et al.[9] showed that the elastin fibers cannot contribute 
to the initial segment of the stress-strain curve (Figure 5.9), and the transition into the 
“toe” region is due to the locking of the collagen fibers.  Once the collagen fibers have 
straightened, the elastin fibers begin to stretch along with the collagen fibers.  In order to 
keep the collagen fibers from stretching to a point of plastic deformation during the strain 
plateau, the elastin fibers must have an inherent property to prevent stress relaxation.  
After the collagen fibers have locked, the elastin begins to stretch and withstand the 
effects of constant strain preventing the collagen fibers from stretching further.  The 
amount of stretch the chordae can withstand due to the decrease in crimp period, 
decreases with age.  As a person ages, Lim et al.[11] showed that the waviness, the amount 
of crimp, of the collagen decreases by 7%.  This decrease in waviness in the collagen 
could be due to the stress relaxation of the collagen since the chordae have a significantly 
more amount of collagen per dry weight than elastin.  Due to the increase in the amount 
of collagen later in life[11], the elastin fibers can no longer provide the elasticity needed to 
bring the chordae back to the initial state before loading.  The amount of crimp in the 
collagen fibers will then decrease.  The decrease in crimp causes a shift in the stress-
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strain curve, and the collagen fibers will lock earlier causing the “toe” region to occur 
with less strain.  The strut chordae will still have a maximum strain of approximately 
5.5%; however, the functioning range of the chordae will occur under less strain due to 
the shift of the “toe” region.  Hence, the chordae withstand a larger strain, relative to their 
functioning range, during the later years of life causing more stress relaxation in the 
chordae.  The elastin fibers may not prevent stress relaxation due to the increase in the 
amount of collagen and the chordae could become longer causing the mitral valve to 
prolapse and hence induce regurgitation.     
During valve opening, there is a sharp increase in strain at approximately 488 msec (see 
Figure 5.4).  This sharp increase in strain stretches the strut chordae to a taut position 
while the leaflet is farthest from the line of coaptation.  It is thought that the strut chordae 
help to keep the leaflet from opening too far towards the septum during diastole.  When 
the strut chordae are cut, the inflow tract for blood goes from a funnel shape with a 
transversely curved anterior leaflet whose concavity is toward the mitral orifice, to a flat 
shape in which the central and lateral portions of the anterior leaflet move 
homogeneously[21].  This funnel shaped curvature should direct the blood flow towards 
the apex of the heart and facilitate ejection.  Figure 6.1 shows the curvature of the 
anterior leaflet during the opening phase of the mitral valve from both the atrial and 
ventricular sides.  The red line drawn shows the transversely curved anterior leaflet 
whose concavity is toward the mitral orifice.  This creates a funnel shape seen in (b) 
which directs the blood flow towards the apex of the heart and facilitates ejection.  In (b), 
the anterior and posterior leaflets create a funnel shape which is seen by the curvature of 
the red lines.   
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Figure 6.1: (a) Picture of the mitral valve from the atrial side during the open phase.  The red line 
drawn shows the transversely curved anterior leaflet whose concavity is toward the mitral orifice.  
This creates a funnel shape seen in (b) which directs the blood flow towards the apex of the heart and 
facilitate ejection. (b) Picture of the mitral valve from the ventricle side during the open phase.   The 
anterior and posterior leaflets create a funnel shape which is seen by the curvature of the red lines.  
 
Figure 6.2 is a diagram representation of the change in curvature of the leaflet surface 
after sectioning of the strut chordae.  In (a), the lateral portions of the anterior leaflet are 
held by the strut chordae.  After sectioning of the chordae as in (b), the lateral and central 
region of the anterior leaflet form a flat shape allowing the two areas of the leaflet surface 
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Figure 6.2: Diagram of the mitral valve (a) before sectioning of the strut chordae and (b) after 
sectioning of the strut chordae.  In (a), the lateral portions of the anterior leaflet are held by the strut 
chordae.  After sectioning of the chordae, the lateral and central region of the anterior leaflet form a 
flat shape allowing the two areas of the leaflet surface to move homogeneously during closure.  
Picture adapted from Goetz et al.[21]. 
 
Studies conducted by Messas et al.[22] showed that cutting of the strut chordae for surgical 
treatment of functional ischemic mitral regurgitation abolished the tethering of the body 
of the anterior leaflet, which increased leaflet coaptation.  However, this surgical repair 
technique is for patients in whom the papillary muscles have relocated towards the apex 
of the heart.  Since the lengths of the chordae remain constant during the relocation, the 
amount of anterior and posterior leaflet surface used for coaptation will decrease.  By 
cutting the strut chordae, the motion of the central region of the anterior leaflet was flat 
with the central and lateral portions of the anterior leaflet moving homogeneously.  
Although this increased the amount of anterior leaflet surface used for coaptation, the 
anterior leaflet did not generate a funnel shape and could potentially interfere with the 
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aortic valve outflow tract.  Figure 6.3 below describes the mitral valve in the open state 
with (a) both the strut chordae intact and (b) the strut chordae cut.  In (a), the strut 
chordae prevent the leaflet from obstructing the aortic outflow tract and also generate a 
funnel shaped curvature to direct the blood flow towards the apex of the heart.  With the 
strut chordae cut as shown in (b), the anterior leaflet protrudes into the aortic outflow 
tract.  The blood is not directed towards the apex of the heart which could influence 
blood recirculation inside the left ventricle and inefficient systolic ejection. 
 
 
Figure 6.3: Models of the mitral valve in the open position with (a) the strut chordae intact and (b) 
the strut chordae cut.  In (a) the leaflets form a funnel shape to direct blood flow to the apex of the 
heart.  In (b) the anterior leaflet protrudes into the aortic outflow tract.  Picture adapted from 
Messas et al.[22]. 
  
Small oscillations in the chordae occur when the valve is open and the fluid flows from 
the atrial chamber through the mitral valve and into the left ventricle chamber.  During 
these oscillations, the strain on the chordae can reach a negative value as seen in Figures 
5.2 and 5.4.  The negative values could be a result of the reference frame in which the 
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chordae are not in a relaxed, no strain situation, but rather a situation in which a constant 
strain is seen on the chordae.  No in vivo data has been collected to determine if the 
chordae are under a small strain during the entire cardiac cycle.  This negative strain 
value could also be the result of out of plane motion.  The strain definition used to 
determine the amount of strain seen in the chordae only accounts for the in plane strain.  
However, due to the dynamic nature of the chordae, there could be out of plane strain that 
needs to be taken into account.  Since the in plane motion was 77.5%±7.7%, the amount 
of strain attributed to the out of plane motion was neglected. 
The uniaxial tests of the chordae show the viscoelastic properties that are characteristic to 
most soft tissues[18].  Three features can be observed from the uniaxial tests: a non-linear 
load-strain relationship; a hysteresis loop in cyclic loading and unloading; and 
preconditioning in repeated cycles.  Several other investigators have performed uniaxial 
tests on the chordae tendineae of the mitral valve; however, their testing procedures 
involve the strain to be computed using the cross-head displacement technique[8,9,11,12].  It 
can be seen that there is a significant difference in the amount of strain incurred when 
comparing the cross-head displacement and the displacement between graphite markers 
located on the central region of the chordae.  The failure properties of the chordae will be 
correct since these do not depend on the strain measurement; however, the extensibility 
measurements will be biased.  There are many methods available to complete load-strain 
tests on soft tissue specimens: direct elongations from the testing machine (cross-head 
displacements), extensometer-based measurements, and strains based on non-contact 
optical methods[23].  All three methods have inherent limitations.  In direct strain 
measurements from the testing machine, extra strain energy is lost due to end effects.  
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This also occurs when the clamps are placed directly on the specimen, causing a 
significant stress concentration around the clamping mechanism.  Therefore, when testing 
tendons many protocols include leaving the tendon attached to the bone and muscle, and 
place the bone and muscle between the clamping mechanism and not the tendon tissue.  
The other two methods of testing, extensometers and non-contact optical methods contain 
their own inherent problems.  When using non-contact optical methods, measurements 
are taken over a specific region of the tissue specimen.  Due to variabilities in tissue 
microstructure over a specimen’s length, the measurements over the specific region 
imaged may not exhibit a true representation of the entire specimen.  However, 
histological studies have shown that the chordae exhibit the same biological make up 
throughout the entire length of the specimen.  The relative concentrations of collagen, 
elastin, and extracellular matrix components were found to be consistent throughout the 
length of the chordae[24].  Therefore, the use of non-contacting optical methods to 
measure strains during uniaxial testing of the chordae tendineae will provide unbiased 
results as compared to direct elongations from the testing machine.  Also, since the in 
vitro experiments were limited to a specific region of the chordae, the uniaxial test should 
use optical methods to measure the strain in the same region of the chordae such that the 
strains measured during the two separate tests can be compared.          
There are many similarities between the chordae tendineae and other tendons.  Tendons 
are composed of collagen fibrils arranged parallel to the direction of loading[18].  A 
similar microstructure was found in the chordae tendineae.  Along with the 
microstructure, the mechanical properties of the chordae tendineae and tendons are also 
similar in the functioning range.  It is known that tendons have a “toe” region between 2-
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5% which represents their normal physiologic functioning range[18].  The “toe” region of 
the chordae was between 3.5-4.5% which lies within the functioning range of the human 
calcaneal tendon[25].  However, the failure strain and failure load of the human calcaneal 
tendon are significantly less and significantly higher than the mitral valve chordae, 
respectively.  The failure strain of the mitral valve chordae varies according to chordal 
type:  posterior marginal 24.9% strain; basal 33.1% strain; anterior marginal 30.3% 
strain; and strut 43.9% strain[8].  The human calcaneal tendon had failure strains for the 
tendon substance of 8.8% strain[25].  The human calcaneal tendon has a greater failure 
load than the chordae.  The failure load of the chordae varies according to chordal type: 
posterior marginal 4.20 N, basal 12.93 N, anterior marginal 7.30 N; and strut 22.70 N[8].  
The failure load of the human calcaneal tendon is 1189 N[25].  Although the chordae and 
tendon exhibit different failure properties, the mechanical properties are similar in the 
extensibility region (“toe” region).   
Surgeons are currently using ePTFE sutures to replace diseased, damaged, or torn mitral 
valve chordae tendineae.  These sutures need to have the same mechanical properties as 
the native chordae in the functioning range.  When sutured to tissue, testing has shown 
that the ePTFE suture, the most commonly used suture material for chordae replacement, 
has a knot strength of approximately 10 N[26], which is above the maximum load attained 
for the chordae during valve closure[13, 17].  A study conducted by Cochran et al.[27] found 
that the elastic modulus of ePTFE sutures was significantly higher than that of the native 
porcine mitral valve chordae tendineae; however, the ePTFE suture did exhibit some 
viscoelastic characteristics, hysteresis and creep, that begin to approach native chordae 
properties. The suture materials can support a higher load during failure like the tendon, 
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but they do not exhibit the same properties in the functional range[28].  The intermediate 
results from patients who underwent replacement of diseased, damaged, or torn chordae 
tendineae with ePTFE sutures show a patient freedom from reoperation at 86% to 94% at 
10 years[29].  However, of the patients needing reoperation, 69% have had rupture of other 
native chordae[30, 31, 32].  This failure of other native chordae could be attributable to force 
redistribution on the native chordae after chordal replacement.  Tissue engineering 
constructs developed out of smooth muscle cells and composed of collagen have been 
developed[33].  The tissue engineered constructs developed have a significantly decreased 
failure stress and extensibility than native chordae[33].  The strain studies presented here 
show that the constructs do not necessarily need to a have a significant strength reserve, 
but they must be able to support maximum strains of approximately 4%.  The tensile 
strength and fatigue resistant characteristics of the native chordae has yet to be imitated 
with synthetic materials.  Presently, ePTFE sutures appear to be the best synthetic 
alternative for chordal replacement due to its viscoelastic characteristics and its ability to 
allow tissue ingrowth[27].  There is still a need to develop a better synthetic or tissue 
replacement for the chordae tendineae that more nearly approximates the mechanical 
behavior of mitral valve chordae tendineae.  Therefore, surgeons could potentially use 
tendons to replace torn, damaged, or diseased chordae since the tendons exhibit the same 
properties in the functioning range but can support a higher load during failure.  
Previous morphology studies of the chordae showed an inner collagen core surrounded 
by a middle layer of elastic fibers, and an outer layer of endothelial cells[6].  Histological 
examinations conducted during this study show that there are three distinct layers as 
previously reported; however, the middle layer is not completely composed of elastic 
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fibers.  A three dimensional model, representing all six types of chordae, is shown in 
Figure 6.4 illustrating the three distinct layers. 
 
The inner layer is composed mainly of densely packed, highly cross-linked collagen 
fibrils with few elastic fibers.  The collagen fibers provide the mechanical strength and 
integrity for the chordae.  The middle layer (Figure 6.4) was found to be composed of a 
loosely connected layer of collagen with elastic fibers interspersed within the collagen 
fibrils.  In a loose configuration, the collagen fibrils do not exhibit the high degree of 
strength found in the densely packed collagen fibers in the inner layer.  The elastin fibers 
found in this middle layer provide the elasticity seen in the chordae at lower stress levels 
when the collagen fibers are uncrimping.  Histological examination showed that during a 
 
Figure 6.4: Three dimensional model of the mitral valve chordae tendineae describing the 
histological composition.  There are three distinct layers: an inner collagen core, a middle layer of 
loose collagen with elastin fibers interwoven, and an outer layer of endothelial cells.  Vessels were 
observed running in the middle layer up the length of the chordae in a twisting motion. 









Vessels running inside 
the middle layer of 
loose collagen from the 
papillary muscle to the 
mitral apparatus 
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relaxed state, the collagen in the chordae had a crimped configuration and the elastic 
fibers were straight, hence giving the chordae mechanical properties that are similar to 
those exhibited by a composite material.  The initial segment of the nonlinear stress-strain 
curve is due to the uncrimping of the collagen and the final slope of the curve is 
attributed to the response of the elastin and the inner collagen core[9].  The highly 
crosslinked collagen seen in the inner layer of the chordae function to prevent creep and 
ultimately chordal elongation during valve closure.  Without the highly crosslinked 
collagen fibers, the chordae would lengthen during valve closure and allow the leaflets to 
prolapse and induce regurgitation.  A single layer of endothelial cells surrounds the entire 
chord.   
Using biochemical assays to study the compositional makeup of the six types of chordae 
(strut, anterior marginal, commissural, basal posterior, posterior intermediate, and 
posterior marginal), it was found that the anterior marginal and posterior marginal 
chordae contain significantly more DNA per milligram of tissue than the other chordae.  
The anterior marginal and posterior marginal chordae function to secure the anterior and 
posterior leaflets, respectively, during valve closure ensuring a line of coaptation.  The 
larger chordae, such as the strut and basal chordae, function to prevent the leaflets from 
prolapsing during valve closure and withstand the highest mechanical load during the 
cardiac cycle.  The thinner chordae, anterior and posterior marginal chordae, function to 
transmit the contractions of the papillary muscles to the mitral leaflets to ensure proper 
coaptation configuration.  The collagen structure in the chordae provides the tensile 
strength needed to perform these functions.  In order to ensure that the collagen structure 
does not degrade, fibroblasts must be present to repair and remodel the collagen matrix 
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by producing extracellular proteins under mechanical loading conditions[34].  In order to 
elucidate the need for fibroblasts to maintain collagen structure, a study was conducted 
on rabbit patellar tendon in which the collagen producing cells were extracted from the 
patellar tendon.  It was found that stress enhancement can affect the extracellular matrix 
of the patellar tendon without living cells[35] .  This infers that intrinsic fibroblasts inhibit 
the mechanical deterioration and repair micro-damage of the extracellular matrix induced 
by the stress enhancement.  Further studies investigated the response of fibroblasts to 
mechanical loading to conclude if mechanical loading was needed to stimulate these cells 
to produce and maintain the collagen matrix.  Sutker et al.[36] and Yang et al.[34] report 
that cyclic uniaxial mechanical stretching stimulates the collagen synthesis and 
proliferation of fibroblasts in vitro which further supports the findings of Tohyama et 
al.[35].  The increase in collagen synthesis and proliferation of fibroblasts which occurs 
during mechanical loading conditions, such as the loading on the chordae during the 
cardiac cycle, is important to the long term functionality of the chordae tendineae.  The 
higher concentration of DNA in the anterior and posterior marginal chordae suggests that 
these chordae have higher rates of cellular turnover and collagen production than the 
other chordae, in order to maintain the microstructure of the chordae and prevent 
mechanical deterioration.  These marginal chordae are essential for the correct coaptation 
of the leaflets; and therefore, they would contain more fibroblasts to maintain the 
collagen matrix in order to ensure mechanical function.     
All six types of chordae (strut, anterior marginal, commissural, posterior intermediate, 
basal posterior, and posterior marginal) contain the same amount of elastin per milligram 
of tissue.  The commissural chordae showed higher values of elastin which could be in 
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response to the amount of constant strain they withstand throughout the cycle.  The 
commissural chordae are taut throughout the cardiac cycle during both valve opening and 
closing.  This would infer that they are under a constant strain throughout the cycle 
causing the commissural chordae to be susceptible to higher stress relaxation conditions.  
Elastin has been shown to have lower stress relaxation properties than collagen[18]; 
therefore, a tissue containing more elastin would withstand the effects of stress relaxation 
more than a tissue with lower amounts of elastin.  The commissural chordae contain more 
elastin fibers than the other types of chordae in order to prevent stress relaxation during 
the cycle. 
The posterior marginal chordae contain more collagen per milligram of tissue than the 
other chordae.  This is in agreement with the DNA results which showed significantly 
more DNA per milligram of tissue.  The chordae which contain more DNA, contain more 
fibroblasts (connective tissue cells) which secrete an extracellular matrix rich in collagen 
and other macromolecules which influence the rate of collagen production and turnover.  
The more collagen the chord contains, the stiffer the chord under elevated stress levels.  
This finding is in agreement with Liao et al.[8] who found that the thicker strut chordae 
were more extensible and less stiff than the thinner marginal chordae.  The stiffness of 
the posterior marginal chordae is important during valve closure.  During valve closure, 
the anterior and posterior leaflets move homogeneously until the marginal chordae are 
extended.  The free margin of the anterior leaflet continues to move toward the posterior 
leaflet until the line of coaptation is formed.  The posterior marginal chordae is 
responsible for maintaining the position of the posterior leaflet during valve closure, 
while the free margin of the anterior leaflet continues to move.  After the posterior leaflet 
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has commenced movement and the anterior leaflet continues to move, the posterior 
marginal chordae needs a high degree of strength to prevent the posterior leaflet from 
prolapsing into the atrium during closure. 
The histological and biochemical examinations of the chordae describe the differences 
between the types of chordae based on function and insertion site on the mitral valve 
leaflets.  These differences must be considered during chordal translocation procedures as 
they may be essential to the long term outcome of the procedure.     
It was previously believed that the chordae tendineae of the mitral valve were simple 
collagenous structures which provided a means of communication between the papillary 
muscles and the mitral valve apparatus during the cardiac cycle[6].  However, vessels 
have been located in the chordae tendineae of the mitral valve and support the conclusion 
that the chordae are more than simple collagenous structures, but living tissues that act to 
support and feed the mitral apparatus.  The observed blood vessels, approximately 200µm 
in diameter, were found in the middle layer of the chordae running in a longitudinal 
manner from the papillary muscle to the mitral apparatus.  The vessels tended to twist 
around the chordae while ascending.  The vessels appear to feed the mitral apparatus and 
not the chordae.  This is supported by that observation that the major vessels running 
along the length of the chordae did not branch until they inserted into the leaflets.  Like 
other tendons, the chordae are thought to be fed through diffusion.  The nutrients from 
the blood first diffuse into the tissue fluid that surrounds the cells and then into the cells 
through four methods:  gases and lipid-soluble substances (fatty acids, dissolved gases) 
cross through the lipid layer of the cell membrane; water crosses by osmosis; ions cross 
by facilitated diffusion; and glucose and animo acids cross by active transport.  It is not 
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known whether the chordae receive nutrients from the diffusion of the nutrients from the 
blood circulating in the heart, or from the diffusion of the nutrients from the blood 
contained within the vessels traveling in the chordae.  Further investigation of these 
diffusion processes is necessary to have a definite answer as to how the chordae obtain 
nutrients from blood.   
Previous studies have shown that the mitral leaflets do contain vessels which bring a rich 
blood supply containing nutrients to the leaflet tissue[36]. These vessels were thought to 
have originated in the annulus of the mitral valve; however, the study presented here 
shows that some blood vessels which do insert into the mitral leaflets extend from the 
papillary muscles through the chordae and into the leaflets.  Further investigations, such 
as dye injection studies, are necessary to determine the origin of the vessels in the mitral 
leaflets.   
The strut chordae, which insert into the rough zone of the anterior leaflet, were found to 
have significantly more vessels than the other chordae.  The marginal chordae, which 
insert into the edges of the anterior and posterior leaflets, may be too small in diameter to 
support many vessels.  The size of the posterior leaflet as compared to the anterior leaflet 
may provide the reasoning behind the lack of vessels in the basal posterior and posterior 
intermediate chordae as compared to the strut chordae, even though they are similar in 
diameter.  Since the posterior leaflet is smaller in height from the valve annulus to the 
free margin than the anterior leaflet, it can obtain more blood from the annulus.  
Therefore, the need for a blood supply through the chordae is not necessary.  The blood 
vessels through the strut chordae lead to the thinner regions of the anterior leaflet which 
are farther from the annulus.  This may imply that the leaflets which are smaller in height 
 118
from the valve annulus to the free margin, commissural and posterior leaflets, obtain 
more blood from the annulus itself; whereas, the anterior leaflet receives blood from both 
the annulus and the chordae. 
Mitral valve repair is becoming a more attractive option instead of replacement.  
Currently silk, nylon, ePTFE, and Gortex sutures are used for chordal replacement.  If 
these synthetic materials are used to replace the native chordae, then the leaflet tissue 
where the native chordae insert may become necrotic due to a lack of blood and nutrient 





This study demonstrates the first in vitro examination of the strain experienced by the 
chordae tendineae of the mitral valve.  Dual camera stereo photogrammetry was used 
to measure in vitro strains experienced by the chordae tendineae of the mitral valve 
under physiologic function.  This non-invasive technique allows measurements of 
other sections of the mitral apparatus during physiologic and pathologic loading 
conditions.  
Geometrical measurements showed that although there was a significant difference in 
the length and diameter of the two strut chordae, there was an insignificant difference 
in the mechanical properties.  This alludes to the conclusion that the anatomical 
positions of the strut chordae are related to the point of insertion in the papillary 
muscle so that the chordae exert the same mechanical forces on either side of the 
anterior leaflet. 
It was found that the chordae experience different strain rates in the loading (75.3% ± 
48.6%) and unloading (-54.8% ± -56.6%) phases as the valve closes and opens.  This 
is similar to the properties of the anterior leaflet of the mitral valve[5].  There is a 
strain plateau of 4.43% ± 3.43% reached during valve closure that supports the 
hypothesis that there is minimal creep experienced by the chordae during valve 
closure.  During valve opening, the strut chordae hold the central region of the 
anterior leaflet in a funnel like shape to facilitate efficient filling of the ventricle 
during diastole.  Three features can be observed from the uniaxial tests: a non-linear 
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load-strain relationship; a hysteresis loop in cyclic loading and unloading; and 
preconditioning in repeated cycles which all are typical responses of biological soft 
tissues.  This suggests that the chordae exhibit similar material properties to the 
human calcaneal tendon in the normal functioning range.   
Histological examination indicated that previous studies have not adequately 
described the histological composition of the mitral valve chordae tendineae.  
Contrary to earlier belief, blood vessels were found in the chordae running from the 
papillary muscle to the insertion sites of the chordae on the mitral leaflets.  These 
vessels do not provide blood to the chordae, but rather act as a supply source to other 
parts of the mitral apparatus.  The presence of vessels characterize the chordae 
tendineae as complex living components that must work in coordination with the 
papillary muscles and valve leaflets to ensure proper mitral valve physiologic 
function.  Therefore, chordal translocation and cutting procedures must consider the 
presence of these biological structures as they will be essential to the long term 
outcome of these procedures. 
Chordae tendineae of the mitral valve have different microstructures according to 
chordal type.  Biochemical examination showed that the chordae contain different 
amounts of collagen, elastin, and DNA depending on chordal type.  It was concluded 
that the amounts of these different components is related to the function and location 
of the chordae.  The chordae which hold the largest load during the cardiac cycle, 
strut chordae, contained more collagen; all six types of chordae have similar elastin 
content to prevent stress relaxation during constant strain, and the chordae, anterior 
and posterior marginal, which function to ensure coaptation of the anterior and 
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posterior leaflets contain more DNA.  During chordal translocation procedures, 
surgeons must consider the biochemical composition of each chordae as it is specific 
to its location and function in the mitral apparatus.         
The findings in this study confirm that the mitral apparatus is composed of many 
components which work together in a complex, dynamic environment to ensure 
proper function.  Further understanding of the mitral apparatus, including the chordae 
tendineae, will help better define surgical techniques aimed at repairing the mitral 
valve to its normal functioning state. 
 
CHAPTER 8 
LIMITATIONS AND RECOMMENDATIONS 
 
8.1 Chordae Tendineae Marker Technique 
The in vitro study was used to define a technique that could measure strains experienced 
on the chordae tendineae of the mitral valve using a physiologic in vitro flow model.  
However, this study was limited to only measure strains on the anterior strut chordae.  
The amount of movement, i.e. the wide range of motion, of the anterior marginal chordae 
compared with the small amount of strain experienced during the cardiac cycle made 
spatial resolution a major factor with this technique.  The markers could not be clearly 
defined during the entire cardiac cycle.  A better calibration technique needs to be 
established to correct this limitation in spatial resolution.   
This study also focused only on normal physiologic conditions.  The study could be 
extended to include the pathological conditions in which the papillary muscles are moved 
in the apical, septal-lateral, and lateral directions.  The working fluid analog used was 
0.9% saline which does not have the same properties as blood.  The viscosity of saline is 
lower than that of blood; however, to use a blood analog with the same viscosity such as 
glycerin/water, the tissue properties would be compromised.  
Only strain information could be obtained using the developed method which is not 
sufficient to understanding chordal function.  However, forces on chordae have been 
measured in previous studies(17) and compliment this study.  
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8.2 Uniaxial Tests 
Uniaxial tests should be completed in which the sampling rate is 500 frames per second 
which is the limitation set by the camera system.  This would ensure less noise and 
fluctuations in the load/strain curves.  The uniaxial tests could also be used to measure 
differences in loading behavior between the six different chordae tendineae; however, 
previous studies have demonstrated the differences between the chordae during uniaxial 
tests[8,9,11,12].  The viscoelastic effect was not quantified to determine the error in load 
measurement and high speed loading control. 
8.3 Histology 
The histological studies need to be conducted on human chordae tendineae.  The 
vascularization of the tissue may be inherent only to porcine tissue.  The exact function of 
the vessels in the tissue has not been determined.  Using a micro-CT, dye can be injected 
into the tissue and the vessel morphology can be determined.  Also, a dye angiography 
can be used on living animals to also determine the role of the vessels during normal 
heart function.   
It has been postulated that the chordae tendineae of the mitral valve do not contain nerve 
fibers; however, it was also postulated that they do not contain vessels.  Therefore, a 
nerve stain should also be completed to determine the innervation of the chordae.  
Preliminary experiments have been conducted on this; however, the controls for both 
methods revealed flaws in the experimental procedure and definite conclusions could not 
be made.  The tissue should be injected with acetylcholinesterase immediately after 
harvest and then snap frozen.  The tissue could then be sectioned and stored as in 
standard histological staining.   
APPENDIX A 
 
VALVE PREPARATION AND HARVESTING PROTOCOL  
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Valve Preparation and Harvesting (Estimated time: 4 hours) 
A. Harvesting and mounting – Obtain fresh, small, porcine hearts from the abattoir 
(available Mondays and Wednesdays only; call a day ahead 770-786-2086).  
Measure the size of the annulus while intact inside the heart using the Edwards 
measurement system (use valve no larger than 34).  Dissect out the mitral valve, 
preserving chordae tendineae and papillary muscles (PM).  Suture the papillary 
muscles and annulus to their holders.  
1. Dissection/harvesting 
a. Identify left and right atria.  Remove left atrium to expose mitral valve.  
Remove right atrium and ventricle. 
b. Identify the aorta.  Cut the aorta lengthwise and into the ventricular 
septum.  Cut through the septum to open the left ventricle. 
c. Cut around the papillary muscles and around the annulus. 
d. Inspect the valve for damage before proceeding.  Using the curved 
scissors, trim around the annulus, leaving 3-5mm for suture.  Trim the 
papillary muscles as small as possible leaving insertion points intact.  
e. Refrigerate in saline. 
2. Suturing 
a. Papillary muscles – Cut a piece of Dacron cloth to fit around the papillary 
muscles.  Using 3-0 sutures (braided silk, Ethicon, NJ), suture the fabric to 
the muscle (side, middle, side).  Sew the fabric between the chordae.  Try 
not to deform the muscle or the chordae.   
b. Annulus – Suture the valve to the saddle-shaped annulus – Position the 
valve such that the anterior side is facing the flat side of the annulus 
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holder.  Tack down four corners with knots (anterior, posterior, 
commissures).  From the last corner, begin suturing around the posterior 
half using the cross-stitch technique.  Sew the anterior half using 2 
threads.  Cross-stitch out from the center of the anterior leaflet.  Finish all 





ENGINEERING DRAWINGS OF  THE IN VITRO FLOW LOOP
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Figure B.1: Plastic spacer placed at the end of the force rod. 
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Figure B.2: Metal turn rod placed at the end of the force rod to enable turning of the force rod. 
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Figure B.3: Metal cylinder placed on the force rod on the outer side of the 
ventricle chamber.  This connects to the inner metal cylinder to ensure no leakage 




Figure B.4: Metal cylinder placed on the force rod on the inner side of the 
ventricle chamber.  This connects to the other inner metal cylinder to ensure no 




Figure B.5: Metal cylinder placed on the force rod on the inner side of the ventricle 
chamber.  This connects to the outer metal cylinder to ensure no leakage through 
the hole in the back of the chamber in which the force rod travels through. 
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Figure B.6: The inner rod which extends out the back of the ventricle model.  The 
gears allowing turning of the force rod screw from outside the ventricle chamber.  




Figure B.7: Outer sheath of the force rod.  The inner rod travels through this to the 
outside of the ventricle chamber.  The papillary muscle holding disks connect 
directly to the end of the rod.   
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Figure B.8: Force rod screw.  The gears connect to the gears on the inner force 

















Figure B.12: Assembly view of the left ventricle model from the back with the papillary muscle 


















































Figure B.13: Left ventricle model.  The octagonal shape allows viewing of all the chordae with the two cameras. 
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Figure B.14: Annular board which the mitral valve is sutured to after extraction from the heart. 
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Figure B.15: Atrial chamber drawing view.  The atrial chamber is attached to the ventricle 














Figure B.17: Assembly view of the atrial chamber and annular board. 
APPENDIX C 
 
DATA ANALYSIS ALGORITHMS 
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C.1 Autotracking Algorithm 
C.1.1 Documentation for Autotracking1.m and marker_check1.m 
1. Copy all picture files to the folder containing the autotracking software 
2. Open Matlab and set the directory to the folder containing the autotracking 
software 
3. At the command prompt, type “autotracking(‘filename’,first frame, last frame, 
number of markers)”.  For example, if you are tracking camera 1, frames 0 to 500, 
and 3 markers, you would type “autotracking(‘a’,0,500,3)”. 
4. On the picture that appears, select the region of interest around each marker to be 
tracked.  Put the cursor in the upper, left corner of the marker and drag to create a 
box around the marker.  When you release the cursor, the program will record the 
coordinates of the search box and show the picture again for the user to select the 
next marker.  Complete this for all markers. 
5. After the last marker is selected, the algorithm will proceed through all the 
pictures.  At the end of tracking, the program will display “You have successfully 
tracked the markers. Test the coordinates with "marker_check.m"”.   
6. At the command prompt, type “marker_check(‘filename’,first frame, last frame)”.   
7. The first frame will appear with a black dot on the centroid of the marker.  Hit the 
enter key to move through all the pictures and check the location of the centroid.   
8. After checking the pictures, the program will respond “You have checked the 
marker_array.  Would you like to create the export file? y/n:”.  
9. If you answer no, the program will exit. 
10. If you answer yes, the program will respond with “You just checked the series 
starting with frame 0 and ending with frame 500”.  It will then ask for a name for 
the export text file. 
11. After typing the name of the text file, enter the first frame number in the series 
you want to export and the last frame number in the series you want to export. 
12. Note, you can start and end the text file at any frame number you desire.  You can 
also start the autotracking program at any frame number you desire.   
13. Caution, if you restart the atutoracking program, the markerarray will be erased; 
therefore, if you want to keep any data, you must run the marker_check algorithm 




% Deveoped by Dennis D. Soerensen on 6/11/2003 
% This software was developed to track markers placed on the leaflet and chordae of the  
% mitral valve during the cardiac cycle. 
% This autotracking uses the minima approach in cropped subimages. 
% This program takes four input arguments: the name of the picture files, the number of  
% the first picture, the number of the last picture, and the total number of marker you  
% wish to track. 
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function autotracking(tif_image , num_of_first , num_of_last , num_of_markers)    
 
% If function is not passed 4 arguments, the error message will be shown 
if nargin ~= 4           
error('Wrong number of input arguments. Use the following format: autotracking( first 




disp(sprintf('\n\nThis autotracking uses the lower 10% intensity to threshold\n\n')) 
 
 
% Renaming of the picture files such that Matlab can read each one consecutively. 
first_frame = num_of_first; 
num_of_frames = num_of_last - num_of_first + 1; 
numofbins = 255; 
ThreeByThree = ones(3)/9;                    
% Difference between conv and corr: matrix filter rotated 180 degrees. Using a 
% symmetric filter matrix means that there is no diff 
j=1; 
 
if num_of_first < 10 
image = imread(sprintf('%s00%d.tif', tif_image , num_of_first )); 
elseif num_of_first < 100 
image = imread(sprintf('%s0%d.tif', tif_image , num_of_first )); 
elseif num_of_first >= 100 
image = imread(sprintf('%s%d.tif', tif_image , num_of_first )); 
end 
 
image = double(image)/255; 
 
%%%%%%%  Defining the search boxes locations and sizes    %%%%%%% 
 
for i = 1:num_of_markers 
    [ x , y , I , rect ] = imcrop(image); 
    filtered_cropped_image = imfilter( I , ThreeByThree , 'replicate' , 'same'); 
    [counts,bin] = imhist(filtered_cropped_image , numofbins); 
    nonzeros_in_counts = find(counts); 
    BandA = nonzeros_in_counts(size(nonzeros_in_counts));  
% BandA equals stop and start indeces, respectively, of the nonzeros in counts in                        
% a (2,1) matrix 
    b = BandA(1); 
    a = BandA(2); 
    intensity_span = b-a; 
    threshold = a + round( intensity_span/10 ); 
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    BW = im2bw(filtered_cropped_image,threshold/255); 
    regionalminima = ones(size(BW))-BW; 
    [labeled,numObjects] = bwlabel(regionalminima , 4);          
            % Finds connected sets. If more than one connected set, the right set have to be 
            % chosen. 
                if numObjects > 1                               
                        % Highly unlikely that the user would choose a marker crop region  
                        % containing more than one marker minima. But in the case it should  
                        % happen, the user gets another chance to define which off the minima is 
                        % interesting  
                    labeled = imclearborder(labeled,8); 
                    [labeled,numObjects] = bwlabel(labeled , 8); 
 
                    if numObjects ~= 1 
                        [labeled,numObjects] = bwlabel(regionalminima , 8);     
                                       % Label components. 
                                             
                        STATS = regionprops(labeled,'Area'); 
                     
                        for position = 1:numObjects 
                            area = STATS(position).Area; 
                            area_vector(1,position) = area; 
                        end 
                     
                        [max_value,max_location] = max(area_vector); 
                        [r,c] = find(labeled==max_location); 
                        labeled = bwselect(regionalminima,c,r,4);  
 
                        labeled = bwlabel(labeled,8); 
                        area_vector = 0; 
                    end                        
                end 
     
    centroid = regionprops(labeled,'Centroid');   
            % the first element of Centroid is the horizontal coordinate (or x-coordinate) of              
            % the center of mass, and the second element is the vertical coordinate (or y- 
            % coordinate).  
    center_pixel_coordinates_in_cropped_image = round(centroid.Centroid);  
            %To get the values in the structure centroid , could probably have used  
            % Centroid{1,2} 
    rect_rounded = round(rect); 
    center_pixel_coordinates_of_marker = rect_rounded([1,2]) + 
center_pixel_coordinates_in_cropped_image([1,2]); 
 
center_pixel_coordinates_in_array(1,1,i,j) = center_pixel_coordinates_of_marker(1,1);       
% i = marker munber 
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    center_pixel_coordinates_in_array(1,2,i,j) = center_pixel_coordinates_of_marker(1,2);                  
    % j = frame number    
end 
 
disp('First frame tracked.') 
 
% All the marker coordinates are now found for the first frame. Now the next two frames 
% are tracked 
 
if num_of_frames > 1 
num_of_first = num_of_first + 1; 
     for n = num_of_first : num_of_first+1             
% Need to run 2 loops to have enough for prediction, which needs 3 frames 
         
    if n < 10 
     image = imread(sprintf('%s00%d.tif', tif_image , n )); 
    elseif n >= 100 
     image = imread(sprintf('%s%d.tif', tif_image , n ));     
    else 
     image = imread(sprintf('%s0%d.tif', tif_image , n )); 
    end        
                    
    image = double(image)/255;        
 
            for p = 1:num_of_markers 
                rect_adjust(1,1,p,j+1) = center_pixel_coordinates_in_array(1,1,p,j) - 
ceil(rect_rounded(1,3)/2);               % New x_upper_right_corner 
                rect_adjust(1,2,p,j+1) = center_pixel_coordinates_in_array(1,2,p,j) - 
ceil(rect_rounded(1,4)/2);               % New y_upper_right_corner 
                x_rect = rect_adjust(1,1,p,j+1); 
                y_rect = rect_adjust(1,2,p,j+1); 
                 
                rect_adjusted = [x_rect , y_rect , rect_rounded(1,3) , rect_rounded(1,4)]; 
                cropped_image = imcrop( image , rect_adjusted);                                       
% cropping rect w/ center of crop on previous marker center 
                filtered_cropped_image = imfilter( cropped_image , ThreeByThree , 'replicate' , 
'same'); 
                [counts,bin] = imhist(filtered_cropped_image , numofbins); 
                nonzeros_in_counts = find(counts); 
                BandA = nonzeros_in_counts(size(nonzeros_in_counts));  
            % BandA equals stop and start indeces, respectively, of the nonzeros in counts in  
            % a (2,1) matrix 
                b = BandA(1); 
                a = BandA(2); 
                intensity_span = b-a; 
                threshold = a + round( intensity_span/10 ); 
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                BW = im2bw(filtered_cropped_image,threshold/255); 
                regionalminima = ones(size(BW))-BW; 
                [labeled,numObjects] = bwlabel(regionalminima , 4);     % Label components. 
                                 
                if numObjects > 1                               
            % Highly unlikely that the user would choose a marker crop region containing  
            % more than one marker minima. But in the case it should happen, the user gets                       
            % another chance to define which off the minima is interesting  
                    labeled = imclearborder(labeled,8); 
                    [labeled,numObjects] = bwlabel(labeled , 8); 
 
                    if numObjects ~= 1 
                        [labeled,numObjects] = bwlabel(regionalminima , 8);        
                                   % Label components. 
                        STATS = regionprops(labeled,'Area'); 
                     
                        for position = 1:numObjects 
                            area = STATS(position).Area; 
                            area_vector(1,position) = area; 
                        end 
                     
                        [max_value,max_location] = max(area_vector); 
                        [r,c] = find(labeled==max_location); 
                        labeled = bwselect(regionalminima,c,r,4);  
                        labeled = bwlabel(labeled,8); 
                        area_vector = 0; 
                    end                        
                end 
                                            
                centroid = regionprops(labeled,'centroid');  % the first element of Centroid is 
the horizontal coordinate (or x-coordinate) of the center of mass, and the second element 
is the vertical coordinate (or y-coordinate).  
                center_pixel_coordinates_in_cropped_image = round(centroid.Centroid); %To 
get the values in the structure centroid , could probably have used Centroid{1,2} 
                 
                center_pixel_coordinates_of_marker(1,1,p,j+1) = rect_adjusted(1,1) + 
center_pixel_coordinates_in_cropped_image(1,1); 
                center_pixel_coordinates_of_marker(1,2,p,j+1) = rect_adjusted(1,2) + 
center_pixel_coordinates_in_cropped_image(1,2);                 
                 
                center_pixel_coordinates_in_array(1,1,p,j+1) = 
center_pixel_coordinates_of_marker(1,1,p,j+1);       % p = marker munber 
                center_pixel_coordinates_in_array(1,2,p,j+1) = 
center_pixel_coordinates_of_marker(1,2,p,j+1);       % j = frame number 
         end 
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            disp(sprintf('Frame %d tracked.', n )) 
            j = j+1; 
end     
       j = j+1;       
end 
 
%%%%%%%%%%%%%% % 4th frame and forward   %%%%%%%%%%%%%%% 
 
if num_of_frames > 3 
                         
for n = num_of_first+2 : 1 : num_of_last    % Now there is enough frames for prediction 
in the last. This loop will start with the 4th frame 
 
    if n < 10 
     image = imread(sprintf('%s00%d.tif', tif_image , n )); 
    elseif n >= 100 
     image = imread(sprintf('%s%d.tif', tif_image , n ));     
    else 
     image = imread(sprintf('%s0%d.tif', tif_image , n )); 
    end         
 
    image = double(image)/255;        
 
    for p = 1:num_of_markers 
                 
        % Motion estimation 
                
        rx0 = center_pixel_coordinates_in_array(1,1,p,j-1); 
        ry0 = center_pixel_coordinates_in_array(1,2,p,j-1); 
         
        vx = (center_pixel_coordinates_in_array(1,1,p,j-1) - 
center_pixel_coordinates_in_array(1,1,p,j-2)); 
        vy = (center_pixel_coordinates_in_array(1,2,p,j-1) - 
center_pixel_coordinates_in_array(1,2,p,j-2)); 
         
        vx0 = (center_pixel_coordinates_in_array(1,1,p,j-2) - 
center_pixel_coordinates_in_array(1,1,p,j-3)); 
        vy0 = (center_pixel_coordinates_in_array(1,2,p,j-2) - 
center_pixel_coordinates_in_array(1,2,p,j-3)); 
         
        avx = vx - vx0;      
        avy = vy - vy0; 
         
        x_estimate = round(rx0 + vx + 0.5*avx); 
        y_estimate = round(ry0 + vy + 0.5*avy);     
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        % The estimated coordinates are inserted into the rect_adjust                 
               
        rect_adjust(1,1,p,j) = x_estimate - ceil(rect_rounded(1,3)/2);              
  % New x_upper_right_corner 
        rect_adjust(1,2,p,j) = y_estimate - ceil(rect_rounded(1,4)/2);                
% New y_upper_right_corner 
        x_rect = rect_adjust(1,1,p,j); 
        y_rect = rect_adjust(1,2,p,j); 
         
        rect_adjusted = [x_rect , y_rect , rect_rounded(1,3) , rect_rounded(1,4)]; 
        cropped_image = imcrop( image , rect_adjusted);                                       
% cropping rect w/ center of crop on previous marker center 
        filtered_cropped_image = imfilter( cropped_image , ThreeByThree , 'replicate' , 
'same'); 
         
        [counts,bin] = imhist(filtered_cropped_image , numofbins); 
        nonzeros_in_counts = find(counts); 
        BandA = nonzeros_in_counts(size(nonzeros_in_counts));  
           % BandA equals stop and start indeces, respectively, of the nonzeros in counts in    
          % a (2,1) matrix 
        b = BandA(1); 
        a = BandA(2); 
        intensity_span = b-a; 
        threshold = a + round( intensity_span/10 ); 
        BW = im2bw(filtered_cropped_image,threshold/255); 
        regionalminima = ones(size(BW))-BW; 
        [labeled,numObjects] = bwlabel(regionalminima , 8);     % Label components. 
         
        if numObjects > 1                               % Worst case scenario is numObjects = 5 
            labeled = imclearborder(labeled,8); 
            [labeled,numObjects] = bwlabel(labeled , 8); 
        end 
         
                if numObjects > 1                               
            % Highly unlikely that the user would choose a marker crop region containing    
            % more than one marker minima. But in the case it should happen, the user gets            
            % another chance to define which off the minima is interesting  
                    labeled = imclearborder(labeled,8); 
                    [labeled,numObjects] = bwlabel(labeled , 8); 
 
                    if numObjects ~= 1 
                        [labeled,numObjects] = bwlabel(regionalminima , 8);     
                                    % Label components. 
                        STATS = regionprops(labeled,'Area'); 
                     
                        for position = 1:numObjects 
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                            area = STATS(position).Area; 
                            area_vector(1,position) = area; 
                        end 
                     
                        [max_value,max_location] = max(area_vector); 
                        [r,c] = find(labeled==max_location); 
                        labeled = bwselect(regionalminima,c,r,4);  
                        labeled = bwlabel(labeled,8); 
                        area_vector = 0; 
                    end                        
                end 
       
      centroid = regionprops(labeled,'centroid');  % the first element of Centroid is the 
horizontal coordinate (or x-coordinate) of the center of mass, and the second element is 
the vertical coordinate (or y-coordinate).  
 
      center_pixel_coordinates_in_cropped_image = round(centroid.Centroid); %To get the 
values in the structure centroid , could probably have used Centroid{1,2} 
       
      center_pixel_coordinates_of_marker(1,1,p,j) = rect_adjusted(1,1) + 
center_pixel_coordinates_in_cropped_image(1,1); 
      center_pixel_coordinates_of_marker(1,2,p,j) = rect_adjusted(1,2) + 
center_pixel_coordinates_in_cropped_image(1,2);                 
       
      center_pixel_coordinates_in_array(1,1,p,j) = 
center_pixel_coordinates_of_marker(1,1,p,j);       % p = marker munber 
      center_pixel_coordinates_in_array(1,2,p,j) = 
center_pixel_coordinates_of_marker(1,2,p,j);       % j = frame number 
       
     end       
              
        image = 0;    % image set to zero, to reduce the size of 'markerarray.mat' by ~10 MB 
        save markerarray;       
        disp(sprintf('Frame %d tracked.', n )) 
     
    j = j+1; 
end 
end 
    image = 0;       % image set to zero, to reduce the size of 'markerarray.mat' by ~10 MB 
    save markerarray; 
             






%Developed by Dennis D. Soerensen on 6/11/2003 
%This software was developed to check the tracking function of 
%autotracking1.m 
%This program generates a text file with the 2D pixel coordinates of each 
%marker placement determined by autotracking1.m. 
%This program takes three input arguments: the name of the picture files, 
%the number of the first picture, and the number of the last picture. 
 
function marker_check(string_part , num_first , num_last )   
 
if nargin ~= 3          
 %If function is not passed 3 arguments, the error message will be shown 
     error('Wrong number of input arguments. Use the following format: autotracking( 
string part of image.tif , number of first image to check , number of last image to check )') 
end 
 
load markerarray        
% center_pixel_coordinates_in_array and num_of_first  and other variables are loaded 
 
 
% The following is done to make it possible for the user to choose certain frames to 
check so the user wont have to go through the entire marker_array 
 
for n = num_first:1:num_last 
     
    if n < 10 
     image = imread(sprintf('%s00%d.tif', string_part , n )); 
    elseif n >= 100 
     image = imread(sprintf('%s%d.tif', string_part , n ));     
    else 
     image = imread(sprintf('%s0%d.tif', string_part , n )); 
    end  
        
    X_pos = center_pixel_coordinates_in_array(1,1,:,n-first_frame+1); 
    Y_pos = center_pixel_coordinates_in_array(1,2,:,n-first_frame+1); 
     
    figure(n+1) 
    imshow(image); 
    hold on; 
         
    for p = 1:num_of_markers 
          figure(n+1);         
        fill([X_pos(1,1,p) X_pos(1,1,p) X_pos(1,1,p) X_pos(1,1,p)],[Y_pos(1,1,p)-4 
Y_pos(1,1,p)-4 Y_pos(1,1,p)+4 Y_pos(1,1,p)+4] ,'b') 
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        fill([X_pos(1,1,p)-4 X_pos(1,1,p)+4 X_pos(1,1,p)+4 X_pos(1,1,p)-4],[Y_pos(1,1,p) 
Y_pos(1,1,p) Y_pos(1,1,p) Y_pos(1,1,p)] ,'b') 
        % fill([X_pos-2 X_pos+2 X_pos+2 X_pos-2],[Y_pos-2 Y_pos-2 Y_pos+2 
Y_pos+2] ,'r') 
        hold on; 
    end 
 
    [P1 P2]=ginput(1); 
     hold off 
     close 
end 
clc 
reply = input('\nYou have checked the marker_array. \nWould you like to create the 
export file? y/n: ','s'); 
 
if isempty(reply) 
    reply = 'y'; 
end 
 
if reply == 'n' 
   disp('OK. You are done.')  
         
elseif reply == 'y' 
     
    disp(sprintf('\n\nYou just checked the series starting with frame %d and ending with 
frame %d.', num_first , num_last)) 
    disp(sprintf('\nMarkerarray starts with frame %d and ends with frame %d.', first_frame 
, num_of_last)) 
    text_file_name = input('\nType the name for the export text file (only the part 
BEFORE .txt !):','s'); 
    string_first = input('\nPlease enter FIRST frame number in the series you want to 
export:','s'); 
    chosen_num_of_first = str2num(string_first); 
     
    string_last = input('\nPlease enter LAST frame number in the series you want to 
export:','s'); 
    chosen_num_of_last = str2num(string_last); 
     
    fid=fopen(sprintf('%s.txt',text_file_name),'w'); 
    fprintf(fid,'%d\t',chosen_num_of_first); 
    fprintf(fid,'%d\n',chosen_num_of_last); 
 
    y_origin = 1023; %image(1,1) 
     
        for n1 = chosen_num_of_first : 1 : chosen_num_of_last, 
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            for n2 = 1 : num_of_markers, 
       
            x_coordinate = center_pixel_coordinates_in_array(1,1,n2,n1-first_frame+1); 
            fprintf(fid,'%d\t',x_coordinate-2);                     % minus 2 to reduce offset error 
     
            y_coordinate = center_pixel_coordinates_in_array(1,2,n2,n1-first_frame+1); 
            fprintf(fid,'%d\r',y_origin-y_coordinate+2);          % 3D software has y=0 at 
bottom of image, MATLAB at top of image     
 
            end 
        end 
 
    fclose(fid); 
     
    disp(sprintf('You are done.\nFrame number %d to frame number %d have been 
converted and saved in "%s.txt"\nYou can import the file in the 3D software', 
chosen_num_of_first , chosen_num_of_last , text_file_name)) 
      
end 
 
C.2 3D Transformation Algorithm 
C.2.1 Documentation of MATLAB 3D coordinate calculation (README1.doc) 
 
This documentation describes the programs sw3d6.m, revised by S. Wanant from the v6.m demo 
sent by B. Sugimoto from the University of Pittsburgh.  All original code has been left in, but 
commented out where necessary.  Extensive additional comments have been added for 
clarification.  Please refer to the code itself for programming details.  This documentation is meant 
only to define variables and functions for the user.   
 
MATLAB 3-dimensional reconstruction program (sw3d6.m) 
This program computes 3D coordinates (X,Y,Z) from 2D coordinates (U,V) by Direct 
Linear Transform (DLT).   
The program utilizes the functions dltfu.m and reconfu.m originally written by Christoph 
Reinschmidt from the University of Calgary.   
 
There are 4 phases: Loading the 2D data sets, Calibrating camera coordinates, Computing 
3D coordinates, and Writing the output file.   
 
Loading 2D data sets – The program will ask for 2 file names.  These are where the 2D 
coordinates are stored for each camera (e.g. acoord.txt and bcoord.txt).  Press ENTER for 






 Column 1 Column 2 
Row 1 First frame number Last frame number 
Row 2 U1 V1 
…  … … 
Row n+1 Un Vn 
 
The first row holds the frame number limits, which are used to synchronize the cameras 
with each other and with the pressure-flow data.  The limits are read and stored and is 
cropped off the matrix.  The matrices from the 2 cameras are then compared and cropped 
so that they are the same size and are synchronized with respect to frame numbers.  (The 
matrices will not be the same size if one of the cameras cannot see all of the markers in a 
certain frame number.  Those frames will be discarded.)  The new matrices are combined 










Row 1 UA1 VA1 UB1 VB1 
Row 2 UA2 VA2 UB2 VB2 
…  … … … … 
Row n UAn VAn UBn VBn 
coaptation line 
annulus 
•13  •14  •15  •16 
•9    •10  •11  •12 
•5    •6    •7    •8 
•1    •2    •3    •4 
 
Markers may be digitized in any order as long as it is 
consistent.  For example, a 4×4 array may be numbered as shown at right (all images are 
handled as they appear in the acquired images, i.e. upside-down in reality; however, it 
should be noted that the orientation of the cameras does not matter.): 
 
Calibrating camera coordinates – The program will ask for 3 files.  These are where the 
calibration files (2D coordinates of cube corners) and reference file (known 3D 
coordinates of cube) are stored (e.g. acal.txt, bcal.txt, reference.txt).  Calibration files 
should be .txt files in the format:  
 Column 1 Column 2 
Row 1 U1 V1 
Row 2 U2 V2 
…  … … 
Row 7 U7 V7 
The reference file should also be a .txt and should be similar to: 3 70  0  0 
0  0  9.525 2 60  9.525  9.525 z 0  9.525  0 
9.525  0  0 y 4 9.525  0  9.525 
x 9.525  9.525  9.525 1 5These columns correspond to (X,Y,Z) coordinates for a 0.375in 
(9.525mm) cube with the origin located at point 1 as shown on 
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previous page.  The reference file can be modified to accommodate any numbering 
scheme; however, the calibration data should be digitized using a consistent numbering 
scheme.   
 
Each calibration matrix is sent with the reference matrix to the function dltfu.m.  Dltfu.m 
returns a column vector containing 11 DLT coefficients (L1-L11).  (See notes on DLT 
method or www.kwon3d.com/theory/dlt/dlt.html.)  The column vectors from each camera 
are combined into matrix A: 
 Column 1 Column 2 
Row 1 LA1 LB1 
Row 2 LA2 LB2 
…  … … 
Row 11 LA11 LB11 
 
Computing 3D coordinates 
Function reconfu.m receives matrices A (DLT coefficients) and D (2D coordinates) and 
returns matrix H (See notes on DLT or www.kwon3d.com/theory/dlt/dlt.html.): 
 
 Column 1 Column 2 Column 3 Column 4 Column 5 








…  … … … … … 





‘Residual error’ refers to the residual from using the least squares regression method.  
‘Cameras used’ will be 12; this means cameras ‘one two’, not ‘twelve’.   
 
Writing the output file – The program will ask for a filename for the output (e.g. 
markers3d.txt).  The program will also ask for 2 pressure files (ventricular and 















The output will be written in the following format: 
 
 Column 1 Column 2 Column 3 Column 4 





Row 2 <blank>    




Row 4 X1 Y1 Z1  
… … … …  
Row 19 X16 Y16 Z16  
… <blank>    
for each 
frame… 









%This program computes 3D coordinates (X,Y,Z) from 2D coordinates (U,V) by Direct  
%Linear Transform (DLT).  The program utilizes the functions dltfu.m and reconfu.m  
%originally written by Christoph Reinschmidt from the University of Calgary.   
% 
%There are 4 phases: Loading the 2D data sets, Calibrating camera coordinates,   
%Computing 3D coordinates, and Writing output file. 
% 
%(1)Loading 2D data sets- The program will ask for 2 filenames.  These are where  
%the 2D coordinates are stored for each camera.  Press ENTER for defaults (acoord  
%& bcoord).   
% 
%(2)Calibrating camera coordinates- The program will ask for 3 filenames.  These  
%are where the 2D coordinates of cube corners (acal & bcal) and known 3D  
%coordinates of cube (reference) are stored.   
% 
%(3)Computing 3D coordinates- X,Y,Z coordinates will be calculated using the  
%least squares method. 
% 
%(4)Writing output file- The program will ask for a filename for the output  
%(markers3d).  The program will also ask for 2 pressure files (ventricular and  
%transmitral).  The output will be in the following format: 
%  Row 1: #frames, #markers 
%  Row n: frame#, time, LVpressure, TMpressure 
%  Row n+1: X,Y,Z 
 
%___________________________END HELP TEXT____________________________ 
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% 3D location calc using part of KineMat demo 
% with addition of writing text file 
% May 27, 2001 
%This revision allows the operator to input filenames to be used. 
%This revision allows the 2D marker data to be read from separate files. 
%This revision adds frame number data to input and output marker files. 
%This revision sets default file names. 





disp('This program executes the 3d reconstruction routine.') 
disp('camera coefficients will be calculated and location of markers') 
disp('can be extracted.') 
disp(' '); 




disp('_____(1) LOADING 2D DATA SET _____') 
disp(' ') 
filename2dA=input('Enter the filename of the 2D marker coordinates for camera A (e.g. 
acoord.txt)> ', 's');% do not need to use quote mark for s 
filename2dB=input('Enter the filename of the 2D marker coordinates for camera B (e.g. 
bcoord.txt)> ', 's'); 
if isempty(filename2dA) filename2dA='acoord.txt'; end   %default file 
names 
if isempty(filename2dB) filename2dB='bcoord.txt'; end 
 
disp(' ') 
disp('Loading marker data...') 
disp(' ') 
d1=load(filename2dA);  d2=load(filename2dB); % input the datafile to d1. Matrix is the 
same as datafile 
 
%storing the frame numbers (entered in the first row of the data sets) 
%and removing the row from the matrix 
%three after frmlim has the beginning of frame and end of frame 
frmlim=[d1(1,:); d2(1,:)];        %row1 
contains frame limits for camera1, row2 for camera2 
            




mkrnum=size(d2,1)/(frmlim(2,2)-frmlim(2,1)+1); %mrknum is the number of markers 
per frame (i.e. 9, 16) 
           
 % return the number of rows, remove first rows from matrix 
%cropping the larger matrix; matrices will not be the same size if a camera cannot see all 
markers 
delta=(frmlim(1,:)-frmlim(2,:))*mkrnum;     %delta is the difference 
between rows 
 
if delta(1) < 0          
 %the next 2 if statements match frame numbers and matrix size 
    d1=d1(1-delta(1):size(d1,1),:);   % Move down to the same rows as 
d2 and read the data, crop d1 
else  
    d2=d2(1+delta(1):size(d2,1),:);   %align the beginning 
end 
 
if delta(2) > 0          
 %this probably won't ever be used (crops off back end) 
   d1=d1(1:size(d1,1)-delta(2),:); 
else            
 % align the end 
   d2=d2(1:size(d2,1)+delta(2),:); 
end 
 
frmlim=[max(frmlim(:,1)) min(frmlim(:,2))];  %redefine new frame limits 
frmnum=frmlim(2)-frmlim(1)+1;      
 %frmnum is the number of frames 
            






disp('_____(2) NORMALIZING CAMERA COORDINATES _____') 
disp(' ') 
filenameAcube=input('Enter the filename of the first calibration set (e.g. acal.txt)> ', 's'); 
filenameBcube=input('Enter the filename of the second calibration set (e.g. bcal.txt)> ', 
's'); 
filenameref=input('Enter the filename of the reference coordinates (e.g. reference.txt)> ', 
's'); 
if isempty(filenameAcube) filenameAcube='acal.txt'; end 
if isempty(filenameBcube) filenameBcube='bcal.txt'; end 




disp('Loading calibration data and computing DLT coefficients...') 









disp('_____(3) 3D RECONSTRUCTION  _____') 
disp(' ') 













disp('_____(4) WRITING OUTPUT FILE _____'); 
disp(' ') 
%OUTPUT filename 
filename3d=input('Enter the filename for the OUTPUT (e.g. m3d.txt)> ','s'); 
if isempty(filename3d) filename3d='m3d.txt'; end 
 
%Reading LV and TM pressure data 
filenamePV=input('Enter the filename of the ventricular pressure data (e.g. VP.txt)> ','s'); 
if isempty(filenamePV) filenamePV='VP.txt'; end   %default filename 
PV=load(filenamePV);    %input the ventricular pressure PV 
 
filenameTM=input('Enter the filename of the transmitral pressure data (e.g. TM.txt)> 
','s'); 
if isempty(filenameTM) filenameTM='TM.txt'; end   %default filename 





 for h=frmlim(1):frmlim(2) 
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    %P=[frame# time LVpressure TMpressure]; 
  P(h-frmlim(1)+1,:)=[h PV(h+1,:) TM(h+1,2)]; 
end;   
 
%WRITE the first row: [# of frames, # of markers]; 
[tempfile] = fopen(filename3d, 'wt'); 
count = fprintf(tempfile, '%d %d\n', frmnum, mkrnum); 
 
%WRITE sets of data for each frame 
[tempfile] = fopen(filename3d, 'at'); 
for f=1:frmnum 
   count = fprintf(tempfile, '\n%d %f %f %f\n', P(f,:)); 
   Htemp=H((1+(f-1)*mkrnum):(f*mkrnum),1:3); 
   count = fprintf(tempfile, '%f %f %f\n', Htemp'); 
end; 
    
fclose(tempfile); 
 
disp(sprintf('Output is in %s.', filename3d)) 
disp('Please see help file for formatting.'); 
disp(' ') 
 





%This program is called by SW3D6.m 
% Description: Program to calculate DLT coefficient for one camera 
%               Note that at least 6 (valid) calibration points are needed 
%               function [A,avgres] = dltfu(F,L,Cut) 
% Input: - F      matrix containing the global coordinates (X,Y,Z) 
%                        of the calibration frame 
%    e.g.: [0 0 20;0 0 50;0 0 100;0 60 20 ...] 
%  - L      matrix containing 2d coordinates of calibration  
%                        points seen in camera (same sequence as in F) 
%                        e.g.: [1200 1040; 1200 1360; ...] 
%               - Cut    points that are not visible in camera; 
%                        not being used to calculate DLT coefficient 
%                        e.g.: [1 7] -> calibration point 1 and 7  
%    will be discarded. 
%          This input is optional (default Cut=[])  
% Output: - A      11 DLT coefficients 
%               - avgres average residuals (measure for fit of dlt) 
%    given in units of camera coordinates 
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% 
% Author: Christoph Reinschmidt, HPL, The University of Calgary 
% Date:  January, 1994 
% Last changes: November 29, 1996 
% Version: 1.0 
% References: Woltring and Huiskes (1990) Stereophotogrammetry. In 
%               Biomechanics of Human Movement (Edited by Berme and 
%               Cappozzo). pp. 108-127. 
 
function [A,avgres] = dltfu(F,L,Cut) 
 
if nargin==2; Cut=[]; end; 
 
m=size(F,1); Lt=L'; C=Lt(:); 
 
for i=1:m 
  B(2*i-1,1)  = F(i,1);  
  B(2*i-1,2)  = F(i,2);  
  B(2*i-1,3)  = F(i,3); 
  B(2*i-1,4)  = 1; 
  B(2*i-1,9)  =-F(i,1)*L(i,1); 
  B(2*i-1,10) =-F(i,2)*L(i,1); 
  B(2*i-1,11) =-F(i,3)*L(i,1); 
  B(2*i,5)    = F(i,1); 
  B(2*i,6)    = F(i,2); 
  B(2*i,7)    = F(i,3); 
  B(2*i,8)    = 1; 
  B(2*i,9)  =-F(i,1)*L(i,2); 
  B(2*i,10) =-F(i,2)*L(i,2); 
  B(2*i,11) =-F(i,3)*L(i,2); 
end 
 















%This program is called by SW3D6.m 
%function [H] = reconfu(A,L) 
% Description: Reconstruction of 3D coordinates with the use local (camera 
%  coordinates and the DLT coefficients for the n cameras). 
% Input: - A  file containing DLT coefficients of the n cameras 
%       [a1cam1,a1cam2...;a2cam1...] 
%  - L  camera coordinates of points 
%       [xcam1,ycam1,xcam2,ycam2...;same at time 2] 
% Output: - H  global coordinates, residuals, cameras used 
%       [Xt1,Yt1,Zt1,residt1,cams_used@t1...; same for t2] 
% Author: Christoph Reinschmidt, HPL, The University of Calgary 
% Date:  September, 1994 
% Last change:  November 29, 1996 
% Version: 1.1 
 
function [H] = reconfu(A,L) 
 
n=size(A,2); 
% check whether the numbers of cameras agree for A and L 
if 2*n~=size(L,2); disp('the # of cameras given in A and L do not agree') 




H(size(L,1),5)=[0];         % initialize H 
 
% ________Building L1, L2:       L1 * G (X,Y,Z) = L2________________________ 
 
for k=1:size(L,1)  %number of time points 
    q=[0]; L1=[]; L2=[];  % initialize L1,L2, q(counter of 'valid' cameras) 
  for  i=1:n       %number of cameras 
    x=L(k,2*i-1); y=L(k,2*i); 
    if ~(isnan(x) | isnan(y))  % do not construct l1,l2 if camx,y=NaN 
     q=q+1; 
     L1([q*2-1:q*2],:)=[A(1,i)-x*A(9,i), A(2,i)-x*A(10,i), A(3,i)-x*A(11,i);... 
                        A(5,i)-y*A(9,i), A(6,i)-y*A(10,i), A(7,i)-y*A(11,i)]; 
     L2([q*2-1:q*2],:)=[x-A(4,i);y-A(8,i)]; 
    end 
  end 
 
  if (size(L2,1)/2)>1  %check whether enough cameras available (at least 2) 
   g=L1\L2; h=L1*g; DOF=(size(L2,1)-3); 
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   avgres=sqrt(sum([L2-h].^2)/DOF); 
  else 
   g=[NaN;NaN;NaN]; avgres=[NaN]; 
  end 
    
 %find out which cameras were used for the 3d reconstruction 
  b=fliplr(find(sum(reshape(isnan(L(k,:)),2,size(L(k,:),2)/2))==0)); 
  if size(b,2)<2; camsused=[NaN]; 
     else,    for w=1:size(b,2), b(1,w)=b(1,w)*10^(w-1); end     
              camsused=sum(b'); 
  end   
 
  H(k,:)=[g',avgres,camsused]; 
end 
 
C.3 Strain Calculation Algorithm 
%___________________________PROGRAM STRAIN1.M______________________ 
%This program calculates the total distance between the first and last marker of a chord. 
%This program uses the infinitesimal strain definition (x-xinitial)/xinitial to calculate strain 
%where x is the distance between three markers.  The distance formula is used to 
%calculate the distance between two markers √((x2-x1)2+(y2-y1)2+(z2-z1)2). 
%It takes the output text file from SW3D6 as the input file. 





%Loading the input file from SW3D6 
filename1=input('Please enter the filename of the 3D marker coordinates (eg. m3d.txt): 
','s'); 
if isempty(filename1) 
    filename1='m3d.txt'; 
end 
 














%Input the reference frame which will be used to calculate the initial length of the chord 
reffrm=input('\nPlease enter the reference frame: '); 
 
%Input the initial length of the chord so strain measurements can be done 
%initial=input('\nPlease enter the initial length of the chord in mm: '); 
 






    matrix(j,:)=[data(i,1) data(i,2) data(i,3)]; 






    x=(matrix(i,1)-matrix(i+1,1))^2; 
    y=(matrix(i,2)-matrix(i+1,2))^2; 
    z=(matrix(i,3)-matrix(i+1,3))^2; 
    temp=sqrt(x+y+z); 









    frmnum(i,1)=data(temp1,1); 
    time(i,1)=data(temp1,2); 
    vp(i,1)=data(temp1,3); 
    tm(i,1)=data(temp1,4); 
    %This inputs the x, y, z coordinates for all the markers 
    for j=1:nummrks 
        coord(j,:)=[data(temp1+j,1) data(temp1+j,2) data(temp1+j,3)]; 
    end 
    %This calculates the distance between each marker and the total distance between the 
first and last marker and also the strain. 
    for j=1:nummrks-1 
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        distance(i,j)=sqrt((coord(j,1)-coord(j+1,1))^2+(coord(j,2)-
coord(j+1,2))^2+(coord(j,3)-coord(j+1,3))^2); 
        totaldistance(i,1)=distance(i,j)+temp2; 
        infinitestrain(i,1)=(totaldistance(i,1)-initial)/initial; 
        temp2=totaldistance(i,1); 
    end 
    temp1=1+nummrks+temp; 
    temp=temp1; 
    temp2=0; 
end 
 
%Creates the output file in a .txt format 
filename2=input('\nPlease enter the filename of the distance coordinates (eg. 
distance.txt): ','s'); 
if isempty(filename2) 
    filename2='distance.txt'; 
end 
 






C.4 Lowpass Filter Algorithm 
%___________________________PROGRAM LOWPASS.M_____________________ 
%This program creates a low pass filter for the marker digitization 
%This program uses the fast Fourier Transform to calculate the power spectrum. 
%The user can then input the upper and lower bounds for the second order Butterworth 
%filter.  The program then shows the power spectrum of the Butterworth filter. 
%Using the filter command in Matlab, the data is filtered and an output text file is 
%generated.  The final power spectrum of the filtered data is also output. 




%Input the strain and time as a matrix 
%matrix=infinitestrain; 
%time=time; 
%If the strain1 program has not been run last use the following to input the strain and 
time 
 
%Generate the power spectrum of the strain data 
sample=input('\nPlease enter the sample frequency (eg. 500): '); 
if isempty(sample) 
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title('Power Spectrum Before Filter') 
 
%Determine the upper and lower bound for the filter 
N=2;        %a second order butterworth filter 
fhz_lower=input('\nPlease enter the lower bound frequency (eg. 0): '); 
if isempty(fhz_lower) 
    fhz_lower=2.5*10^-10; 
end 
 
fhz_upper=input('\nPlease enter the upper bound frequency (eg. 11.67): '); 
if isempty(fhz_upper) 













title('Power Spectrum of Butterworth Filter') 
 
%Filter the strain data 
sf=filter(Bb,Ab,matrix); 
 
%Create a text file of the filtered data 
filename=input('\nPlease input the filename for the filtered strain data (eg. filtered.txt): 
','s'); 
if isempty(filename) 











title('Strain Data After Filter') 
 












HISTOLOGY AND BIOCHEMICAL ASSAY PROTOCOLS 
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D.1 Hematoxylin & Eosin Stain 
Protocol: 
1. Stain in Hematoxylin for 30 seconds 
2. Rinse in deionized water 
3. Dip in acid alcohol 
4. Rinse in deionized water 
5. Place in Scott’s solution for 30 seconds 
6. Rinse in deionized water 
7. Wash in 95% alcohol for 1 minute 
8. Stain in alcoholic Eosin for 30 seconds 
9. Dehydrate through ascending grades of alcohol and clear to xylene.  Mount in a 
permanent mounting media. 
 
Results: 
1. Cell nuclei: black 
2. Collagen: dark pink 
3. Elastin: light pink 
 




2. Potassium Iodide________4g 
3. Distilled Water__________100ml 
Place iodine and potassium iodide into a flask with 20ml of water.  Stir until iodine 
dissolves and then add remaining water. 
 
10% Ferric Chloride: 
1. Ferric Chloride_________50g 
2. Distilled Water_________500ml 
Store at 4°C 
 
Verhoeff’s Elastic Stain: 
1. Hematoxylin (C.I. 75290), 5% in 95% alcohol_______________30ml 
2. Ferric Chloride, 10% solution________12ml 
3. Verhoeff’s Iodine_____12ml 
 
5% Sodium Thiosulfate: 
1. Sodium Thiosulfate_______5g 
2. Distilled Water__________100ml 
 
Van Gieson’s Solutions: 
1. Acid Fuchsin (C.I. 42685), 1% aqueous_____20ml 




1. Deparaffinize and rehydrate to distilled water. 
2. Stain for 20 minutes in Verhoeff’s elastic stain.  Tissue should appear completely 
black. 
3. Wash in two changes of distilled water. 
4. Differentiate in 1% Ferric Chloride.  Control differentiation under microscope by 
rinsing slides in water to check.  Differentiate until the elastic fibers are black and 
the background is colorless.  If the slides are over differentiated, return slides to 
Verhoeff’s solution and repeat the stain. 
5. Rinse in distilled water. 
6. Place in 5% Sodium Thiosulfate for 1 minute to remove iodine. 
7. Wash in running tap water for 5 minutes. 
8. Counterstain in van Gieson’s solution for 1 minute. 
9. Dehydrate through ascending grades of alcohol and clear to xylene.  Mount in a 
permanent mounting media. 
 
Results: 
1. Elastic fibers: blue-black to black 
2. Nuclei: blue to black 
3. Collagen: red 
4. Other tissue elements: yellow 
 




2. Potassium Iodide________4g 
3. Distilled Water__________100ml 
Place iodine and potassium iodide into a flask with 20ml of water.  Stir until iodine 
dissolves and then add remaining water. 
 
10% Ferric Chloride: 
1. Ferric Chloride_________50g 
2. Distilled Water_________500ml 
Store at 4°C 
 
Verhoeff’s Elastic Stain: 
1. Hematoxylin (C.I. 75290), 5% in 95% alcohol_______________30ml 
2. Ferric Chloride, 10% solution________12ml 
3. Verhoeff’s Iodine_____12ml 
 
5% Sodium Thiosulfate: 
1. Sodium Thiosulfate_______5g 
2. Distilled Water__________100ml 
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Light Green Stock Solution: 
1. Light Green SF Yellowish_______0.2g 
2. Distilled Water_______________100ml 
3. Glacial Acetic Acid____________0.2ml 
Mix well. 
 
Light Green Working Solution: 
1. Light Green Stock Solution______10ml 
2. Distilled Water________________50ml 
 
Protocol: 
1. Deparaffinize and rehydrate to distilled water. 
2. Stain for 20 minutes in Verhoeff’s elastic stain.  Tissue should appear completely 
black. 
3. Wash in two changes of distilled water. 
4. Differentiate in 1% Ferric Chloride.  Control differentiation under microscope by 
rinsing slides in water to check.  Differentiate until the elastic fibers are black and 
the background is colorless.  If the slides are over differentiated, return slides to 
Verhoeff’s solution and repeat the stain. 
5. Rinse in distilled water. 
6. Place in 5% Sodium Thiosulfate for 1 minute to remove iodine. 
7. Wash in running tap water for 5 minutes. 
8. Counterstain in Light Green solution for 1 minute. 
9. Dehydrate through ascending grades of alcohol and clear to xylene.  Mount in a 
permanent mounting media. 
 
Results: 
1. Elastic fibers: blue-black to black 
2. Nuclei: blue to black 





 1% Bovine serum albumin (BSA)/Phosphate buffered saline (PBS): 
1. V BSA (Sigma #A2153)______1g fraction 
2. 1X PBS___________________100ml 
Mix until fully dissolved.  Aliquot into 5ml volumes and store at -20°C. 
 
Solution A, Citric Acid (109mM): 
1. Citric Acid___________4.2g 
2. dH2O_______________200ml 
 
Solution B, Sodium Citrate (100mM): 
1. Sodium Citrate_________14.7g 
2. dH2O_________________500ml 
 
10mM Citrate Buffer, pH 6.0 (500ml): 
1. Solution A___________9ml 
2. Solution B___________41ml 
3. dH2O_______________450ml 
Adjust pH to 6.0.  Bring up to 500ml.  Final concentrations are 1.96mM citric acid 
and 8.2mM sodium citrate. 
 
Diaminobenzidine Tetrahydrochloride (DAB): 
1. Sigma #D-5905; 10mg tables X 50 tablets. 
 
Elite ABC-Peroxidase Kit : 
1. Vector #PK-6100 
  
 30% Hydrogen Peroxide: 
1. Sigma #H1009 or any other brand 
 
10X PBS: 
Boehringer Mannheim #1666789 
 
Protease: 
1. Dissolve protease (Sigma #P-8038) in PBS for a stock concentration of 
100mg/ml.  Aliquot and store at -20°C. 
 
Proteinase K: 
1. Dissolve proteinase K (Sigma #P-4914) in dH2O for a stock concentration of 
20mg/ml.  aliquot and store at -20°C. 
 
TBS: 
1. Tris Base_____________12.1g 
2. Sodium Choloride______8.77g 
3. dH2O________________1L 
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pH to 7.6 
 
Primary Antibody: 
Anti-human von Willebrand factor, IgG fraction of antiserum, developed in rabbit 
Sigma Product Number F 3520 
 
Secondary Antibody and Normal Animal Sera: 
IgG fraction of antiserum, goat anti-rabbit 
Vector Laboratories, Inc. Product Number BA-1000 
 
1% Acid Alcohol: 
1. HCl (Fisher #A144s)______2ml 
2. 70% Ethanol_____________198ml 
 
Hematoxylin: 






Mix until dissolved. 
 
 Protocol:  
1. Fixed paraffin embedded tissue is deparafinized, and rehydrated in descending 
grades of alcohol.  Sections are washed in 1X PBS for 5 minutes. 
2. For antigen retrieval, dilute 150ul of 100mg/ml of stock protease in 150ml of 1X 
PBS.  Incubate the tissue for 10 minutes with the 100ug/ml protease pretreatment 
in humid chamber. 
3. Wash sections in 1X PBS twice for 5 minutes each. 
4. Block endogenous peroxidase using 0.3% H2O2 in methanol for 15 minutes. 
5. Rehydrate sections in 1X PBS twice for 5 minutes each. 
6. Block tissue using 1% gelatin/PBS mixture for 20 minutes. 
7. Prepare the working dilution of the primary antibody in 1% BSA in 1X PBS.  Blot 
off gelatin/PBS and apply primary antibody.  Incubate sections in a humid 
chamber for 1 hour.  For negative control, do not apply primary antibody. 
8. Blot off excess antibody and wash slides in 1X PBS twice for 5 minutes each. 
9. Prepare working dilution of the biotinylated secondary antibody in 1% BSA in 1X 
PBS, and add 2% normal serum from the source animal (goat) of the secondary 
antibody.  Prepare secondary antibody at a 1/400 dilution.  Apply antibody and 
incubate for 30 minutes in a humid chamber. 
Prepare the working solution of the ABC-peroxidase complex from the Vectastain 
Elite ABC Kit (#PK-6100) after application of the secondary antibody.  Mix 5ml 
of 1X PBS, 2 drops of reagent A, and 2 drops of reagent B.  Allow to sit for 30 
minutes prior to use. 
10. Blot off excess antibody and wash slides in 1X PBS twice for 5 minutes each. 
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11. Apply prepared ABC mixture to each slide.  Incubate in a humid chamber for 1 
hour. 
12. Blot off excess solution and wash slides in 1X PBS twice for 5 minutes each, 
followed by one wash in sterile deionized/distilled water for 5 minutes. 
13. Make up substrate solution, diaminobenzidine (DAB), immediately before use.  
DAB is a carcinogen so wear gloves, goggles, work on a diaper, and save liquid 
waste to be disposed of with chemical waste.  In order, add: 15ml of TBS pH 7.6, 
1 tables DAB (10mg), and 12ul of 30% H2O2.  Mix to dissolve table.  Filter using 
Whatman #1.  Apply filtered solution to each section.  Incubate slides in the dark 
up to 10 minutes, checking color reaction periodically.  Stop reaction by blotting 
off substrate and rinsing in 1X PBS 3 times for 5 minutes each. 
14. Lightly counterstain sections with hematoxylin.   
a. Place in hematoxylin for 10 seconds 
b. Rinse in tap water until clear 
c. Dip once in 1% acid alcohol 
d. Rinse in water 
e. Place in Scott’s solution for 20 seconds 
f. Rinse in water  
15. Rinse slides well in water until water is clear.  Dehydrate through graded 
alcohols, then xylene and coverslip. 
 
 
D.5 Biochemical Digestion 
D.5.1 Protenaise K 
1. Buffer for 100mL 
a. 95mL dH2O 
b. 5mL 50mM Tris-HCL 
c. 3.72g 0.1M EDTA 
d. 1.168g 0.2M NaCl 
pH to 7.4 
2. Aliquot amount needed (1mL/construct or 1M cells) 
3. Add: 0.5mg/mL proteinase K and 0.1mg/mL SDS 
4. Dissolve and free excess aliquots 
5. Add 1mL of proteinase K solution to each sample 
6. Place in bath at 55°C and check every 24 hours until digested 
 
D.5.2 Pepsin 
1. Calculate the amount of pepsin needed (2mg of dry tissue weight : 1mg of pepsin)   
2. Calculate the amount of pepsin/acetic acid solution needed (5mg pepsin/mL in 
0.5M acetic acid) 
3. Prepare 5mg pepsin/mL in 0.5M acetic acid to give desired final volume from 
step 2  
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4. For every 2mg of dry tissue weight, add 1 mg of pepsin to the eppendorf tube (the 
amount of pepsin/acetic acid solution added to each eppendorf tube is equal to 
one-tenth the dry weight of the specimen) 
5. Place on mechanical shaker overnight 
6. Place in water bath at 80°C until the tissue has been digested completely.  
Depending on the dry weight of the tissue, this process takes from 4 hours to 24 
hours.  Check tissue every 2 hours. 
 
D.6 Fastin Elastin Assay 
1. Precool elastin precipitation reagent in fridge before use 
2. Label 1.5mL tubes (standards, blanks, samples) 
3. Prepare blanks - 100µL buffer/salt/water solution 
4. Prepare standards – 12.5, 25, 50, 75µL of α-elastin standard.  Bring each tube up 
to 100µL with dH2O 
5. Prepare samples - 100µL of sample.  Bring each tube up to 100µL with dH2O 
6. Add 1mL of cold elastin precipitating reagent to each tube 
7. Incubate in ice-water overnight 
8. Next morning, change ice-water to ice and incubate for 30 minutes to bring 
samples to 0°C 
9. Centrifuge while cold at 12,000g for 10 minutes.  Elastin will appear as a gel 
10. Drain tubes and gently tap on paper towel to remove excess water 
11. Add 1mL of dye reagent 
12. Add 200µL of 90% saturated ammonium sulfate 
13. Vortex until elastin is back in solution 
14. Incubate and gently agitate at room temperature for 1 hour 
15. Centrifuge tubes at 12,000g for 10 minutes 
16. Drain tubes and gently tap on paper towel to remove excess water 
17. Add 1mL dissociation reagent 
18. Vortex to dislodge pellet 
19. Mix gently for 10 minutes to release all dye 
20. Add 100µL aliquots into each well  
21. Set fluorescence to 513nm and endpoint measurement 
 
D.7 Collagen Assay 
1. Label 1.5mL tubes (standards, blanks, samples) 
2. Prepare blanks - 100µL buffer/salt/water solution 
3. Prepare standards – 5, 10, 25, 50µg of collagen standard.  Bring each tube up to 
100µL with dH2O 
4. Prepare samples - 100µL of sample 
5. Add 1mL of Sircol Dye reagent to each tube 
6. Place tubes in a mechanical shaker for 30 minutes 
7. Centrifuge at 12,000g for 10 minutes   
8. Drain tubes and gently tap on paper towel to remove excess dye 
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9. Add 1mL of Alkali reagent 
10. Vortex until bound dye has been dissolved back into the solution 
11. Mix gently for 10 minutes to release all dye 
12. Add 200µL aliquots of samples into each well  
13. Measure absorbance in microplate reader.  Set wavelength to 540nm and endpoint 
measurement 
 
D.8 Hoescht Dye DNA Assay 
10x TEN: 
1. 0.01M Tris 
2. 0.001M Na2EDTA 
3. 0.1 M NaCl 
pH=7.4 
 
Hoechst Dye Solution: 
1.   Hoechst Stock dye is 1mg/mL in dH2O 
2.   Add as 10,000 X into 0.1µg/mL buffer (100µg /100mL 1xTEN) 
 
Dye Stock: 
1. Calculate approximate total volume of dye needed.  Use 0.2ml per  
standard/sample 
2. Add 10µL of dye stock (10,000X) per 100mL of working dye needed in an amber 
bottle (dye is light sensitive) 
3. Add final volume desired of 1x TEN 
 
Standards: 
1. Set up 7 eppendorfs in a tube rack 
2. Thaw one 1mL cryovial of the 10µg/mL DNA stock solutions in the -70°C freezer 
3. add 500µL of PBE to each eppendorf 
4. serial dilute by taking 500µL of the 10µg/mL DNA stock and placing it in the 
first eppendorf (final concentration of 5µg/mL) 
5. mix by pipet, and repeat, taking 500 µL of the 5µg/mL solution and placing it into 
the next eppendorf (final concentration of 2.5 µg/ml) 
*Final standard concentrations: 10µg/ml, 5µg/ml, 2.5µg/ml, 1.25µg/ml, 0.625µg/ml, 
  0.3125µg/ml, 0.15625µg/ml, and 0µg/ml). 
 
Assay: 
1. Pipet 10µl sample and 200µl Hoechst dye aliquots into each well (use the black 
96 well plates).  Cover the plate with foil until ready to read. 
2. Measure fluorescence using microplate reader.  Set excitation to 365nm and 





BIOCHEMICAL ASSAY RESULTS 
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E.1 DNA Assay Results 
 
The DNA assay results for each chordae are displayed in Table E.1.  The DNA content 
has been normalized by the dry weight.  Table E.2 below shows the DNA content for 
each specimen for each chordae.  The average and standard deviation are given at the 
bottom of the table.  Table E.3 gives the p-value between each chordae.  A p-value below 
0.05 was considered significant. 
Table E.1: DNA assay results for each chordae tendineae.  The chordae measured is listed at the top 
of each column of data. 
Strut 
Sample Fluoresence Dry Weight, mg DNA Content, ug/mg 
1 156.750 3.800 0.652 
2 155.831 3.800 0.642 
3 159.267 3.800 0.679 
4 170.989 4.400 0.694 
5 176.787 4.400 0.747 
6 154.603 4.400 0.543 
7 163.631 3.500 0.787 
8 159.749 3.500 0.743 
9 183.684 3.500 1.019 
10 183.124 3.900 0.945 
11 185.678 3.900 0.973 
12 180.987 4.900 0.734 
13 182.84 4.900 0.750 
14 238.489 9.100 0.661 
15 234.551 9.100 0.642 
16 228.507 13.600 0.411 
17 232.298 13.600 0.423 
18 192.964 5.600 0.732 
19 202.912 5.600 0.807 
20 194.002 4.800 0.863 
21 197.606 4.800 0.895 
22 199.658 10.600 0.457 
23 201.609 10.600 0.465 
24 210.782 17.200 0.309 
25 226.518 17.200 0.349 
26 236.367 18.100 0.355 
27 226.918 18.100 0.332 
28 227.227 11.200 0.538 
29 230.178 11.200 0.550 
30 202.775 9.800 0.508 
31 220.744 9.800 0.587 
32 200.849 10.400 0.470 
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Table E.1 (continued). 
33 200.452 10.400 0.469 
    
    
Anterior Marginal 
Sample Fluoresence Dry Weight, mg DNA Content, ug/mg 
1 157.821 1.4 1.801 
2 156.309 1.4 1.757 
3 154.729 1.4 1.712 
4 184.527 1.8 2.080 
5 183.862 1.8 2.065 
6 173.176 0.8 4.085 
7 179.982 0.8 4.442 
8 175.755 2 1.688 
9 179.186 2 1.760 
10 183.358 1.7 2.174 
11 210.631 1.7 2.848 
12 171.469 1.5 2.131 
13 170.122 1.5 2.093 
14 183.1 1.5 2.457 
15 190.035 1.5 2.651 
16 187.066 1 4.299 
17 181.714 1 4.068 
18 189.043 6.5 0.674 
19 199.645 6.5 0.745 
20 204.759 9.3 0.544 
21 202.408 9.3 0.533 
22 183.156 3.6 1.147 
23 181.409 3.6 1.126 
24 205.269 5.4 0.941 
25 204.677 5.4 0.936 
26 191.296 3.2 1.400 
27 190.635 3.2 1.391 
28 200.723 6.1 0.801 
29 199.382 6.1 0.792 
    
    
Commissural 
Sample Fluoresence Dry Weight, mg DNA Content, ug/mg 
1 162.887 1.8 1.514 
2 168.267 1.8 1.635 
3 177.208 1.8 1.835 
4 155.493 1.8 1.348 
5 153.027 1.8 1.293 
6 158.7 1.8 1.420 
7 179.061 3.1 1.134 
8 182.175 3.1 1.176 
9 186.899 2.8 1.373 
10 186.831 2.8 1.372 
11 175.674 2.9 1.163 
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Table E.1 (continued). 
12 176.265 2.9 1.172 
13 111.517 2 0.339 
14 104.185 2 0.185 
15 177.465 1.2 2.874 
16 172.92 1.2 2.714 
17 203.876 7.8 0.644 
18 191.996 7.8 0.578 
19 174.098 2.5 1.496 
20 190.2 2.5 1.773 
21 262.861 12.5 0.605 
22 272.644 12.5 0.639 
23 182.727 3.7 1.111 
24 183.566 3.7 1.121 
25 197.776 4.4 1.082 
26 204.468 4.4 1.147 
    
     
Basal 
Sample Fluoresence Dry Weight, mg DNA Content, ug/mg 
1 142.069 1.8 1.047 
2 151.859 1.8 1.267 
3 141.849 1.8 1.042 
4 142.976 2.3 0.836 
5 163.782 2.3 1.201 
6 177.739 2.3 1.446 
7 192.001 2.1 1.857 
8 163.909 2.1 1.317 
9 151.192 2.1 1.073 
10 176.824 2.5 1.369 
11 182.764 2.5 1.468 
12 182.086 5.6 0.650 
13 178.002 5.6 0.620 
14 197.296 3.6 1.189 
15 214.821 3.6 1.394 
16 184.808 2.6 1.445 
17 185.218 2.6 1.451 
18 187.889 3.9 0.996 
19 185.246 3.9 0.968 
20 178.708 2.1 1.667 
21 182.572 2.1 1.744 
22 213.241 9.3 0.583 
23 225.16 9.3 0.639 
24 191.952 5 0.902 
25 187.318 5 0.862 
26 222.208 10.9 0.533 
27 220.372 10.9 0.526 
28 174.704 4.9 0.769 
29 184.111 4.9 0.851 
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Table E.1 (continued). 
 
Posterior Intermediate 
Sample Fluoresence Dry Weight, mg DNA Content, ug/mg 
1 137.33 1.1 1.540 
2 143.971 1.1 1.784 
3 151.334 1.1 2.054 
4 156.021 4.2 0.583 
5 158.311 4.2 0.605 
6 152.069 4.2 0.545 
7 210.501 6.2 0.780 
8 205.495 6.2 0.746 
9 203.031 7.9 0.572 
10 204.981 7.9 0.583 
11 181.323 4.1 0.881 
12 209.881 4.1 1.173 
13 177.439 2.1 1.641 
14 178.137 2.1 1.655 
15 173.855 3.1 1.063 
16 169.196 3.1 1.000 
17 168.685 4.4 0.700 
18 175.693 4.4 0.767 
19 190.629 4.3 1.035 
20 197.805 4.3 1.107 
21 264.948 7 1.093 
22 240.016 7 0.940 
23 204.512 6.1 0.828 
24 211.697 6.100 0.879 
25 190.26 5.700 0.778 
26 186.545 5.700 0.750 
27 188.945 4.100 1.068 
28 188.581 4.100 1.064 
    
    
Posterior Marginal 
Sample Fluoresence Dry Weight, mg DNA Content, ug/mg 
1 168.427 1.6 1.843 
2 166.286 1.6 1.789 
3 172.818 1.6 1.954 
4 180.354 1.8 1.983 
5 193.337 1.8 2.286 
6 160.939 1.7 1.620 
7 191.432 1.7 2.373 
8 182.626 0.8 4.581 
9 175.037 0.8 4.183 
10 180.678 1.800 1.991 
11 170.675 1.800 1.757 
12 181.062 1.200 2.999 
13 190.081 1.200 3.315 
14 182.294 1 4.093 
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Table E.1 (continued). 
15 182.769 1 4.113 
16 188.708 0.9 4.855 
17 188.601 0.9 4.850 
18 181.736 2.6 1.565 
19 186.326 2.6 1.641 
20 179.064 2.7 1.464 
21 174.956 2.7 1.399 
 
 
Table E.2: DNA content for each chordae tendineae.  The average and standard deviation for each 
chordae is given at the bottom of the table. 
Sample Strut 
Anterior 





1 0.652 1.801 1.514 1.047 1.540 1.843 
2 0.642 1.757 1.635 1.267 1.784 1.789 
3 0.679 1.712 1.835 1.042 2.054 1.954 
4 0.694 2.080 1.348 0.836 0.583 1.983 
5 0.747 2.065 1.293 1.201 0.605 2.286 
6 0.543 4.085 1.420 1.446 0.545 1.620 
7 0.787 4.442 1.134 1.857 0.780 2.373 
8 0.743 1.688 1.176 1.317 0.746 4.581 
9 1.019 1.760 1.373 1.073 0.572 4.183 
10 0.945 2.174 1.372 1.369 0.583 1.991 
11 0.973 2.848 1.163 1.468 0.881 1.757 
12 0.734 2.131 1.172 0.650 1.173 2.999 
13 0.750 2.093 0.339 0.620 1.641 3.315 
14 0.661 2.457 0.185 1.189 1.655 4.093 
15 0.642 2.651 2.874 1.394 1.063 4.113 
16 0.411 4.299 2.714 1.445 1.000 4.855 
17 0.423 4.068 0.644 1.451 0.700 4.850 
18 0.732 0.674 0.578 0.996 0.767 1.565 
19 0.807 0.745 1.496 0.968 1.035 1.641 
20 0.863 0.544 1.773 1.667 1.107 1.464 
21 0.895 0.533 0.605 1.744 1.093 1.399 
22 0.457 1.147 0.639 0.583 0.940   
23 0.465 1.126 1.111 0.639 0.828   
24 0.309 0.941 1.121 0.902 0.879   
25 0.349 0.936 1.082 0.862 0.778   
26 0.355 1.400 1.147 0.533 0.750   
27 0.332 1.391   0.526 1.068   
28 0.538 0.801   0.769 1.064   
29 0.550 0.792   0.851     
30 0.508           
31 0.587           
32 0.470           
33 0.469           
Average 0.63 1.90 1.26 1.09 1.01 2.70 
Std. Dev 0.19 1.14 0.61 0.38 0.40 1.24 
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Table E.3: p-value between each chordae for the DNA assay results.  A p-value less than 0.05 was 
considered significant.  
  Strut 
Anterior 





Strut - 0 0 0 0 0 
Anterior 
Marginal 0 - 0 0 0.208 0.208 
Commissural 0 0 - 0.279 0 0 
Basal 0 0 0.279 - 0 0 
Posterior 
Intermediate 0 0 0.126 0.378 - 0 
Posterior 
Marginal 0 0.208 0 0 0 - 
 
 
E.2 Collagen Assay Results 
 
The collagen assay results for each chordae are displayed in Table E.4.  The collagen  
content has been normalized by the dry weight.  Table E.5 below shows the collagen 
content for each specimen for each chordae.  The average and standard deviation are 
given at the bottom of the table.  Table E.6 gives the p-value between each chordae.  A p-
value below 0.05 was considered significant. 
 
 
Table E.4: Collagen assay results for each chordae tendineae.  The chordae measured is listed at the 
top of each column of data.  
Strut 
Sample Absorbance Dry Weight, mg Collagen Content, ug/mg 
1 0.5592 9.700 6.068 
2 0.5973 9.700 6.482 
3 1.2258 13.500 9.558 
4 1.2928 13.500 10.080 
5 2.1483 15.500 14.589 
6 2.2978 15.500 15.605 
7 0.184 4.600 4.211 
8 0.1818 4.600 4.160 
9 0.657 10.400 6.650 
10 0.3173 10.400 3.212 
11 0.3071 15.000 2.155 
12 0.2413 15.000 1.693 
13 0.2357 16.000 1.551 
14 0.304 16.000 2.000 
15 0.3031 7.500 4.254 
16 0.1243 7.500 1.745 
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Table E.4 (continued). 
17 0.2767 7.400 3.936 
18 0.2954 7.400 4.202 
19 0.3744 10.500 3.753 
20 0.3891 10.500 3.901 
    
Anterior Marginal 
Sample Absorbance Dry Weight, mg Collagen Content, ug/mg 
1 0.2006 3.7 5.707 
2 0.2054 3.7 5.844 
3 0.1981 2.2 9.478 
4 0.1938 2.2 9.273 
5 0.3173 2 16.700 
6 0.3071 2 16.163 
7 0.2413 2.2 11.545 
8 0.2357 2.2 11.278 
9 0.304 4.7 6.809 
10 0.3031 4.7 6.788 
11 0.1243 1.4 9.346 
12 0.1237 1.4 9.301 
13 0.1789 1.6 11.770 
14 0.1777 1.600 11.691 
15 0.1538 2.500 6.476 
16 0.153 2.500 6.442 
17 0.0973 1.900 5.391 
18 0.1001 1.900 5.546 
19 0.3261 5.300 6.477 
20 0.3417 5.300 6.786 
    
Commissural 
Sample Absorbance Dry Weight, mg Collagen Content, ug/mg 
1 0.1868 4.2 4.682 
2 0.1897 4.2 4.754 
3 0.1316 1.7 8.149 
4 0.1389 1.7 8.601 
5 0.0982 2.4 4.307 
6 0.0977 2.4 4.285 
7 0.1923 1.6 12.651 
8 0.1876 1.6 12.342 
9 0.2479 3.3 7.907 
10 0.2464 3.3 7.860 
11 0.1495 3.4 4.628 
12 0.1522 3.400 4.712 
13 0.0885 2.400 3.882 
14 0.0854 2.400 3.746 
15 0.0861 2.500 3.625 
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Table E.4 (continued). 
Basal 
Sample Absorbance Dry Weight, mg Collagen Content, ug/mg 
1 0.4705 7.9 6.617 
2 0.495 7.9 6.962 
3 0.2375 4.7 5.615 
4 0.2444 4.7 5.778 
5 0.1865 1.2 17.269 
6 0.1817 1.2 16.824 
7 0.2083 2.4 9.644 
8 0.2085 2.4 9.653 
9 0.2231 6.3 3.935 
10 0.237 6.3 4.180 
11 0.355 7.1 5.556 
12 0.3589 7.1 5.617 
13 0.3394 7.8 4.835 
14 0.351 7.8 5.000 
15 0.0896 3.200 3.111 
16 0.0896 3.200 3.111 
17 0.0913 2.800 3.623 
18 0.0892 2.800 3.540 
     
Posterior Intermediate 
Sample Absorbance Dry Weight, mg Collagen Content, ug/mg 
1 0.1898 3.3 6.391 
2 0.1859 3.3 6.259 
3 0.0947 2.4 4.384 
4 0.0954 2.4 4.417 
5 0.0773 2.4 3.579 
6 0.0755 2.4 3.495 
7 0.2547 5.3 5.340 
8 0.266 5.3 5.577 
9 0.1446 3.5 4.590 
10 0.1483 3.5 4.708 
11 0.1009 3.1 3.616 
12 0.1015 3.100 3.638 
13 0.1501 2.800 5.956 
14 0.1502 2.800 5.960 
15 0.2163 1.500 16.022 
16 0.2135 1.500 15.815 
    
Posterior Marginal 
Sample Absorbance Dry Weight, mg Collagen Content, ug/mg 
1 0.1124 0.6 20.815 
2 0.111 0.6 20.556 
3 0.1443 1.9 8.439 
4 0.1474 1.9 8.620 
5 0.1708 2.5 7.591 
6 0.171 2.5 7.600 
7 0.2077 1.9 12.146 
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Table E.4 (continued). 
8 0.2041 1.9 11.936 
9 0.1137 2.7 4.679 
10 0.1128 2.7 4.642 
11 0.234 1.8 14.444 
12 0.2314 1.8 14.284 
13 0.1676 1.1 16.929 
14 0.1616 1.1 16.323 
15 0.156 1 17.333 
16 0.1575 1 17.500 
17 0.255 1.500 18.889 
18 0.2502 1.500 18.533 
19 0.2032 0.800 28.222 
20 0.204 0.800 28.333 
 
 
Table E.5: Collagen content for each chordae tendineae.  The average and standard deviation for 
each chordae is given at the bottom of the table.  
Sample Strut 
Anterior 





1 6.068 5.707 4.682 6.617 6.391 20.815 
2 6.482 5.844 4.754 6.962 6.259 20.556 
3 9.558 9.478 8.149 5.615 4.384 8.439 
4 10.080 9.273 8.601 5.778 4.417 8.620 
5 14.589 16.700 4.307 17.269 3.579 7.591 
6 15.605 16.163 4.285 16.824 3.495 7.600 
7 4.211 11.545 12.651 9.644 5.340 12.146 
8 4.160 11.278 12.342 9.653 5.577 11.936 
9 6.650 6.809 7.907 3.935 4.590 4.679 
10 3.212 6.788 7.860 4.180 4.708 4.642 
11 2.155 9.346 4.628 5.556 3.616 14.444 
12 1.693 9.301 4.712 5.617 3.638 14.284 
13 1.551 11.770 3.882 4.835 5.956 16.929 
14 2.000 11.691 3.746 5.000 5.960 16.323 
15 4.254 6.476 3.625 3.111 16.022 17.333 
16 1.745 6.442 3.634 3.111 15.815 17.500 
17 3.936 5.391   3.623   18.889 
18 4.202 5.546   3.540   18.533 
19 3.753 6.477       28.222 
20 3.901 6.786       28.333 
Average 5.49 8.94 6.24 6.71 6.23 14.89 






Table E.6: p-value between each chordae for the collagen assay results.  A p-value less than 0.05 was 
considered significant. 
  Strut 
Anterior 





Strut - 0.006 0.545 0.368 0.582 0 
Anterior 
Marginal 0.006 - 0.017 0.08 0.033 0.001 
Commissural 0.545 0.017 - 0.708 0.999 0 
Basal 0.368 0.08 0.708 - 0.733 0 
Posterior 
Intermediate 0.582 0.033 0.999 0.733 - 0 
Posterior 
Marginal 0 0.001 0 0 0 - 
 
 
E.3 Elastin Assay Results 
 
The elastin assay results for each chordae are displayed in Table E.7.  The elastin  content 
has been normalized by the dry weight.  Table E.8 below shows the elastin content for 
each specimen for each chordae.  The average and standard deviation are given at the 
bottom of the table.  Table E.9 gives the p-value between each chordae.  A p-value below 
0.05 was considered significant. 
 
Table E.7: Elastin assay results for each chordae tendineae.  The chordae measured is listed at the 
top of each column of data.  
  
Strut 
Sample Absorbance Dry Weight, mg Elastin Content, ug/mg 
1 0.9364 10.6 30.067 
2 1.0137 17.2 20.357 
3 0.8972 18.1 16.728 
4 0.8313 11.2 24.640 
5 0.2173 9.8 2.683 
6 0.259 10.4 4.159 
    
Anterior Marginal 
Sample Absorbance Dry Weight, mg Elastin Content, ug/mg 
1 0.1271 1 -10.385 
2 0.9305 6.5 48.663 
3 0.4278 9.3 12.031 
4 0.7214 3.6 64.245 
5 1.0241 5.4 65.624 
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Table E.7 (continued). 
6 0.5871 3.2 55.209 
7 0.2532 6.1 6.704 
    
Commissural 
Sample Absorbance Dry Weight, mg Elastin Content, ug/mg 
1 1.011 4.3 81.173 
2 0.1829 7 1.758 
3 0.2172 6.1 4.304 
4 0.1893 5.7 2.616 
5 0.206 4.1 5.293 
    
Basal 
Sample Absorbance Dry Weight, mg Elastin Content, ug/mg 
1 0.7634 9.3 26.705 
2 0.589 5 35.488 
3 0.2049 10.9 1.950 
4 0.4927 4.9 28.221 
     
Posterior Intermediate 
Sample Absorbance Dry Weight, mg Elastin Content, ug/mg 
1 1.011 4.3 81.173 
2 0.1829 7 1.758 
3 0.2172 6.1 4.304 
4 0.1893 5.7 2.616 
5 0.206 4.1 5.293 
    
Posterior Marginal 
Sample Absorbance Dry Weight, mg Elastin Content, ug/mg 
1 0.1261 1 -10.791 
2 0.1327 0.9 -9.008 
3 0.9222 2.6 120.360 








Table E.8: Elastin content for each chordae tendineae.  The average and standard deviation for each 
chordae is given at the bottom of the table. 
Sample Strut 
Anterior 





1 30.067 -10.385 43.780 26.705 81.173 -10.791 
2 20.357 48.663 133.827 35.488 1.758 -9.008 
3 16.728 12.031 24.875 1.950 4.304 120.360 
4 24.640 64.245 87.347 28.221 2.616 10.808 
5 2.683 65.624 8.515   5.293   
6 4.159 55.209 -9.698       
7   6.704         
Average 16.44 34.58 48.11 23.09 19.03 27.84 
Std. Dev 11.03 31.02 53.58 14.61 34.77 62.45 
 
 
Table E.9: p-value between each chordae for the elastin assay results.  A p-value less than 0.05 was 
considered significant. 
  Strut 
Anterior 





Strut - 0.203 0.187 0.433 0.866 0.664 
Anterior 
Marginal 0.203 - 0.581 0.509 0.434 0.813 
Commissural 0.187 0.581 - 0.397 0.325 0.597 
Basal 0.433 0.509 0.397 - 0.835 0.887 
Posterior 
Intermediate 0.866 0.434 0.325 0.835 - 0.795 
Posterior 
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